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SUMMARY
Non-aqueous size exclusion chrom atography was used to determine 
M ark-Houwink constants and to characterize the molecular weight 
distribution of PHB. The SEC column was calibrated using an universal 
method and an iterative algorithm enabled the M ark-Houwink constants 
for PHB to be determined from polydisperse samples of polymer. The 
SEC assay was used to study the catalytic degradation of PHB in non- 
aqueous solution and the degradation of PHB films in the presence of 
aqueous solutions. Random chain scission of PHB occured in non-aqueous 
solution. Degradation of PHB and P(HB/HV) films in the presence of 
w ater occured by surface hydrolysis w ith no change in molecular weight 
or crystallin ity  of the bulk film. The rate of surface hydrolysis was 
influenced by pH, tem perature and copolymer composition. Hydroxyl 
ions catalysed the degradation of all polym ers studied.
Release of m ethyl red from cast films was characterised according to 
the theory of release by diffusion from  matrices. Surface erosion of 
polymers played a minor part in influencing release of m ethyl red from 
polymer films. Release rate was influenced by loading of m ethyl red and 




POLYMERIC MATERIALS AND DRUG DELIVERY
1.1 In tro d u c tio n .
Polymeric m aterials have been used for many years in the 
form ulation of medicines as suspending and em ulsifying agents, 
flocculating agents, adhesives, packaging and coating m aterials. Many 
traditional m aterials have been of natu ra l origin or have been semi­
synthetic  derivatives of natural products, such as cellulose derivatives. 
However, the availability  of synthetic polym ers and a desire to improve 
the control of drug release from  medicines have led to a rapid expansion 
in the use of polym ers in pharm acy. In early developments, drugs were 
coated w ith slowly dissolving barrier m aterials (such as shellac) 
perm itting form ulation as unit dosage form s w ith prolonged activity 
(H aw kins and Thompson, 1953). However, the release of drug from  such 
system s was neither precisely nor completely controlled. For example, 
the rate of dissolution of the coating m aterial varied according to the pH 
of gastrointestinal tract (Levy and Hollister, 1965). Various term s were 
used to describe the release of drugs from this generation of delayed 
release preparations, such as sustained release, prolonged action and 
repeat-action.
De Haan and Lerk (1984) have defined each products as follows:
• A prolonged ac tio n  product provides a slow release of a drug 
at a rate sufficient to cause a therapeutic response over a period 
of time, measurable increased in length when compared to the 
usual single dose.
2•  A susta ined  release dosage form provides an am ount of drug 
initially  made available to the body to cause the desired 
therapeutic response, followed by a constant release of 
medication for maintenance of activity  over a period of time.
• A rep ea t-ac tio n  product is considered to provide a dose 
which is released im m ediately upon adm inistration and a 
second dose which is released some time after adm inistration. 
A rep ea t-ac tio n  product is considered to have no therapeutic 
advantage over individually adm inistered single doses since the 
drug profile of concentration in the blood against tim e is 
sim ilar to those produced after repeated adm inistration of 
conventional dosage form s (Figure l . l ) .
Since these first generation system s for drug optimization 
were significantly influenced by the physiology and local mileau of the 
gastro intestinal tract, a second generation of products, often called 
co n tro lled  release system s have been developed. C on tro lled  release 
sy stem s have been defined as those which result in the delivery of an 
active agent from a device to a target site at a rate and for a duration that 
are controlled by the device itself (M ills and Davis, 1987). Such 
device-controlled delivery may offer several im portant advantages over 
conventional therapy. These advantages are rapidly becoming w idely 
appreciated and accepted. They include:-
• maintenance of optim al drug concentrations in body tissues, 
resulting in greater efficacy of treatm ent.
•  avoidance of peaks and troughs in drug concentration resulting 
in fewer side-effects and enhanced safety.
• ability to adm inister drugs w ith narrow  therapeutic indices or
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Figure 1.1:- Theoretical drug profiles in biological 
fluids assuming first order linear 
pharmacokinetics and assuming a linear 
correlation between drug concentration 
biological response, after extravascular 
administration of four types of drug 
delivery systems. IV administration is 
shown for comparison 1 - intravenous 
administration; 2 - conventional 
extravascular administration; 3 - delayed 
release form; 4 - sustained release 
dosage form; 5 - idealized controlled 
release dosage form.
(Reproduced from Rubinstein and 
Robinson , 1987).
4short biological half-lives.
•  greater patient convenience and compliance resulting from the 
use of few er adm inistrations per unit time.
The above considerations have m otivated both academic and 
industrial scientists to study a wide variety of co n tro lled  release 
d e liv e ry  sy stem s. These take the form of transderm al system s and 
im plants as well as system s for oral adm inistration. However the term 
co n tro lled  d e liv e ry  should be used with caution. Thus far there are 
few examples of delivery system s which allow modification of release 
rate in vivo , that is a fter the product has been adm inistered. In the 
fu tu re , one expects a th ird  generation of devices to develop w ith this 
extra dimension of control to provide a higher quality  of drug therapy 
which will perm it adjustm ent of dosage rate in response to the course of 
disease.
The development of drug delivery system s has depended on an 
understanding of diffusion in polymeric m aterials. This is considered in 
section 1.2. A brief review of the variety of different delivery systems 
(section 1.3) is followed by a sum m ary of the scope of the present study 
(section 1.4).
1.2 D iffusion through polym eric m aterials.
Diffusion can be defined as the tendency for particles to move 
spontaneously from  a region of higher concentration to a region of lower 
concentration un til equilibrium  occurs. The mechanism of release from 
controlled delivery system s often involves diffusion across polymeric 
membranes. T ransport of drugs through m embranes occurs by a process 
in which the solute first dissolves in the m em brane and then diffuses 
through the m em brane in a direction tow ards the lower solute
5concentration. The diffusion process is described by an expression known 
as Fick’s first law which states that the rate of diffusion across a plane 
perpendicular to the direction of diffusion is proportional to the 
concentration gradient across the plane (Crank, 1975). M athem atically 
Fick’s first law is given by equation 1.1
d Q    ( 1 .1 )d t dx
where
Q is the mass of m aterial diffusing, 
t is the unit time.
Thus dQ /d t represents the rate of mass transfer and dc/dx represents the 
change in concentration per unit distance.
Using D as the proportionality constant, Fick’s first law  can be 
w ritten  as
-^2- = - d |H .   (1.2)d t dx
where D is defined as the diffusion coefficient (or diffusivity). The 
negative value of D indicates that diffusion occurs in a direction opposite 
to that of increasing concentration. Equation 1.2 implies unit area flux, 
that is dQ /dt m ust be divided by the surface area, A as follows:
^  =  - D A ^ -  ..... (1.3)d t dx
When diffusion across a polym er membrane is of interest,
dc _  AC 
dx 1
c r- c d
1
Thus
^ 2 . = d  ad t
6where and Cj^ represent concentration of the drug on the receptor side
and donor side of the membrane respectively.
Chien (1980) observed that the release rates of various steroids 
from silicone capsules were slower in vitro  than they were in 
vzvo.These results were attributed  to the lack of sink conditions in vitro  
dem onstrating the importance of their maintenance during in v itro/in  
vivo correlation experiments. Sink conditions are met by setting the 
concentration of drug in the bulk solution (receptor phase) very  close to 
zero. When this condition is met, equation 1.3 can be approxim ated to
d Q = D A C  ( }
d t 1 ..... U '
where C is the concentration of drug in the membrane at the donor surface.
When the concentration of drug on the donor side is m aintained by 
a suspension of drug, as in m any reservoir devices, then a saturated solution 
of drug will be present on the donor side of the membrane and C can be 
taken to the solubility of drug in the polym er membrane. W hen C is a 
constant, integration of equation 1.4 gives equation 1.5
D  A  C p  ,  NQ =  J— £-t ..... (1.5)
where is the solubility of the drug in the membrane. In the special case
represented by Equation 1.5, maintenance of the term s on the right hand 
side of the equation w ill generate a constant rate of drug release, that is 
dQ /dt = K, which is the aim of m any reservoir-controlled delivery systems. 
By reference to equation 1.4, it can be seen that the rate of diffusion through 
a polymer membrane is governed by tw o factors: the diffusion coefficient (or 
dififusivity) of the drug and its solubility in the polymer, both of which 
will be influenced by the chem istry of the polym er and the drug. Smith 
and Lonsdale (1985) in their review  have highlighted
7factors that affected the diffusion coefficient:- the solute molecular 
weight, the glass transition tem perature of the polym er and the 
crysta llin ity  of the polymer. Figure 1.2 shows the empirical correlation 
between diffusion coefficient and solute molecular weight reported by the 
previous authors. Increase in solute molecular weight results in a lower 
diffusion coefficient.
The flexibility of the polym er also determ ines the diffusion 
coefficient. As indicated in Figure 1.2, polystyrene in the glassy state at 
25°C was associated w ith the lowest diffusivities and greatest dependence 
on solute molecular weight. Two other polystyrenes, which were in a 
rubbery state, were associated w ith  high diffusivities and less dependence 
on solute molecular weight. Sm ith and Lonsdale (1985) explain that 
rubbery polymers exhibit much greater chain flexibility than do glassy 
polym ers and therefore perm it higher diffusivities especially for large 
solute molecules. Diffusion of solutes in low molecular weight liquids, 
such as water, is very much more rapid than diffusion in polym ers as 
indicated by Figure 1.2.
Polymer crystallin ity  also influences solute diffusivity. C rystalline 
or sem i-crystalline bulk polym ers contain crystallites which consists of 
regions of ordered, tight chain packing. Solute molecules cannot usually 
penetrate polymer crystallites (i.e. they have very low solubility in 
crystallites) and are therefore confined to diffuse in the amorphous 
regions between crystallites. C rysta llin ity  thus reduces diffusivity in 
bulk  polymers by causing diffusion to take place by way of irregular, 
to rtuous pathways. This effect is demonstrated in Figure 1.2 . Solutes 
have a higher diffusivity in low density polyethylene, which is 50% 
crystalline, than they do in high density polyethylene, which is 





















Figure 1.2:- Dependence of diffusion coefficient 
on solute molecular weight in water,
( #); low-density polyethylene (LDPE), 
( ▲ ); high-density polyethylene (HDPE) 
( □ ) and polystyrene, ( O). Data at 
25 °C.
(Reproduced from Smith and Lonsdale, 
1985).
9An experimental study on diffusion from  an aqueous solution 
through a polym er film has been reported by Pitt et at. (1979). In their 
diffusional study of poly ( e - caprolactone), poly ( d l- lactate ) and their 
copolym er films, the steady state diffusion coefficient was obtained by 
considering the presence of an aqueous boundary layer at the surface of 
the polym er film . The concentration of a drug in the polym er was taken 
as the product of the partition coefficient, K, and the aqueous solubility  of 
the drug in the aqueous boundary layer. Thus the boundary layer may 
well play a significant part in the overall rate of mass transfer.
In some circumstances, drug is encapsulated w ithin the bulk 
polym er itself which leads to a different mode of delivery. Devices of 
this type are usually  referred to as m atrix system s. Drug release from 
m atrix  system s is highly dependent on the efficiency of entrapm ent of 
the drug and the perm eability of the polymer system  to the surrounding 
medium. Release from  reservoir system s and m atrix devices are 
discussed separately in sections 1.3.1 and 1.3.2.
1.3 Drug delivery  devices and m echanism s o f  drug release.
1.3.1. Reservoir system s.
Reservoir system s consist of a reservoir of an active ingredient 
enclosed by a polym eric membrane. Drug release is controlled by 
diffusion through the polymeric membrane and w ill be constant at steady 
state as predicted by Equation 1.5.
In practice, reservoir system s will not deliver drugs at a constant 
rate initially  or tow ards the end of their working life due to tw o non­
steady state conditions. During the initial period, the release rate can 
either be higher or lower than steady state release rate depending on the 
storage history of the device. For example, if the membrane device is 
stored for a long period of time, under conditions during which release
docs not occur, then the membrane will become saturated w ith the 
drug and the initia] release rate will be higher than the steady state 
release. This is often referred to as the burst effect (H adgraft and Guy, 
1987). If the device is used imm ediately a fte r m anufacture, there may 
be a slow release until the steady state is achieved after a lag time. If 
the drug concentration in the reservoir falls below saturation tow ards the 
end of its life, then, as drug release continues, the driving force for 
diffusion through the membrane decreases and the release rate decreases 
w ith tim e (Sm ith and Lonsdale, 1985).
Examples of commercially produced reservoir system s are 
Progcstasert® and Ocusert® . Progestasert® was a uterine contraceptive 
system which was capable of delivering progesterone to the uterus for a 
duration of one year (Brenner et al. , 1975). The system consisted of a 
drug reservoir of progesterone in silicone oil together w ith barium  
sulphate being enclosed by ethylene/v inyl acetate copolymer membrane. 
Drug release from  th is device was reproducible bu t the device is no 
longer used due to problems associated w ith its presence in the uterus. 
The Ocusert® therapeutic system delivers pilocarpine to the eye for the 
treatm ent of glaucoma. The drug delivery device consists of an 
ethylene/v inyl acetate copolymer barrier membrane which encloses the 
drug dispersed in an alginic acid vehicle.
Heilman (1984) showed that the in vivo release rate of progesterone 
from  Progestasert® was not constant but decreased w ith time. The 
release rate  decreased by about 25% from its predicted rate over the 
course of a year. This decrease was due to a decrease in the volume of 
reservoir solution and the consequent decrease in membrane surface area 
contacted.
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Chandrasekaran et al. (1978) showed lhat in vitro  release rate 
of progesterone from  the Progestasert® device was higher than the in 
vivo release rate. This was explained by the presence of a boundary - 
layer (hydrodynam ic layer) around the device in vivo which was caused 
by an insufficient rate  of drug removal from the membrane surface.
Since Equation 1.5 does not take into consideration the contribution 
of the hydrodynam ic layer tow ards diffusion, Chien (1980) pu t fo rw ard  
a modified equation for diffusion which is shown below
CpKDsDd 
Q =  KDshp+D phd 1 ..... ° ’6)
w here
Q is the cum ulative am ount of drug released from  a un it 
surface area of a capsule type delivery device
C is the solubility  of drug in the polymeric membrane
K is the partition coefficient of drug between polymeric device 
and surrounding tissues fluid
Dg is the diffusion coefficient of drug in the surrounding tissues
Dp is the diffusion coefficient of drug in the polymeric 
m em brane
hp is the thickness of the polymeric membrane
h^ is the thickness of the hydrodynam ic diffusion layer 
When KDghp is very much higher than Dph^ , then Equation 1.6 is 
reduced to Equation 1.5 and the release of drug is controlled only by the 
m em brane.
1.3.2 M atrix  system s
Generally, the term  m atrix  is used to describe drug delivery
system s in which the drug is dispersed, either m olecularly or as 
solid drug particles, w ithin a polym er netw ork. The major 
advantages of m atrix  devices are the ease of m anufacture and the fact 
that drug cannot be released rapidly by mechanical damage. Rapid 
release or dumping of the contents can be a serious problem upon rup ture  
of a reservoir device. An example of a m atrix drug delivery 
system  is the transderm al Scopodcrm® TTS which delivers 
scopolamine to trea t kinetosis or motion sickness. Scopoderm® TTS is 
applied on the skin and provides 72 hour protection against dizziness, 
nausea and vom itting.
When a drug is trapped in a polym er which is impermeable to the 
surrounding medium the encapsulated drug particles cannot be released 
until they undergo the following process (Chien, 1980). The outerm ost 
surface layer of the drug m ust dissociate from  the crystal lattice, 
dissolve into the surrounding polym er structure, diffuse through it and 
finally partition into the elution medium surrounding the delivery device. 
Following his studies on the release of various steroids from  silicone 
polym ers, Chien (1980) found that the rate lim iting step was the 
solvation of drug and that this process was very dependent on the 
chemical structure  of the steroid.
However, release of drug from  m atrix system s does not alw ays 
occur by diffusion of the drug through the polym er. When the loading 
of drug is high, penetration of w ater can often take place by gradual 
dissolution of adjacent crystals of w ater-soluble drug (Siegel and Langer, 
1984; Hsu and Langer, 1985), the rate of release is determined by 
diffusion through aqueous pores form ed in the polym er m atrix. This 
is the basis of sustained release from  m any dosage form s for oral 
delivery which are compacts of drug and polym er prepared by
1 3
tab letting . Such m atrices usually  contain more drug than polym er and 
drug release is designed to be comparatively rapid (less than 24 hours) 
(K orsatko et al., 1983).
System s for im plantation are designed to release their drug content 
over a longer tim e period and usually contain a lower loading of drug. 
Release m ay be by aqueous pore diffusion or by diffusion through the 
polym er. The nature of the entrapm ent and loading of drug will affect 
crucially  the mechanism of release. The cum ulative release of drugs 
from  m atrix  system s can often be represented by Higuchi’s w ell-know n 
equation (Higuchi, 1961).
Q =[( 2 A -C p ) Cp Dp t P  ..... (1.7)
where
Q is the cum ulative mass of drug released from a plane of un it 
area containing a homogenous dispersion of drug.
A is the initial am ount of drug incorporated in a un it volume 
of the m atrix  device
Cp is the solubility  of drug in the polymer phase
Dp is the diffusivity  of drug in the polymer m atrix  structure.
Equation 1.7 was derived for a m atrix with the geometry of a slab or 
film using the following assum ptions. A region of depleted drug 
gradually  form s at the surface and begins to penetrate the m atrix. The 
rate of diffusion per unit area throughout this depleted region is 
independent of position. Equation 1.7 implies that the rate of drug 
release is dependent on the square root of time. In a subsequent paper, 
Higuchi (1963) considered the release of drug from spherical matrices. 
He found that the release of drug from  these systems was also given by 
Equation 1.7 provided that the initial drug loading, A, was very much 
higher than the solubility of the drug in the
1 4
polym er (i.e. A >  >  Cp ).
However, Brophy and Deasy (1987) observed that Higuchi’s equation 
can only be used for drug release over a short duration. These authors 
modified Higuchi’s equation by considering the extension of the depleted 
drug zone for a m icroparticulate system . Their modified equation is 
shown below
Q—Bj t I/2- B 2 t ..... (1.8)
where
B| = [ ( 2 A - Cp ) Cp Dp t Y 2 as in equation 1.7
B2 = 4 /9  c C  D (3 A  - 2Cp ) ( 2A - Cp )_1
where c = 24 X the original length of a cube.
Brophy and Deasy (1987) used their model to study the release 
of sulphamethiazole from poly( /3-hydroxybutyrate) microparticles. 
They observed that equation 1.8 modelled experimental results more 
completely than Higuchi’s original equation. These authors recommend 
that Equation 1.8 can be used to represent drug release from matrices of 
any geometrical shape.
1.3.3 Degradable system s
There is much interest in the use of degradable polym ers as the 
bases for im plant devices largely because surgical removal of the device 
would not be required if the polym er were degraded and eliminated from  
the body. The release of drugs from matrices based on degradable 
polymers can be complicated by the degradation of the polym er (W ise 
et al. , 1979); indeed there is the possibility that the polym er degradation 
itself could be used to control drug delivery. Several polyesters are
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already used as surgical sutures (Gilding, 1980) and recently many authors 
have suggested that these polymers could be used in sustained delivery of 
polypeptides (W ise et al. , 1987; Hutchinson and Furr, 1987). One such 
product, Zoladex® , entered the British m arket in 1987 (Pharmaceutical 
Journal, 1987). However the mechanisms controlling drug release from  such 
system s are not well known and this is a major consideration of the 
cu rren t study (Part III). Hence the use of biodegradable system s is 
reviewed in detail in Chapter 5 of this thesis.
1.3.4. Particulate system s.
C urrent research trends in drug delivery involve the use of microparticles 
fo r delivery of drugs directly  to their site of action. Particulate system s 
can be injected locally, for instance into joints for the treatm ent of 
a rth ritis  (Ratcliffe et al. , 1984), or can be directed to certain organs after 
intravenous injection. The la tter organ-specific delivery has been termed 
passive  ta rg e tt in g  (Tomlinson et al. 1984). Particulate system s themselves 
are varied in their design and m anufacture and may release their content as 
a reservoir, as in the case of microencapsulated systems, or more commonly 
as matrices. Another advantage of particulate polymeric system s is that they 
can protect a labile drug, such as a polypeptide, from enzymatic degradation. 
Thus biodegradable particulate system s have great potential for controlled 
delivery of peptides (W heatley and Langer, 1987). The advantage of a colloidal 
suspension is clear in tha t an injectable system could be form ulated for 
in tram uscular or subcutaneous use. This would obviate the need for a surgical 
im plantation procedure. Particulate system s are best produced by emulsion 
polym erisation which leads to controlled size although this technique can only 
be used for certain polymers, such as acrylates (Douglas et al. , 1987; Louvreur 
et al. , 1986).
Most degradable particulate system s have been produced by solvent 
evaporation techniques (Bissery et al. ,1984) which are convenient on a 
laboratory scale but could not be used commercially. No commercial 
techniques are curren tly  in use although spray drying of polymer 
solutions has potential (Deasy, 1984). A fu ll review of the use of 
particulate system s is beyond the scope of this report although it is 
interesting to note that biodegradable polyesters increasingly are being 
used as particulate system s (Juni and Nakano, 1987b) and recently poly( 
j3-hydroxybutyrate) (PHB) has been prepared as a particulate system 
(Brophy and Deasy 1986, 1987; Bissery et al., 1984).
The size of the m icroparticles is im portant in determining 
their distribution a fte r intravenous injection. This has been 
demonstrated by m any authors w ith  a variety of colloidal systems 
(W illm ott et al. , 1984 ; Sjoholm and Edman, 1984; Couvreur et al. , 
1986). Bissery et al. (1984) have injected m icroparticles of PHB of 
less than 15 fim  intravenously. These particles were distributed to 
the fixed macrophages of the lung, liver and spleen in a sim ilar manner 
to other particulate system s (A rtursson, 1987). Thus PHB particles 
could be used for delivery of antiparasitic or macrophage stim ulants to 
the reticulo-endothelial system .
1.3.5. Other polym eric drug d e livery  system s
As well as im plant and oral drug delivery system s previously 
described in sections 1.3.1 and 1.3.2, in term s of their reservoir or m atrix 
design, there are other specialised delivery system s in which polymers 
have a vital role to play. These delivery systems will be reviewed briefly 
in this section.
An im portant class of controlled delivery system s have used osmotic
pressure to facilitate zero order release. These are generally referred to as 
osmotic pum ps (EckenhofT and Yum, 1981; Fara, 1985). Osmotic pum ps 
are used as im plants for toxicological testing in anim als and have been 
m anufactured as tablets for oral adm inistration. An elem entary osmotic 
tablet consists of a core reservoir of drug and in most cases, an additional 
excipient to assist in creating osmotic pressure. The core is coated w ith a 
semipermeable membrane, permeable to w ater but not the drug, which is 
continuous but for a single hole drilled into the mem brane using a laser.
The release of drug occurs as follows. Osmotic activ ity  ensures 
that w ater from  the gastrointestinal tract penetrates the system  
through the semipermeable membrane. The influx of w ater is constant 
and its rate is determ ined by the large mass of drug which m aintains a 
saturated solution w ithin the core. The influx of w ater forces the 
saturated solution out through the laser-drilled orifice at a constant rate. 
The uptake of w ater and thus the release of drug in a saturated solution 
rem ains constant as long as there is an excess of undissolved substance 
in the reservoir. When no more solid drug rem ains and the saturated 
drug solution becomes diluted by the continued influx of w ater, the rate 
of release steadily declines in a manner sim ilar to that of a first order 
release.
The first commercial product of this type contained indomethacin 
for treating autoim m une diseases. However, due to the incidence of 
localised irritation  to the mucosal surface which led to peptic 
ulceration and bleeding, the product was w ithdraw n (Heilmann, 
1984). This was a major setback to the use of osmotic pum ps 
although recently a salbutam ol form ulation of this type has been 
introduced (Pharmaceutical Journal, 1988).
Another delivery system in which polym ers determ ine the rate of 
release is the transderm al therapeutic system s. A transderm al 
therapeutic system has the appearance of a plaster patch. Such system s 
deliver drugs at a controlled rate to the surface of the skin. As long as 
the drug is absorbed to a great enough extent through the skin, these 
system s can be used to deliver drugs at a zero-order rate to the systemic 
circulation (Shaw, 1985). The benefits of transderm al therapeutic 
system s can be summarized as follow:
•  improved patient compliance especially in cases which would 
require relatively frequent oral adm inistration.
•  Avoidance of hepatic-first-pass metabolism.
•  constant level of drug in biological fluids achieved at steady- 
state.
The main disadvantage of this type of drug delivery system is the 
significant barrier presented by the stratum  corneum, the outerm ost layer 
of skin, which lim its the num ber of drugs which can be adm inistered by 
the route (Hadgraft, 1985).
There has been considerable interest in recent years in targetting
of drugs by way of soluble polymeric carriers to which drugs are
covalently linked. M acromolecular drug-carrier system s are able to
m odify the pharmacokinetic d istribution of drugs such tha t the effects 
of drugs at a desired site of action are enhanced relative to their 
unw anted effects (Kopecek and Duncan, 1987). Detail examples of
carriers to which drugs have been bound and their crosslinking agents 
were reviewed by Poznansky and Cleland (1980). These applications 
of polymers in drug delivery are likely to be of great importance in the 
fu tu re  but are outside the scope of the current project.
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1.4 Origins and scope o f  th is study
Poly(/3-hydroxybutyrate) is an optically active aliphatic polyester 
produced by a wide variety of bacteria (Dawes and Senior, 1973). Its 
biological function in these microorganisms is to serve as an energy and 
carbon storage product in much the same way as glycogen in m ammalian 
tissue and starch in plants.
Recently this therm oplastic biopolymer has attracted industrial 
a ttention as a possible candidate for large scale biotechnological 
production since PHB has a high tensile strength, comparable to that of 
isotactic polypropylene and is said to degrade to a normal metabolite of 
the hum an body, d-/3-hydroxybutyric acid (Holmes, 1985; Ratledge, 
1986; Technical Insights, 1985). The polymer can be obtained in the pure 
state  unlike other synthetically produced polymers which may contained 
catalyst or initiator residues.
Since PHB is related to a group of other biodegradable polyesters 
already in use, such as poly(lactate) and poly(glycolate), PHB has great 
potential for use in drug delivery systems. The present study aimed to 
examine the mode of in vitro hydrolytic  degradation of PHB. Techniques 
have been used to allow distinction between tw o possible degradation 
mechanisms; random chain scission and surface hydrolysis. Central to 
the success of the project was the need to determ ine polym er molecular 
weight distribution on a routine basis. A size exclusion chromatographic 
m ethod has been studied with this aim in mind. Developmental studies 
of th is technique are reported in Part II of this thesis.
Copolymers of j3-hydroxbutyrate w ith /3-hydroxyvalerate are also 
available which may have advantages over the homopolymer. Thus 
degradation of various copolymers has been studied as a comparison w ith 
the homopolymer.
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A third  objective of this project has been to study the suitability  of 
these polym ers for controlling the release of drugs. Several workers have 
reported the use of PHB in sustained release systems. (Juni, et al., 1986; 
Korsatko et al., 1983; Gould et al., 1987; Brophy and Deasy, 1986). The 
release of drug is expected to be a complex function of the morphology of 
the m atrix and the physical properties of the drug. The scope of this 
study is lim ited in this respect. Studies have focused on a low molecular 
model compound, m ethyl red, which is soluble in the same solvents as 
the polym ers themselves, making casting of films a simple process. The 
aim of the release studies reported here has been to establish the role of 
polym er degradation in release of low molecular weight drugs.
PARTII




ASSAY OF POLYMER MOLECULAR WEIGHT DISTRIBUTION: 
AN INTRODUCTION
2.1 Introduction
Synthetic polymers and many naturally  occuring macromolecules 
possess a range of molecular weights. It is therefore im portant to 
characterize both average molecular weights and the molecular weight 
distributions of polymers since they affect the physical properties of the 
polymers. For example, the strength and toughness of polyethylene film 
increases w ith an increase in the num ber-average molecular weight 
(Billmeyer, 1962). Also, the molecular weight of a polym er affects the 
release of drugs from polymeric drug delivery systems. The release of 
bovine serum album in from  different molecular weights of a copolymer, 
ethylene vinyl acetate (Evac), was studied by Hsu and Langer (1985). 
These authors found that molecular weight was a sensitive factor which 
affected the kinetics of drug release; the higher the molecular weight of 
the polymer carrier, the slower was the release of bovine serum album in.
Commonly three param eters are used to characterize a polym er that
is:
•  Number-average molecular weight,
•  Weight-average molecular weight,
•  Degree of polydispersity, Mw/M n
The number-average molecular weight, , is defined as the mass of the 
sample in grams divided by the total num ber of molecules present. 
M athematically, it can be represented as shown below:
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where
W. , M- and Nh are the total weight molecular weight and 
num ber of molecules respectively w ith molecular weight i.
i represents the incrementing index which covers the entire 
m olecular weight distribution.
Experim entally, Mn is obtained by m easurement of colligative 
properties.
The weight-average molecular weight, M w is defined according to 
the equation shown below:
_  I N M 2 _  
w ZN,m,   (2'2)
From the two equations above, Mw is alw ays larger than Mn except
when these values are identical in the case of a monodisperse system.
Thus the ratio of Mw/M n is a measure of the breadth of the polym er
m olecular weight distribution being equal to unity  for a monodisperse
system.
2.2 Absolute m olecular w eight methods: Types, Advantages and 
L im itations.
Practical methods to determine the molecular weight of polymers 
may be either relative or absolute. Relative methods require calibration 
w ith samples of known molecular weights; these include viscometry and 
vapour-phase osmometry. Absolute methods are classified according to 
the type of average molecular weight obtained. For instance, absolute 
colligative techniques yield num ber-average, whereas, light scattering
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and ultracentrifuge techniques yield weight-average (Cowie, 1973).
Determination of num ber-average molecular weight, Mn , involves 
use of end-group assay, therm odynam ic or transport methods. The 
disadvantage of using these methods is that they are not sensitive to 
high molecular weight polymers. Such polymers can be 
characterised using the weight-average molecular weight methods. One 
of the requirem ents of Mw m ethods is that the polymer m ust be 
dissolved in a highly clarified solution. Therefore, these techniques are 
difficult and in addition, the light scattering methods of obtaining M w is 
time consuming. W ith the practical lim itations of absolute methods in 
mind, in this study, size exclusion chromatography was used to 
analyse the molecular weight distributions of polymers. The method 
requires small am ounts of m aterial for analysis and the results can be 
obtained w ithin 15-20 minutes.
2.3 Size-Exclusion Chrom atography.
2.3.1 Introduction.
Size-exclusion chrom atography, or gel-permeation chromatography, 
is a technique that separates molecules according to their hydrodynam ic 
radii in solution. The principal uses of the method have been for the 
characterization of the molecular weight distribution (MW D) of 
polymers and also in the analysis of oligomers and low molecular weight 
compounds (Cooper, 1982).
The origin of size-exclusion chrom atography (SEC) is a ttribu ted  to 
Porath and Flodin (1959) who analysed w ater soluble polymers using 
soft, cross-linked dextran gels. Modern high performance SEC has 
resulted from the development of sm all, more rigid, porous particles for 
column packings. The advance together w ith the introduction of high
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quality  instrum entation have reduced the time required for analysis.
2.3.2. Solute R eten tion  in SEC.
In size-exclusion chrom atography, polymeric solutes are partially  
excluded from the column packing and elute ahead of small molecules. 
As a solute band moves along w ith the solvent down the column and 
around the packing particles, the solute molecules continously diffuse in 
and out of the pores of the packing particles.
Size separation in SEC can be explained on the steric basis that large
molecules can only partially  permeate the pore volume of the column
m aterial. According to Yau et al. (1979), small molecules (such as the
eluant) fu lly  permeate the pores of the support/packing m aterial and are
eluted in a volume Vm , equivalent to the total volume of eluant on the
column. Larger molecules which cannot enter any of the pores are
to tally  excluded and are eluted in the extra particle volume or void
volume, V . Molecules of interm ediate size are eluted between and ’ o o
Vm . The degree of permeation of such interm ediate molecules into the
pore volume of the particles, is denoted by Ksec and is termed as the
exclusion coefficient. K is related to the elution volume, V of anysec r J
solute by an equation as shown below:
Vr= V 0+K secV ......  (2.3)
The pore volume is related to Vm and VQ by the equation as shown
below:
Vm= V 0+ V p   (2.4)
The general relationship of the retention volume to solute
molecular weight for each packing m aterial is usually displayed as a
plot of the logarithm of the molecular weight (M W ) against the
retention volume V and is called an exclusion cu rve  or SECr
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c a lib ra tio n  curve. An example is shown in Figure 2.1. Various theories 
of separation by SEC have been proposed (see below). In practice, 
when the solutes are well dissolved in the eluant, separation is a 
function of hydrodynam ic radius and various calibration methods can be 
employed (see section 2.4.).
2.3.3. M echanism  o f SEC sep ara tio n  •
The mechanism of SEC separation has been modelled by tw o major 
theories (Cooper, 1982) namely:
•  Equilibrium model (see 2.3.3.1)
•  Steric exclusion model (see 2.3.3.2)
The equilibrium  model explains the separation of solute molecules based 
on therm odynam ic principles while the steric exclusion model explains 
the separation in term s of diam eters of the solute molecules and the 
pore structures. Besides the tw o generally accepted theories of 
separation in SEC, other mechanisms have been put fo rw ard  to explain 
SEC separation. These mechanisms failed to model the observed 
separation totally and were specific to certain processes only. I refer to 
the restricted diffusion mechanism (A ckers,!964) , separation by flow 
(DiMarzio and Guttm ann, 1969) and the stochastic mechanism 
(Carmichael, 1968).
2.3.3.1 E qu ilib rium  m odel.
Separation in SEC involves the migration of solute molecules between 
the moving and stationary phases. This process will continue until a 
therm odynam ic equilibrium  is achieved. The therm odynam ic 
equilibrium  of solute distribution is defined as the condition in which the 
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Figure 2.1 : A hypothetical SEC calibration curve
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phases.
For dilute solutions at equilibrium , solute distribution can be related 
to the standard free energy change ( AG° ) between the phases at constant 
tem perature and pressure:
AG°=—R T ln k    (2.5)
A G °= A H °-T A S ° ..... (2.6)
where
k is the solute distribution coefficient,
R is the gas constant 
T is the absolute tem perature.
AH° and AS0 are the standard enthalpy change and standard 
entropy change between the phases respectively.
Since SEC is governed mainly by the entropy change between the 
phases, K.gec can be derived as follow: (Dawkins, 1976).
AS0
Ksec= e  R ..... (2.7)
The equation above implies that there is no enthalpy change occuring in 
SEC and that the process is independent of tem perature. In reality 
tem perature changes have an effect on the hydrodynam ic radii of 
polymeric solute molecules which in tu rn  affect the value of AS° . (Mori, 
1984).
2.3.3.2. Steric Exclusion Models.
The steric exclusion model explains quantitatively  the exclusion
coefficient, K , and the SEC calibration as a function of the size and the ’ sec
shape of the solute and the pores. There are various models representing 
the form s and structures of solute molecules and also the conformations
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of the pore structures which can be used to explain the separation process 
in SEC.
Giddings el al. (1968) have obtained a theoretical relationship 
between the partition coefficient, K , and param eters which characterise 
the solute and the stationary phase, assuming a uniform  pore size and 
shape and a rigid solute molecule. Their statistical theory which showed 
the dependence of K on the physical properties of solute molecules 
and the stationary phase was developed for solutes of spherical (example: 
serum  album in) to thin rod shape (example: DNA) and for pores which 
range in cross-sectional shape from  circles to infinite slabs. An example 
of their theory, in this case modelling the separation of a spherical 
molecule by a circular pore, is shown in Figure 2.2:
The solute molecule has a radius of r  and the pore is an infinite 
cylinder of radius R. Since the centre of the mass of the molecule cannot 
approach closer than a distance r  from  the wall of the pore, the part of 
the pore volume accessible to the centre of the mass is a cylinder of 
radius (R-r). Thus, the exclusion coefficient, K , is equal to theoCv




R~ <  1 (2 .8)
Ksec“  0 for
r
~R <  1 (2.9)
For a column w ith m any pores the exclusion coefficient is equivalent 
to the ratio of the volume of pores accessible to the centre of the mass 
of the molecules ( ) to the total volume of the pore ( Vp ) that is:
V.
K =^sec y (2 .10)
3 0
R -r
(a) END VIEW (b) SIDE VIEW
Figure 2.2:- Exclusion volume in SEC. The volume 
excluded by the macromolecule is a 
sphere of radius r, while exclusion 
due to the pore wall is the region 
outside the cylinder of radius R - r .
Besides proposing the above relationship for separation of 
spherical molecules by circular pores of infinite length, Giddings et al. 
(1968) have obtained equations for spherical molecules separated by 
various pore geometries and for thin rods separated by various pore 
geometries. However their equations do not take into consideration the 
polydispersity of pore size distribution within the stationary phase.
Van Kreveld and Van den Hoed (1973) attem pted to overcome the 
problem of pore size distribution by proposing the random sphere 
model. The random sphere model gives a more realistic representation 
of the separation process by comparing the pore shapes inside SEC 
packing particles to the voids between random ly arranged 
microspheres. The above authors correlated K values obtainedoCL
experim entally w ith those calculated theoretically and arrived at a good 
agreement. They proceeded from these experimental findings to an 
examination of the m icrostructure of porous silica by electron 
microscopy. The particles of silica apparently consisted of 
agglomerates of microparticles of spherical shape, which justified their 
theoretical proposals.
The theory developed by Van Kreveld and Van den Hoed (1973) 
was based on uniform  size spheres. Knox and Scott (1984) have 
developed the random sphere model fu rther by accounting for the 
presence of polydisperse spheres. They correlated K values obtained 
experim entally w ith those calculated theoretically and were able to 
improve on the agreement achieved by Van Kreveld and Van den Hoed 
(1973).
Since the conformation of a flexible polymer chain in a good solvent 
is random coil, Casassa (1971) has modelled the separation of random ly 
coiled solute molecules by SEC. The starting point of Casassa's theory is
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random  flight statistics which describe the conform ation of a flexible 
polym er chain w ith one end fixed inside the cavity centre. This author 
derived the theoretical value of K for different geometrical pore shapes 
as a function of the stationary pore geometry and molecular size. 
Good agreem ent between theoretical and observed results was obtained.
2.4. C a lib ra tio n  o f  SEC colum ns.
The raw  data obtained from  SEC experiment is actually the 
detector output, which represents the concentration of each molecular 
weight in the eluant. Retention can be determined as retention tim e or 
retention volume. Generally the retention time is used assuming the pum p 
is capable of pumping at a constant rate.
The shape of the chromatogram will be determined by the pore size 
d istribu tion  w ithin the porous packing and the sizes of the polym er 
molecules in solution. Usually in order to determ ine the molecular weight 
d istribu tion  (M W D) from  the raw  data, a calibration of the column is 
required.
SEC can be considered as an absolute method for the direct 
determ ination of molecular weight provided that the m olecular weight of 
the polym er can be measured as it elutes in the solvent. This requires a 
system  equipped w ith dual detectors for determining both the concentration 
and the m olecular weight of the eluting polymer. An example of such a 
system  is the low angle laser light scattering method as used by Grinshpun 
et al. (1984).
T raditionally  SEC columns have been calibrated by determ ining 
retention tim es of polym er fractions of known molecular weight. Because 
separate experim ents are required, first to establish the calibration curve 
and secondly to obtain the chromatogram for an
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unknow n polym er fraction, the chromatographic conditions such as the 
flow rate and the composition of the solvent and tem perature m ust 
remain constant. The methods for establishing the calibration curve can 
be divided into 3 categories, namely: (Gilding et al. , 1981)
•  P rim ary  method
•  Empirical method
•  Universal method
The prim ary  and empirical methods, relate to calibration with 
known fractions of the same polym er which is to be characterized. The 
prim ary and empirical methods make use of known samples w ith narrow 
molecular weight d istributions (MWD) and broad MWD respectively. 
These two m ethods will be discussed together in the following section.
2.4.1. Prim ary and em pirical methods.
The prim ary  method involves use of reference standards w ith 
low polydispersities which cover a wide molecular weight range. 
Reference standards having low polydispersities ( Mw /M n <  l . l )  
have become available for various polymers, for example, 
polym ethylm ethacrylate, polyisoprcne, polytetrahydrofuran,
polystyrene, poly a  - m ethylstyrene and polyethylene oxide. (Polymer 
Laboratories, 1985).
For other hom opolym ers, when reference standards are not freely 
available, polym er fractionation techniques may be considered but the 
experimental w ork involved is time consuming and another method of 
molecular weight determ ination would need to be employed. The 
calibration curve that results from using narrow  distribution reference 











Figure 2.3:- Molecular weight calibration 
curve.
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Since reference standards have a polydispersity, ( Mw /M n ), less 
than 1.1, the retention time corresponding to each molecular weight is 
assumed to be the retention time of the peak of concentration as the 
polym er elutes, that is,
Mpeak Mv
As shown in figure 2.3, there is usually a region, between M 2  and 
M^, which is linear and thus the calibration curve is given by the 
equation below:
lo g 10 M = C , - C 2 V   (2 .11 )
where C | and C 2  are constants.
The whole range of the calibration curve, between and M j, can 
be represented by a polynom ial curve which gives the best polynomial fit 
to the experim ental data points as shown below:
logio M=A +  B V  + C V 2 + D V 3 + - “  ..... (2.12)
where A,B,C,D  are the coefficients of the polynomials. These
coefficients can be determ ined by a least squares fit of the polynomial to 
the experimental calibration data points. An example of the polynomial 
fit to the calibration curve has been reported by Van Dijk et al. (1983).
The pore size of the column affect the linearity of the calibration and 
the m olecular weight separation range. This observation was made by 
Yau et al. (1978) using porous inorganic silica as the column packing 
m aterial. Their results are shown in Figure 2.4 and Figure 2.5. These 
authors observed tha t the linear portion of the calibration curve holds 
over 4-5 decades of m olecular weight for a combination of tw o porous 
silicas each having a different pore size. Each packing m aterial when 
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Figure 2.4:- Molecular weight fractionation 
ranges for polystyrene for 
two porous silicas with pore 
size distributions differing 
by about one decade ( • ) , 
silica PSM 60&; ( O ), silica 
PSM 750A.




























Figure 2.5:- Molecular weight calibration 
curve for polystyrene for 
bimodal column system assembled 
with porous silicas having 
calibration in Figure 2.4. 
(Reproduced from Yau et a l . , 1 978).
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linear portion of the calibration curve for the mixed silicas corresponded 
to the entire range covered by the separate columns.
The column m aterial used in this study was spherical, semirigid, 
highly crosslinked, styrene/divinylbenzene copolymer beads about 
5/im in diam eter. Seven different pore sizes were contained in the same 
column making use of the same phenomenon as that observed by Yau 
et al. (1978) that is to expand the linear portion of the calibration 
curve so that one column can be used for a wide range of molecular 
weight analysis. The separate calibration curves obtained from  each 
pore size by the m anufacturer shown in Figure 2.6(a) and the 
calibration curve obtained from a combination of the seven pore sizes 
are shown as in Figure 2.6(b).
When the empirical calibration method is used, errors are introduced 
because the condition
M ’= M = M = M peak n w v
no longer holds. Unless the polydisperse samples are well characterised, 
the empirical method is undesirable.
2.4.2 U niversal m ethod.
In the absence of well-characterized reference m aterials of the same 
polym er which is later to be analysed, a calibration curve can be obtained 
using the assum ption that the hydrodynam ic volume is the param eter 
which determ ines retention on the column. This is the basis for the 
universal method.
From studies of the dilute solution viscosity of synthetic polymers, 
Flory (1953) introduced the concept of the equivalent hydrodynam ic 
sphere to represent the polym er molecule in solution. Flory made
3 9
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Figure 2 . 6  (a) : Ca libra ti on curves of p o lys ty rene
standards obtained from seven dif fe re nt 
pore sizes. (Each pore size is in A)
(b) : Calib ra tion curve of the same p o l ystyr en e
standards obtained from a mixed column 
containing seven different pore sizes as 
above. ( from Polymer L a b o r a t o r i e s ,1985)
use of the Einstein’s viscosity equation: 
[tj]M= 0.025NAVh ..... (2.13)
where
[ 7) ] is the intrinsic viscosity,
M is the molecular weight,
is the Avogadro’s num ber 
is the hydrodynam ic volume of the equivalent sphere.
Equation 2.13, as shown above, shows that the product of [ rj ]M is a 
direct measure of the hydrodynam ic volume of the particles. Thus, if the 
hydrodynam ic volume controls the separation in SEC, a plot of [ rj ]M 
versus retention time w ill be the same for all polymers. An experimental 
examination of the nature of the plot of [ rj ]M versus retention tim e was 
given by Grubisic et at. (1967). In their study, homopolymers and 
copolymers having various chemical and geometrical structures were 
used to test the universal method. Since all the polym ers fitted on a 
single curve of log [ rj ]M versus retention time, th is observation proved 
that the hydrodynam ic volume determines the retention in SEC.
Since equation 2.13 represents spherical particles, Flory (1953) 
modified the equation to take into consideration the dimensions of 
flexibly coiled polymers. The modified equation is shown below.
3 3
2< r 2>  2= 0 'o < s2> (2.14)
where
2 1/2< r  >  is the root-m ean-squre end-to-end distance
2 1/2< s  >  is the root-m ean-square radius of gyration
4 1
and <J>'q are universal constants.
Thus these molecular param eters can be used as measures of 
hydrodynam ic volume. As an example, Cantow et al. (1967) 
have used the average end-to-end distance as a m easure of 
hydrodynam ic volume for the calibration curves of polystyrene and 
polyisobutylene in 1,2,4-trichJorobenzene.
Coll and Gilding (1970) instead have used another param eter to 
represent the hydrodynam ic volume. They represented the hydrodynam ic 
volume by the equation proposed by P titsyn and Eizner (1960) fo r the 
m ean-square end-to- end distance as shown below:
( < r 2> l 2 = S f  ( Z I 5 )# 1 )
where
0(e)=<I>o 1—2.63e+2.86e2
where 0  is a constant as in equation 2.14. The function € is a param eter 
which depends on polym er-solvent interaction and is related to a  in the 
M ark-Houwink equation, [ rj ] = K Ma  , by the equation shown below:
€ = (2o - 1) (2 16)
Finally, it can be said that the universal method proposed by Grubisic et 
al. (1967) was well supported by the various size param eters discussed 
previously.
Thus at a given retention time, the relationship shown below w ill 
apply.
logW p M p^o g W p , Mps ..... (2.17)
where p refers to the polym er requiring analysis and ps refers to the 
standard polym er .
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W ith knowledge of the M ark-Houwink param eters fo r test and 
standard polymer, the universal method can be used. Moreover, the 
theory can be extended to allow determ ination of M ark-H ouw ink 
param eters. These concepts are dealt w ith in the following three sections 
(2.4.2.1, 2.4.2.2 and 2 .4 .23).
2.4.2.1. Evaluation o f  in tr in sic  v iscosity .
From equation 2.17, the relationship between intrinsic viscosity and 
* molecular weight m ust be known or determined in order to make use of 
the universal method. This section w ill discuss the determ ination of the 
intrinsic viscosity. The viscosity of a polym er solution can be calculated 
from  an equation of the form
T }= ap (t--^ -) ..... (2.18)a t
where
p is the density of solvent (or solution)
a  and j3 are calibration constants, the la tte r which takes
account of the small correction for kinetic energy.
In this study, the viscosities of dilute polym er solutions were
measured using a suspended level dilution viscometer. The
m easurem ents of solution viscosity were made by comparing efflux time, 
t, the tim e required for a specified volume of polym er solution to pass 
through a capillary tube, w ith the corresponding efflux tim e, tQ, fo r 
the solvent. In such studies one is concerned w ith  the increase in the 
viscosity of the solution caused by the polymeric solute. This is 
expressed as the relative viscosity, rj ^ , where,
r-3-
17re .=  f  ......  ( 2 - 1 9 )
x0
Equation 2.19 is obtained by assuming that the correction factor for kinetic 
energy is small and, for a dilu te solution, the densities of the solvent and the 
solution are the same.
The specific viscosity rj = rjr - 1 , is a measure of the increm ental
increase in viscosity a ttributed  to the polymeric solute. The ratio rj /c  , wheresp
c is the polym er concentration, is a measure of the specific capacity of the 
polym er to increase the relative viscosity. The lim iting value of th is ratio 




The intrinsic viscosity is usually  calculated using the Huggins* equation as 
shown below:-
V s p _ [rj] +  k '[rj]2 c ..... (2.21)c
where k* is a constant for a given polym er a t a given tem perature in a given 
solvent.
2.4.2.2 In tr in s ic  v iscosity  - m olecu lar w e ig h t re la tio n sh ip
When the logarithms of the intrinsic viscosities for a series of fractionated 
linear polym er homologues are plotted against the logarithm s of their molecular
weights, a linear relationship usually  exists which can be expressed by the
M ark-Houwink equation;
[r)]= K Ma ..... (2.22)
where K and a  are constants determined respectively by the intercept and
the slope of the above plot. For random ly coiled polymers, the exponent a  
varies from  0.5 in theta solvents to a maximum of about
4 4
1.0. For m any system s in good solvents, a  lies between 0.6 and 0.8.
2.4.2.3. C a lib ra tio n  procedures by  u n iv e rsa l m ethod .
It follows from  equation 2.17 that at a given retention volum e/tim e, 
the relationship below will apply.
l°g[r)]p Mp=log[rj]ps Mpj 
Here subscript P refers to a polym er requiring analysis and subscript PS 
to a polym er standard.
In the absence of polym er fractions of narrow  molecular 
distributions and known M ark-Houwink constants it is possible to use 
an iterative procedure described by Van Dijk et al. (1983) which 
allow s determ ination of M ark-Houwink constants from  polydisperse 
sam ples of polym er. Van Dijk et al. (1983) were able to use this 
m ethod to obtain SEC calibration curve for poly (d l-lactate). The steps 
taken by Van Dijk et al. (1983) are outlined below.
According to the universal calibration method the product of the 
m olecular weight M and the intrinsic viscosity is a universal function of 
the elution volume,V, or tim e,t, for various polym ers ie:
M[r}}= fi (v ) ..... (2.23)
The method of Van Dijk et al. (1983) proceeds as follows. Intrinsic 
viscosities of monodisperse fractions of the standard  polym er and 
polydisperse fractions of the test polym er are determ ined by classical 
viscom etry. Values of fi (the universal function; Eqn 2.23) are 
calculated for the standard polymer. These can then be plotted against 
elution times to give a universal plot of log /i against V. Estimates of fi 
fo r the test polym er fractions are obtained from  the universal plot using 
the peak of the chromatograms at the corresponding elution times. Using
45
the estim ates of fi for the test polymer, initial estim ates of M ark- 
Houwink constants for the test polymer (ie a  and K) are obtained by 
plotting log [ 7) ] against log fi for the test polymer in accordance w ith
l0g M = T ^ l ° g M + T ^ - logK ......  (2.24)
The slope of the plot enables estim ation of the constant a  and the 
intercept yields an estim ate the value of K.
The estimates of a  and K for the test polym er can then be used 
to calibrate the SEC column for the unknown polym er by correcting 
for the differences between the M ark-Houwink constants of test and 
standard polymer in accordance w ith equation 2.25 shown below:
  (2.25)
where the subscripts refer to tw o polym ers labelled 1 and 2.
Since the values of K and a  for the test polym er have been 
estim ated using polydisperse fractions of the test polymer, the next 
step is to carry out an iteration process which enables calculation of 
the true  M ark-Houwink constants for the test polymer. The iteration 
process involves inserting the initial values of K and a  into equation 
2.25 and, after perform ing a SEC experiment, using the calibration 
curve to obtain the viscosity-average molecular weight fo r test 
polym er fractions. The M ark-Houwink relationship is then replotted 
using the intrinsic viscosities, [ rj ] and the above-obtained values of My , 
producing new values of a  and K. Again these values are inserted into 
equation 2.25 and a second SEC experiment is performed, resulting in 
th ird  estimates of a  and K. The iterative process is perform ed in this 
w ay until constant values of a  and K are obtained.
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Chapter 3




Chloroform  for size exclusion chrom atography and viscom etry was 
obtained from  Fison (UK). The grade used for the size exclusion 
chrom atography was high performance liquid chrom atography (HPLC) 
standard. For viscom etry, analytical grade (AR) was used.
3.1.2. P olystyrene standards.
A series of polystyrene samples w ith different molecular weights 
was obtained from  Polym er Laboratories Ltd (UK). The polystyrene 
standards were prepared by anionic polymerization and have been 
reported by the m anufacturer to be chemically stable. Characterization 
of the polystyrene standards was perform ed by Polym er Laboratories 
Ltd. Specifications of these polymers used for size exclusion 
chromatography are shown in Table 3.1.
3.1.3. Poly( fi -hydroxybutyrate) (PHB)
PHB was obtained from  Marlborough Biopolymers Ltd (UK). 
Samples of tw o batches w ith  different mean m olecular weights were 
obtained. Both samples were of high pu rity  grade; the batch num bers 
used were as follows:-
•  High m olecular weight PHB. Batch num ber:- Bx 1C 83/2
•  Low m olecular weight PHB. Batch num ber:- B x lC 8 3 /l-4 B
Table 3.1 : Specification of polystyrene standards used for SEC
Peak molecular weight 















3.1.4. Other m aterials.
Methanol (analytical grade) was obtained from  Fisons (UK), p- 
Toluene sulphonic acid, obtained from  Fisons (UK) was a laboratory 
grade agent. W ater was freshly  distilled from  an all glass apparatus.
3.2. Chromatographic equipment.
Figure 3.1 is a schematic diagram of the chromatographic equipm ent 
used for the determ ination of polym er molecular weight distribution.
3.2.1. Column and precolumn.
The SEC column packing consisted of 5 fim  beads of a cross-linked 
sty rene/d iv iny l benzene copolymer w ith  mixed pore volumes (PL gel 5 
fin i MIXED), 0.3 x 30cm, from  Polym er Laboratories Ltd (UK). A 
precolumn was used to guard the main column from  im purities. This 
was a 10cm column of mixed PL gel 5 fim  also obtained from Polym er 
Laboratories Ltd (UK).
3.2.2. Pumping system .
A single head reciprocating pum p fitted w ith a pulse dampener was 
used. (Gilson model 303 fitted w ith a 10S pum p head; obtained from  
Anachem Ltd (UK) ).
3.2.3. Valve.
A Rheodyne syringe - loading injector valve (model 7125) fitted w ith  
a 20 fil injection loop was used throughout. Both valve and loop were 
obtained form Anachem Ltd. (UK).
3.2.4. Detector and Detector cell.
Polymers were detected by way of a Perkin Elmer Infrared 
spectrophotometer (model 782). A sodium chloride cell w ith 1.0mm 
path length was converted fo r use as a flow - cell and fitted to the
Sample 
inj ection












A BBC model B microcomputer was connected to the in frared  
spectrophotometer via a 15 pin D connector obtained from  RS Ltd (UK ). 
The internal analogue - to - digital converter provided w ith  the BBC 
com puter was used to digitise the 1 V analogue output from  the 
spectrophotometer. Programs were w ritten  in BBC BASIC to
•  sample the output from  the infrared spectrophotometer and
% normalise the chromatogram and calculate the m olecular 
weight distribution of a polymer.
3.3. V iscom etric Equipment.
3.3.1. Constant tem perature viscom eter bath.
A constant tem perature viscometer bath obtained from  Laboratory 
Thermal Equipment Ltd (UK) was used at 25 ±  0.1 °C.
3.3.2. Viscom eter.
A suspended level dilution viscometer (type BS/IP/SL, size 2) was 
used throughout. This was obtained from  Poulten Selfe Lee (PSL) Ltd 
(UK).
3.4. M ethods.
3.4.1. The degradation o f  PHB to obtain samples o f  different 
m olecular w eight distributions.
The degradation of PHB was perform ed according to the method of 
Araki and Hayase (1979). These authors degraded poly-j3-esters by using 
either of two catalysts:- p-toluene sulphonic acid (pTSA) or imidazole. 
Catalysts and polym ers were usually dissolved in a m ixture of
chloroform  and methanol. In th is study, 12.5 g of PHB was refluxed in a 
500ml of a m ixture of chloroform and methanol (2:3 by volum e) for 
about 15 m inutes. The dissolved PHB was cooled to room tem perature 
and the required am ount of catalyst (pTSA) was then added to the 
polym er solution. PHB was refluxed for an appropriate tim e w ith  a 
variety  of concentrations of catalyst to obtain ten batches of degraded 
polymer. The conditions of degradation are sum m arised in Table 3.2.
A fter refluxing for the appropriate time, the dissolved PHB was 
precipitated by pouring the solution into a m ixture of methanol: distilled 
w ater (4:1 by volume), in which the pTSA was soluble. The degraded 
sample was then collected by filtering the sample through a W hatm an 
No. 52 filter paper. The filtrate was washed w ith excess methanol to 
dissolve any traces of pTSA left on the surface of the filtrate. The 
degraded samples were then dried under vacuu .m at 40°C for 24 hours.
3.4.2. V iscosity  measurement.
Prior to viscosity measurement, all glassware used was soaked 
overnight in chromic acid. The glassware was then rinsed w ith plenty of 
freshly  obtained distilled water. Viscometers were then rinsed w ith  
acetone and dried using a filtered compressed air line. Viscometers, stock 
solutions of the degraded PHB samples and filtered chloroform  were 
equilibrated in a w ater bath at 25°C.
Subsequently 15 mis of chloroform  was pipetted into the viscometer 
through its wide-m outhed tube. The pipette was allowed to drain fo r 2 
m inutes and was removed from  the viscometer w ith care to avoid 
contact w ith the sides of the viscometer. The flow tim e for passage of 
chloroform between the tw o m arks on the viscometer was measured until 
three consecutive results w ithin 0.2% were obtained. The mean of these 
three flow times was used in subsequent calculations.
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Table 3.2 : Duration of reflux and concentration of pTSA used to obtain 
ten degraded samples of PHB
Sample code 
as used in Chapter 4
Duration of reflux 
w ith pTSA (m inutes)
Concentration of pTSA 












5mls of the stock solution of PHB was added and the solution 
mixed by blowing carefully  down the side arm . A fter appropriate 
mixing, the flow time for the PHB solution was determ ined. 
Chloroform  was then added successively to dilu te the PHB solution in 
the viscometer, the flow times being determined for 6 to 7 different 
concentrations of the PHB.
Intrinsic viscosity was determ ined by linear regression of the 
Huggins plot. The viscometric experiment was replicated for each 
degraded sample of PHB and a statistical t-test (B artlett test) was 
perform ed on the values of intrinsic viscosity to validate the data. 
When no significant difference was evident, a mean value of intrinsic 
viscosity was taken to be the representative of each particular sample of 
PHB.
3.4.3. Infrared analysis o f PHB, polystyrene and chloroform .
A high molecular weight sample of PHB was dissolved in 
chloroform and poured onto a clean glass plate to form  a thin film. The 
film was removed and then analysed using a scanning infrared 
spectrophotometer. Spectra for polystyrene and chloroform were 
obtained from the literature ( Sad tie r Research Laboratories,! 962).
The three spectra were compared to allow selection of suitable 
wavenum bers for the analysis of PHB and polystyrene in chloroform . 
Both polystyrene and chloroform absorbed strongly at 2930 cm’ * , the 
C-H stretching region. Although polystyrene also absorbed at 1500 
c m ~ \ it was felt that 2930cm- * was the preferred wavenum ber fo r 
detection because the absorption coefficient (E ° in 0.2mm cell) was 
much greater at 2930 cm- * (E * ^  = 0.60) than at 1500cm- * (E*^° = 
0.55).
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Figure 3.2 shows the infrared spectrum  of polystyrene dissolved 
in chloroform at a concentration of 1% w /v . The infrared spectrum of 
poly ( j3-hydroxybutyrate) (PHB) as a thin film is shown in Figure 3.3. 
The wavenum ber chosen for detection of PHB \vas 1760cm- * . This 
corresponded to absorption due to stretching of the carbonyl bond.
3.4.3.1. Beer-Lambert plots for  polystyrene in chloroform
Figures 3.4 and 3.5 show the Beer Lambert plots at 2930cm- * of the 
lowest molecular weight polystyrene (M ^ = 1200) and the highest 
m olecular weight polystyrene (M p = 2750000) respectively. The plots 
were linear up to polym er concentrations of at least 1 % w /v and the 
slopes of both curves were identical.
These data validated the use of the infrared detector for molecular 
weight analysis of polystyrene in accordance w ith the criteria suggested 
by Pokorny (1984). According to the latter author, the response of the 
detector should be proportional to the concentration of the eluting 
polymer. In other words, there should be a linear dependence of the 
response on concentration. The second requirement is that the response 
should be independent of molecular weight. Both criteria were satisfied 
for polystyrene in chloroform at 2930cm- *.
3.4.3.2. Beer-Lambert plots for  PHB in chloroform .
Figure 3.6 and 3.7 show the Beer Lam bert plots of the lowest 
m olecular weight of PHB and the highest molecular weight of PHB 
respectively. Again both plots were linear w ith identical slopes. For 
PHB, the concentration required to produce an absorbance of 0.5 units 
was approxim ately 0.1% w /v .
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Figure 3.2:- Infrared spectrum of polystyrene 
dissolved in chloroform (1% w/v )
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Figure 3.3:- Infrared spectrum of poly (/3-hydroxybutyrate) 
as a thin film.
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Figure 3.4:- Beer Lambert plot for the lowest
molecular weight polystyrene in
chloroform (Mp = 1200)
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Figure 3.5:- Beer Lambert plot for the highest
molecular weight polystyrene in
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Figure 3.6:- Beer Lambert plot for the lowest
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Figure 3.7:- Beer Lambert plot for the highest 
molecular weight PHB in chloroform 
(Mw = 868000)
3.4.4. Size Exclusion Chrom atography (SEC)
The absorbance of the two polymers as determined by the Beer- 
Lam bert plots were considered and standard concentrations were chosen 
for molecular weight analysis. All SEC experiments were perform ed at 
concentration of 1% w /v  for polystyrene and 0.1% w /v  for PHB. The 
conditions used for all SEC experiments were as follows. Injected sample 
volume was 20/ul; tem perature was controlled at 25 ±  0.5°C by placing 
the solvent reservoir in a w ater bath; the flow rate of the mobile phase 
was 0.74 m l/m in .
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Chapter 4
ASSAY OF POLYMER MOLECULAR WEIGHT DISTRIBUTION : 
RESULTS AND DISCUSSION
4.1 V iscom etry.
In any viscosity determ ination, the general principle involves 
measuring the time for a reproducible volume of the liquid to flow 
through the capillary of a viscometer under an accurately reproducible 
head and at a closely controlled tem perature.
In this study, the flow times have been determined for various 
m olecular weight fractions of PHB at a variety  of concentrations of 
polymer. The raw  data is tabulated in Appendix 1.
From these values of flow times the value of intrinsic viscosity, [ tj ], 
was determined in duplicate for each polym er sample using the Huggins’ 
equation shown below:-
^ =[r)]+k '[77P c ..... (4.1)
where
c is the concentration of the polym er solution in g /dl
k ' is the Huggins’ constant.
An example of Huggins plot is shown in Figure 4.1. This plot 
represents a sample of PHB having a weight-average molecular weight 
of 868K . Reproducibility of the values of intrinsic viscosity was 
analysed using a student’s t-test. It was found that there were no 
significant differences (at the 95% level of significance) between the 
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Fiqure 4.1:- Replicate Huggins plots for the PHB 
sample with the highest molecular 
weight (sample 7)
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T able 4.1 : Intrinsic viscosities ±  percent standard deviation for 











[ , 1 T
i 2
1 0.396 ( ± 0.5 ) 0.399 ( ±  0.2 ) 0.398
2 2.357 ( ±  0.7 ) 2.339 ( ±  0.3 ) 2.348
3 0.786 ( ±  0.3 ) 0.789 ( ± 0.3 ) 0.788
4 1.243 ( ± 0.3 ) 1.246 ( ±  0 .6 ) 1.245
5 3.835 ( + 0.8 ) 3.896 ( ±  0.4 ) 3.866
6 1.836 ( ± 0.5 ) 1.828 ( ±  0.4 ) 1.832
7* 4.485 ( ± 0.5 ) 4.566 ( ± 0.6 ) 4.526
8# 0.239 ( ± 0.4 ) 0.240 ( ±  0.4 ) 0.240
* - represent the highest molecular weight PHB as received. #  - represent 
the lowest molecular weight PHB as received.
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The mean of the replicate intrinsic viscosity values was taken 
to represent a given molecular weight. The Huggins’ constant, k ' , gives 
an indication of the shape of the polymeric solute at a given tem perature 
in a given solvent. Huggins (1942) has shown that the value of k ' is 
constant for a given polym er in the same solvent at a given tem perature; 
ie. it is independent of the length of the polym er chain or the molecular 
weight. The value of k' is usually in the range of 0.3 <  k' <  0.4 fo r a 
random coil. Solid spherical particles w ould have k' = 2.0 whereas, a rod 
like shape would give k' = 0.8.
Table 4.2 shows the values of k ' from  two determ ination for each 
PHB fraction. The value of k' varied from  0.2 to 0.4. This was thought 
to be due to the wide polydispersities of fractions studied. In this study  
the polydispersity indexes ( Mw/M n ) of PHB samples were w ithin the 
range 2.7 to 4.8. W ith such wide polydispersities, sampling problems 
may have accounted for the variation in the values of the Huggins’ 
constants, which are highly dependent on the precision of the 
determ ination of intrinsic viscosity. The mean value of k' fo r all 
samples was 0.31 ±  0.05. This implies that in dilute solution in 
chloroform PHB has a random coil configuration. This is in .agreement 
w ith the work of Akita et al. (1976) who studied PHB in chloroform 
at 30°C. However, M archessault et al. (1970) reported that PHB exists 
as a rigid rod in chloroform at 30°C. Their conclusion was based on a 
study of optical rotary dispersion.
Table 4.3 shows intrinsic viscosities of four other fractions of 
PHB. This table shows the data for PHB fractions which failed the 
statistical t-test for the replication of the tw o determ inations of 
intrinsic viscosity i.e. the replicates were significantly different (at 95% 
level). The raw data for fractions 9-12 are tabulated in Appendix 2.
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The Huggins plot for each determ ination were linear ; an example pair 
is shown in Figure 4.2. There was a statistical difference in the slope of 
the tw o determ inations, hence in Figure 4.2 it can be seen that the two 
curves were antiparallel. The data suggest that it was not possible to 
replicate the stock solutions for these fractions either due to sampling 
problem s or difficulties in dissolving high molecular weight molecules. 
In view of this sampling problem, only the first group of PHB fractions 
(Table 4.1) were used for determ ination of M ark-Houwink constants.
Since the molecular weight of each PHB fraction was unknown, 
size exclusion chromatography (SEC) was used to estim ate their 
molecular weight in accordance w ith the methods described in Chapter 
Two. Molecular weight was routinely determined using the universal 
calibration method, that is w ith reference to a standard m aterial, in this 
case, polystyrene. The universal calibration method requires 
knowledge of the M ark-Houwink constants for the reference m aterial. 
Therefore the intrinsic viscosities of various polystyrene standards were 
determined.
Figure 4.3 shows the replicate Huggins plots for determination of 
the intrinsic viscosity of a polystyrene sample of molecular weight, M^ = 
68000. A t-test was performed to compare the tw o values of intrinsic 
viscosities for each sample and there were no significant differences 
between them. Table 4.4 shows the replicate intrinsic viscosities for 
each polystyrene sample. A mean value was taken to represent a given 
m olecular weight. Table 4.5 shows the values of the Huggins’ 
constant, k' , fo r each polystyrene fraction. The values of k' were not 
very reproducible even though the values of intrinsic viscosity were 
w ithin 0.5% of each other suggesting that variation in k' is normal. The 
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Figure 4.2:- Replicate Huggins plots for a degraded 
sample of PHB (sample 9). This pair 
of replicates were significantly 
different (see text).
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Table 4.3 : Intrinsic viscosities ( ±  percent standard deviation ) for 











r l d l
T
1 2
9 0.912 ( ±  0.1 ) 1.021 ( ±  0.3 ) 0.967 ( ±  8.0 )
10 1.056 ( ±  0.7 ) 1.124 ( ±  0.4 ) 1.090 ( ±  4.4 )
11 2.758 ( ±  0.2 ) 2.727 ( ±  0.2 ) 2.743 ( ±  0.8 )
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Figure 4.3:- Replicate Huggins plots for a
polystyrene sample of molecular 
weight Mp = 68,000
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T able 4.4 : Intrinsic viscosities ( ±  standard deviation ) fo r different 
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l 2
1080000 2.580 ( ±  0.2 ) 2.574 ( ±  0.5 ) 2.577
490000 1.467 ( ±  0.1 ) 1.463 ( ±  0.3 ) 1.465
195000 0.779 ( + 0.3 ) 0.779 ( ±  0.1 ) 0.779
68000 0.343 ( ±  0.3 ) 0.344 ( ±  0.4 ) 0.343
28000 0.185 ( ±  0.2 ) 0.180 ( ±  0.3 ) 0.183
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( ° C )
Ref erences
0.011 0.73 25 present work
0.007 0.76 25 Oth and Desreux (1954)
0.011 0.73 25 Bawn et al. (1950)
0.005 0.79 30 Endo and Takeda (1962)
0.026 0.73 30 Endo and Takeda (1962)
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value of k' for polystyrene, was 0.31 ±  0.07 indicating that
polystyrene, like PHB, exists as a random coil in chloroform .
Since the molecular weight of each polystyrene sample had been 
determ ined by the m anufacturer, it was possible to plot the relationship 
between molecular weight and intrinsic viscosity for polystyrene. This 
relationship is described by the empirical M ark-Houwink equation as 
follow s:-
[tj} =  K M° ..... (4 .2)
where
K and a  are constants, known as the M ark-Houwink constants
M is the molecular weight of the polymer.
Figure 4.4 shows a plot of log [ T) ] against log M for polystyrene.
The value of a  was obtained from the slope of this plot and the value of
K was obtained from the intercept. Using least squares linear
-4regression analysis, a  was determined as 0.730 and K as 1.10 x 10 
d l/g .
Besides its usefulness in the determ ination of molecular weight, 
the M ark-Houwink relationship also provides an assessment on the 
influence of solvent on the configuration of the polym er chain. Flory 
(1953) has shown that in the theta condition, a condition at which 
polym er molecules are on the verge of precipitation from  the 
solution (that is unpertubed dimensions), the value of a  is 0.5. In 
good solvents, polym er molecules will expand and the value of a  w ill 
be greater than 0.5 up to a maximum value of 0.8. Based on this 
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Figure 4.4:- Mark - Houwink plot of
polystyrene in chloroform 
at 25°C.
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Table 4.6. shows values of M ark-Houwink constants for polystyrene 
in chloroform  determ ined at 25°C. The M ark-Houwink constants 
obtained in this study were in good agreement w ith those reported by 
previous authors. Table 4.6 also shows that the values of M ark-Houwink 
constants are dependent on tem perature. Therefore when the universal 
SEC calibration is used, M ark-Houwink constants are required at the 
operating tem perature for both standard and test polymers.
4.2. Size-exclusion chrom atography.
The conditions used for SEC of polystyrene and PHB solutions were 
chosen on the basis of the infrared studies described in section 3.4.3. 
Using an injection volume of 20 /xl, the concentrations of polystyrene and 
PHB used were 1% w /v  and 0.1% w /v  respectively.
It was considered im portant to use the same concentration for each 
molecular weight analysis. Chiantore and Guarta (1986) highlighted the 
importance of this factor by showing that sample concentration of 
polystyrene in tetrahydrofuran  affected the molecular weight peak 
retention time. They found that the peak retention time of polystyrene 
increased w ith increasing concentration of the injected solution. The 
shift was more pronounced for polym ers with higher molecular weights. 
This change was thought to be due to a decrease in the diversion of 
flexibly coiled polymers as the polym er concentration is increased.
Table 4.7. shows the retention times obtained for molecular 
weights standards of polystyrene. Since each polystyrene sample had a 
low value polydispersity index (M w/M n <  l . l ) ,  Mn , Mw and My were 
considered equivalent. Thus polym er molecular weight was represented 
by the chromatographic peak molecular weight. Table 4.7 represents 
the variation in the calibration curve of polystyrene over a period of
7 7











1 2 3 4 5 6
1200 12.70 12.70 12.70 12.60 12.60 0 12.66 ± 0.05
3770 11.90 12.00 12.00 12.00 12.00 12.00 11.98 ± 0.04
10200 11.30 11.30 11.30 11.20 11.20 11.20 11.25 ± 0.05
28000 10.70 10.80 10.70 10.70 10.70 10.70 10.72 ± 0.04
68000 10.20 10.20 10.30 10.20 1030 10.10 10.22 ± 0.08
195000 9.40 9.40 9.40 9.30 9.40 0 9.38 ± 0.04
490000 9.00 9.00 9.00 9.00 9.00 9.00 9.00 ± 0
1080000 8.50 8.50 8.50 8.40 8.50 8.60 8.50 ± 0.06
1750000 8.30 8.40 8.30 8.30 8.30 8.30 8.32 ± 0.04
2750000 8.10 8.10 8.10 8.10 8.00 8.00 8.07 ± 0.05
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one year. A comparison of these six calibration curves using a 
statistical t-test indicated no significant differences between them.
Figure 4.5 shows the average calibration curve of polystyrene 
obtained from  six different calibration curves. There exists a good 
correlation w ith the first order of the polynomial equation, hence the 
curve was represented by a straight line equation for the range of 
m olecular weights used. Since the assay was so dependable, it was 
possible during the later stages of the project to refer to previous 
calibration curves. The performance of the column was tested on a more 
routine basis, before each days work, by testing the retention tim es of 
four to five polystyrene standards injected sim ultaneously. These were 
alw ays superimposed on the calibration curve.
A calibration curve for PHB was obtained using the universal 
calibration m ethod. The basis fo r th is method has been explained in 
Chapter Two. The method is based on the assumption that separation in 
SEC is controlled by the hydrodynam ic size of the polym er molecule. 
Hence, at a given retention time, all polymer molecules will have the 
same hydrodynam ic size, that is,
where
M [rj]=/i ( v or t ) ..... (4.3)
M is the molecular weight 
[ T) ] is the intrinsic viscosity
fx is a universal function of the retention time, t  , or elution 
volume ,v.
<*pup 1
l°gMpHB= 74— l°gM+ TT~~ l°gKPHB ..... (4.4)
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Figure 4.5:- SEC calibration curve 
for polystyrene.
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[ 7} ]pj_jg is the intrinsic viscosity of PHB
a PHB’ KPHB are the M ark-Houwink constants for PHB
/jl is the universal constant given by Equation 4.3
Values of /jl for the polystyrene standards were calculated using 
the M ark-Houwink constants determined previously. The logarithm of 
/jl was plotted against the retention time, t, to produce a universal 
curve (Figure 4.6).
The unknown PHB samples were then injected onto the SEC column 
and their retention times were estimated using the retention tim e 
corresponding to the top of the chromatographic peak. By reference to 
the universal curve (Figure 4.6), values of /jl were assigned to each of 
eight poly disperse samples of PHB (Table 4.8). The intrinsic viscosities of 
these samples had been determined previously (see section 4.1). This 
allowed calculation of initial estim ates of the M ark-H ouw ink constants 
for PHB in accordance w ith equation 4.4. A plot of log /i against log [ r\ ] 
was linear (Figure 4.7) allowing the initial estim ates of the M ark- 
Houwink constants to be calculated by least squares linear regression
Thus an initial calibration curve for PHB was obtained allowing 
the molecular weight d istributions of the eight PHB samples to be 
estimated. This initial calibration curve of PHB was obtained by 
using equation 4.5 as shown below:-
As all the param eters above were known, the calibration curve of PHB 
was obtained as follows :
analysis ( a  = 1.00, K = 0.1 x 10 ^ d l/g).
logMpslogMPHB: (4.5)
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Figure 4.6:- Universal SEC calibration curve 
(log /x plotted against 
retention time)
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1 6.24 6.11 6.17 0.09
2 7.63 7.70 7.66 0.05
3 6.79 6.92 6.85 0.09
4 7.01 7.11 7.06 0.07
5 8.00 8.10 8.05 0.07
6 7.53 7.55 7.54 0.01
7 8.39 8.43 8.41 0.03
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log^Q universal function (log^/i )
Figure 4.7:- log., Q [ rj ] against log
for polydisperse samples 
of PHB (samples 1-8)
Since the initial estim ates of Mark-Houwink. constants for PHB 
were obtained from  polydisperse fractions, im provem ent of these values 
was achieved by an iteration process. The iteration process involved 
obtaining the viscosity-average molecular weights from  PHB fractions 
by size exclusion chrom atography and then re-calculating the M ark- 
Houwink constants by plotting the logarithm of viscosity-average 
molecular weight for each fraction against log [ tj ]. These new values 
of the M ark-H ouw ink constants were then used to re-determ ine My by 
SEC, leading to another estim ate of M ark-H ouw ink constants. This 
iteration was repeated until there were no significant differences between 
new estim ates of the M ark- Houwink param eters.
Figure 4.8 shows the M ark-H ouw ink plot obtained after the first 
iteration. New values of the M ark-H ouw ink constants were obtained 
from  the slope and intercept of such plots . The values of the M ark- 
Houwink constants after each iteration are shown in Table 4.9 . Figures 
4.8 to 4.15 show the M ark-Houwink plots after iterations 1 to 8 
respectively. A comparison of the values of a  using a statistical t-test 
showed that there were no significant differences from  iteration 3 
onwards. Hence the average value of a  was taken as the mean of the 
values generated by iterations 3 to 8. Figures 4.16 and 4.17, respectively, 
show the variation in cx and K a fte r each iteration. It can be seen that 
the values of a  and K reached a constant level after the th ird  
iteration.
Finally, Table 4.10 compares the M ark-Houwink constants 
determined during the present w ork w ith  those determ ined by other 
authors. There was good agreement between data obtained in the present 
study and that obtained by A kita et al. (1976) but the value of a  
obtained by M archessault et al. (1970) was higher at 0.82. All three
Table 4.9 : Values of Mark-Houwink constants at each iteration
Iteration a K ( ml X 102 ) mg
Initial estim ate 1.00 0.1
Iteration 1 0.87 ±  0.04 0.6
Iteration 2 0.79 ±  0.03 1.1
Iteration 3 0.76 ±  0.03 1.6
Iteration 4 0.75 ±  0.02 1.6
Iteration 5 0.76 ±  0.02 1.4
Iteration 6 0.75 ±  0.02 1.9
Iteration 7 0.77 ±  0.02 1.4
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Figure 4.15:- Mark - Houwink plot of PHB after
eight iteration
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Figure 4.17:- The variation of K after each
iteration
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T able 4.10 : M ark-Houwink constants of poly( /3-hydroxybutyrate ) 
in chloroform .
K ( ml  ) mg Oi Tem perature ( °C ) References
1.6 XI O '2 0.76 25 Present work
7.7 X 10 '3 0.82 30 M archessault et al. (1970)
i . 2  x i c r 2 0.78 30 A kita et al. (1976)
9 7
studies suggest that PHB exists in a random coil configuration in 
chloroform  at am bient tem peratures although M archessault et al. (1970) 
have concluded from  optical rotation studies that PHB exists as a rigid 
helix in chloroform .
The iteration procedure described above proved to be a rapid 
method for determ ination of M ark-Houwink constants from  
polydisperse samples of a polymer. The SEC assay was reliable and 
stable over a period fo three years. However the molecular weight 
determ ination was not as precise as that reported by Van Dijk et al. 
(1983). The latter authors used three SEC columns in series. It is likely 
that the precision of the assay reported here would have been improved 
by the use of a larger volume of gel but this was a financial 
constraint on the study. In practical term s,the SEC method described 
here was useful for routine determ ination of molecular weight 




DEGRADATION AND RELEASE STUDIES 
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Chapter 5
BIODEGRADABLE POLYMER AND DRUG DELIVERY
5.1 Introduction.
Degradable or erodable polym ers in this study are defined as 
m aterials that undergo a degradation process in a biological environm ent 
and are converted to products that can be readily elim inated from  the 
body. If such polym ers are used in im plants the degradation products 
m ust be small enough to be excreted by the kidney. However, if the 
polym ers are used topically on body sites such as the eye or the uterus, 
then high molecular weight w ater-soluble degradation products are 
acceptable.
Biodegradable polymeric drug delivery system s can be divided into 2 
groups (Heller, 1986):
•  Monolithic devices in which the therapeutic agent is physically 
dispersed or dissolved in a polymeric m atrix.
• Devices in which the therapeutic agent is covalently bound to 
the polymer backbone such that the therapeutic agent is 
released by hydrolysis or enzym e-catalysis.
In an ideal situation, a biodegradable drug delivery device would 
release therapeutic agent at a constant or controlled rate over a 
predeterm ined tim e by degradation of the polym er backbone into non­
toxic, biocompatible subunits which would subsequently be 
metabolized or eliminated from  the body. The advantage of 
biodegradable polymeric delivery system s, over non biodegradable 
polymeric delivery system s is that surgical removal of an implanted 
device, a fter depletion of the therapeutic agent, is not required.
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However, care needs to be exercised when form ulating drugs in 
biodegradable im plants, particularly  in m atrix-type form ulations. In 
some cases, rapid scission of the polym er backbone or crosslinks can 
compromise the integrity of the device resulting in rapid release of 
substantial doses of the drug (Jeong and Kim, 1986).
W ithin the second group of devices in which the therapeutic agent is 
covalently bound to the polymer, are a specialised group of w ater-soluble 
system s which have the potential to both prolong release and to target the 
drug. Various authors have reported studies of such soluble 
macromolecular system s (Kopecek, 1984; Feijen et al, 1980; M arriott and 
Pouton, 1986).
The present study is concerned w ith  the aforementioned monolithic 
delivery system s. The purpose of th is chapter is to present a review of 
previous w ork in this field. Most of the polym ers used in monolithic 
system s have been aliphatic polyesters w ith  considerable emphasis on 
poly (lactate), poly(glycolate) and their copolymers. The use of the la tte r 
polym ers is reviewed in detail since they are closely related to PHB and 
its copolymers w ith  HV; the m aterials used in the experimental w ork 
reported in th is thesis. The special properties of PHB are reviewed in 
detail in section 5.5.
5.2 M onolith ic system s.
The release of the therapeutic agent from  a monolithic degradable 
drug delivery system  m ay be influenced by the mechanism and rate of 
degradation of the polym eric carrier. The m ajority of reports relating to 
drug delivery system s have been concerned w ith degradation by 
hydrolysis. Heller (1984) has classified tw o extreme types of hydrolysis 
that a polym er can undergo :- bulk hydrolysis and surface hydrolysis.
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In bulk hydrolysis, chain cleavage takes place throughout the bulk of the 
m aterial while in surface hydrolysis the reaction is confined to the outer 
surface of the solid device.
Monolithic devices which undergo a bulk erosion process may 
exhibit complex drug release kinetics because these are determined 
by drug diffusion phenomena and polym er hydrolysis. In general, 
the initial kinetics of release are comparable w ith those resulting from  
diffusion from  non-erodable monolithic devices; release rate is often 
proportional to the square root of time as described by the Higuchi’s 
equation (Higuchi, 1961). However, as the bulk hydrolysis 
proceeds, the perm eability of the polym er increases and thus the rate 
of diffusion of the drug increases (Heller, 1986; H adgraft and Guy, 
1987).
The kinetics of drug release from  monolithic devices which 
undergo a surface hydrolysis are more predictable. Release by 
diffusion would be expected w ith additional release caused by erosion 
of the polym er. If release by diffusion is slow, such that release by 
erosion is dom inant, then such devices should be capable of providing 
zero-order drug release as long as the surface area of the device remains 
constant. In practice the rate of drug release will decrease w ith decrease 
of the total surface area of the device, which will be a consequence of 
the erosion process. In principle, by controlling the geometry of the 
device one could determ ine its lifetim e, for instance, fo r a laminate the 
lifetim e of the device would be directly  proportional to its thickness.
5.3 Poly(glycolate), poly(lactate) and poly(glycolate-co-lactate).
Poly(lactate)(PLA), poly(glycolate) (PGA) and their copolymers 
have been used by many researchers for the purpose of investigating
-* X i-J-V iT '
1 0  2
Figure 5.1 C hem ical s t r u c t u r e  o f 
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monolithic biodegradable drug carriers. They belong to a group of related 
aliphatic polyesters. The structures of these polym ers together w ith 
other members of the group are shown in figure 5.1.
PLA, PGA and the P(GA/LA) copolymers have been woven for use 
as surgical sutures which are biodegradable, biocompatible and have 
mechanical strength greater than catgut. (Frazza and Schm itt, 1971; 
Gilding and Reed, 1981). PGA sutures are m arketed under the 
tradenam e of Dexon® and P(GA/LA) su tures are m arketed as Vicryl®. 
As a resu lt of the proven biocom patibility of PGA, PLA and 
P(GA/LA) copolymer sutures, extensive studies have been reported on 
the su itability  of these polym ers fo r controlled release of drugs. 
PGA and PLA are produced synthetically  by ring-opening 
polym erisation of the appropriate cyclic diester to produce high 
molecular weight polym ers (Gilding and Reed, 1979).
5.3*1 Physicochem ical properties.
The chemical structure  of lactic acid (LA ) includes a chiral centre, 
thus, PLA can be prepared in the l(+), d (-)  and racemic dl form s. P- 
1-LA is relatively crystalline (degree of crystallin ity  about 37%) w ith a 
melting point of around 180°C and a glass transition tem perature 
(Tg) at 50-60°C. P-dl-LA is to tally  amorphous and also has a Tg at 
about 50-60°C (Gilding and Reed, 1979).
Biodegradation of all polyesters is facilitated by the hydrolysis of the 
ester bond to yield an alcohol and a carboxylic acid. The example of this 
reaction is shown opposite.
PGA is the most hydrophilic of th is group of polyesters. It has a 
melting point of 220-230°C and Tg of about 36°C (Bandrup and 
Immergut, 1975). The degree of crystallin ity  of Dexon® sutures has
1 0  4
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Reaction 1 : Degradation of poly(glycolate) in aqueous solution 
to yield an acid and an alcohol.
1 0  5
been quoted as 46 - 62% (Gilding and Reed, 1979). The effect of 
copolymerisation of GA and 1-LA has a marked effect on degree of 
crysta llin ity  as shown in figure 5.2. All copolymer compositions 
containing between 25 and 67% GA are amorphous. C rysta llin ity  and 
hydrophobicity in tu rn  effect the absorption of w ater by these 
copolymers and influence their rates and mechanisms of degradation.
PGA and P-l-LA homopolymers have been described as 
hydrophilic and hydrophobic crystalline matrices respectively; PLA 
being more hydrophobic than PGA due to the presence of the pendant 
m ethyl group. Gilding and Reed (1981) have examined the effect of the 
hydrophilicity /hydrophobicity  of P(GA/LA) copolymers by measuring 
the equilibrium  w ater uptake of immersed polym er films. These authors 
found that equilibrium  w ater levels were low for the hydrophobic, 
crystalline P-l-LA and copolymers w ith low GA content. 
Equilibrium  w ater absorption increased rapidly to 20-30% w /w  for 
amorphous copolymers, as hydrophilicity (the content of GA) was 
increased. However, above 70 mole % GA, w ater uptake decreased as 
the degree of c rysta llin ity  increased. Copolymers containing 70 mole % 
GA absorbed the highest quan tity  of water. Such polym ers have a high 
rate of degradation and may degrade by mechanisms involving scission 
of the polym er backbone w ithin the bulk sample.
Cohn et al. (1987) reported that the molecular weight of PGA and 
PLA homopolymers can influence their degrees of crystallin ity . They 
observed that samples of PGA and PLA of low molecular weight (Mn 
= 1000) had degrees of crysta llin ity  of 9% and 12.2 % respectively. 
The degree of crysta llin ity  increased to maximum values of 52% and 
37% for PGA (Mn >  20000) and PLA (Mn = 28000) respectively. The 
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Figure 5.2 Percent crystallinities forPGA/PLA
copolymers as a function of composition 
(determined by X-ray and DSC measurement). 
(Reproduced from Reed and Gilding, 1981).
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chain ends which allows crystallisation to proceed without 
interference from  the hydrophilic chain ends which will be present in 
larger quantities in low m olecular weight polymers.
5.3.2 D eg rada tion  o f  PGA, PLA a n d  P(GA/LA) copolym ers in vitro 
and in vivo.
5.3.2.1. Introduction
The degradation of polyesters has been studied in vivo and in vitro. 
It is im portant to study  degradation in vivo to determ ine the effect of 
enzymatic processes on the rate of degradation, although most polymers 
are expected to degrade prim arily  by non-enzym atic processes. 
Mechanisms of degradation are likely to influence the mechanisms of 
release of drugs; therefore a considerable num ber of in vitro  studies have 
been, reported.
In section 5.2, tw o distinct mechanisms of degradation of 
biodegradable polym ers were discussed; bulk hydrolysis and surface 
hydrolysis. Bulk hydrolysis refers to the breaking of backbones of 
polymer chains resulting in shorter chains. Thus bulk hydrolysis is 
characterised by changes in the m olecular weight of the original polymer 
sample. In contrast, surface hydrolysis results in the successive erosion 
of monomers from  the exposed end of polym er chains at the polym er 
surface and thus does not usually  lead to changes in the m olecular 
weight of the bulk  polym er sample. Differentiation of these tw o 
processes is im portant. Determ ination of weight loss of polym er is not 
sufficient and should be accompanied by analysis of the molecular 
weight d istribution during degradation.
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5.3.2.2 D eg rada tion  o f PGA, PLA a n d  P(GA/LA) copolym ers in
vitro.
In  vitro studies of Dexon® sutures at pH 7 and 37°C showed that 
PGA degrades by bulk hydrolysis (Gilding and Reed, 1981). These 
authors used SEC to m easure the changes in the molecular weight of PGA 
during degradation and also measured the changes in weight by a 
gravim etric method. The molecular weight distribution of Dexon® 
changed a fte r 1 week but there was no significant mass loss until the fifth 
week; a clear indication of bulk hydrolysis.
Chu and Louie (1985) studied the degradation of Dexon® sutures in 
vitro  by m onitoring the changes in the tensile strength, the pH, the 
degree of crystallin ity  and the mass of glycolic acid release from the 
sutures. The resu lt of their w ork is shown in Figure 5.3. There appear 
to be tw o stages of degradation for Dexon® sutures. These authors 
have used the m icrofibrillar model for fibre struc tu re  to explain the tw o 
stage degradation. This model, shown in Figure 5.4, was proposed by 
Peterlin in 1972.
The basic element of a fibre is said to be a microfibril which contains 
crystalline and am orphous regions arranged in parallel to the long axis of 
the fibre. The crystalline regions are highly packed and composed of 
chain sequences in ordered conformation. The am orphous regions 
comprise chain folds, chain ends and tie chain segments which are 
denoted by A and B in Figure 5.4. The tie chain segments are thought to 
hold different crystalline regions together. The tie chain segments 
transm it strain  throughout the crystalline zones when a fibre is under 
stress. Based on this concept, Chu and Louie (1985) have proposed that 
when PGA fibre is placed in an aqueous solution the degradation proceeds 
by tw o stages, first w ithin the am orphous regions and secondly w ithin
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Schematic drawing of microfibrillar 
structure of fibres (A) Interfibrillar 
(B) Intrafibrillar tie molecules 
(Reproduced from Chu, 1981)
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the crystalline regions. Thus, c rysta llin ity  increases by reduction in the 
mass of amorphous polym er and possibly because the remaining 
undegraded chain segments in the am orphous regions become more 
mobile, allowing them to reorganize from  a disordered to an ordered 
state.
Tensile strength decreases rapidly perhaps because the tie chain 
segments in the am orphous regions are degraded first. Chu (1985) has 
speculated that the drastic change in pH during the second stage, the 
crystalline hydrolysis, may be due to either of tw o effects:
i.the crystalline regions contain more glycolic per un it volume 
than am orphous regions and hence more glycolic acid is 
released per un it mass during the second stage of hydrolysis.
ii.destruction of the tie-chain segments in the first stage frees 
the crystalline blocks, which were previously linked together 
by tie-chain segments, from  restricted motion. As a result the 
crystals in the m icrofibrils become less densely and orderly 
packed, which makes them more susceptible to degradation.
Chu (1981) also found that the pH of solution has an effect on the 
degradation of Dexon® sutures in vitro. He observed that the degradation 
rate in unbuffered physiological saline (pH = 5.0) was less than that in 
phosphate buffered physiological saline (pH = 7.4). The proposed reason 
for the la tter observation was tha t in the unbuffered system  the acidic 
degradation products remained and accumulated. The hydrolysis process 
was retarded, by the lack of hydroxyl ions, which often catalyse ester 
hydrolysis, thereby decreasing the rate of degradation.
Initial studies by Gilding and Reed (1981) on the degradation of 
films of P(50%GA/50%LA) copolymer indicated that it was a suitable
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m atrix for form ulation of drugs. The molecular weight of this 
copolymer decreased as did its mass under the influence of a w ater 
content of about 25% w /w . These features, they claimed, were suitable 
for the sustained release of hydrophobic drugs. Gilding and Reed 
(1981) also studied degradation of P-l-LA films and found that, despite 
the higher crysta llin ity  and low w ater uptake, degradation still occured 
by backbone cleavage.
5.3.2.3 D eg rada tion  o f  PLA and  P(GA/LA) copolym ers in vivo.
M iller et al. (1977) have reported differences in the rate of 
degradation of P-l-LA and copolymers of 1-LA and GA. W eight loss of 
and tritium  - labelled homopolymer and copolymer pellets was 
studied a fte r im plantation in rats. The results are shown in Figure 5.5 
where the degradation half-lives of the samples are plotted against 
copolymer composition.
The rate of degradation was closely related to the results of the 
crystallin ity  study  reported by Gilding and Reed (1981) suggesting 
that the c rysta llin ity  of the copolymer is a major determ inant of the 
rate of degradation in vivo. For the relatively  crystalline 
homopolymers, the hydrophobicity/hydrophilicity  of the polym er 
appears to determ ine the rate of the degradation. The more 
hydrophobic PLA degrades at a slower rate than PGA.
Schindler et al. (1977) have studied the in vivo degradation of P-l- 
LA using various initial molecular weights (initial viscosities = 0.47, 
1.15, 2.24 and 3.23 d l/g ). Polymer films (2 x 1 cm, 100 fim  thick) were 
implanted subcutaneously in rabbits and changes in the molecular 
weight and the mass remaining were determined during degradation. 
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Figure 5.5 Half-life (in months) of various
ratios of PLA and PGA as copolymers 
implanted in rat tissue.
(Reproduced from Miller et a_l. , 1 977 )
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involved backbone cleavage with no significant weight loss until a critical 
m olecular weight (Mn= 15,000) was reached. The second stage involved a 
marked weight loss together w ith an accelerated decrease of molecular 
weight. The rate of degradation for polym er of different molecular 
weights was found to be sim ilar (initial viscosities:- 0.47, 1.15, 2.24 and 3.23 
d l/g). Chawla and Chang (1985) have also studied the in vivo degradation of 
P-l-LA. These authors used films (1 cm x 1 cm) and monitored mass loss 
following degradation of four different samples of P-l-LA 
(M w =  0.9, 2.0, 2.7, 2.9X106) after im plantation in rats. The highest 
m olecular weight was reported to have the lowest rate of degradation in vivo. 
Thus, there is some confusion in the litera ture  as to the effects of molecular 
weight on rate of degradation.
Visscher et al. (1985) have studied the in vivo degradation of P(50%dl- 
LA/50%GA) form ulated as microspheres. These authors observed the reaction 
of tissues into which microspheres were im planted and also morphological 
changes in the microspheres as they degraded. Microscopic studies indicated 
that the ’microcapsules' became slightly more porous after 4 days of 
im plantation. When they were examined after 49 days of im plantation there 
was a considerable change in the appearance of the internal m atrix which was 
no longer sim ply porous but was showing signs of extensive erosion. 
Microcapsule could not be found after 63 days,suggesting that they had been 
completely absorbed w ith in  this time. The tissues showed only minimal 
response to the presence of these microcapsules w ith no sign of inflammation.
5.3.3 Release o f  drugs from  P(GA/LA) copolym ers
5.3.3.1 Introduction
A variety of P(GA/LA) copolymer system s have been developed for the 
long term  maintenance of therapeutic drug levels. Systems have
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been devised for the delivery of a range of chemical classes of drug 
to achieve delivery periods that vary from days to years. The 
motivation for form ulation in P(GA/LA) copolymer systems has 
usually been in the im provem ent of patient compliance. For example, 
system s for antim alarial drugs, fe rtily  control agents and narcotic 
antagonists have been studied.
However, a recent review by Wise et al. (1987) has highlighted two 
particular areas where the potential of biodegradable polym ers can be 
exploited. One area is the delivery of biological mediators which would 
usually be peptides and proteins. Biodegradable polym ers m ay be capable 
of protecting such labile macromolecules as well as facilitating 
controlled release. One commercial product which was developed w ith 
this approach in mind is Zoladex® which is m anufactured by ICI pic 
(UK) (Hutchinson and Furr, 1985).
Wise et al. (1987) considered that a second im portant area for 
exploitation was the pulsed release of drugs from  biodegradable 
polymers. *Pulse-release could be useful development in controlled 
release of antigens for im m unization. This suggestion relates to previous 
studies on the release of a steroid from  P(LA/GA) copolymer. In the 
la tte r study, a biphasic dual pulsed release of d-norgestrel was reported 
(Figure 5.6). This was in fact a disadvantage in the delivery of d- 
norgestrel but could be used to advantage for delivery of antigens. Wise 
et al. (1987) consider that research should be directed to engineering 
release of antigen/vaccine as tw o distinct, controlled bursts. An initial 
burst of antigen release over a period of several days will be required to 
induce the prim ary im m une response. A fter a period of weeks, the 
system will then be required to release a second antigen pulse. This 











































































Figure 5.6 Biphasic-pulsed release of
d-norgestrel from P(LA/GA) 
copolymer (90% dl-lactate/
10% glycolate).
(Reproduced from Wise et al., 1987)
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reports of release of drugs from biodegradable polym ers are reviewed 
below.
5.3.3.2 Factors affecting release o f  low  m olecular w eigh t drugs.
Since P(G A/LA ) copolym ers undergo bulk hydrolysis, it is im portant 
to determ ine the degradation on the kinetics of drug release. When little  
or no polym er hydrolysis has occured, drug release is expected to be 
controlled by diffusion in the same way as would occur in a non- 
degradable system . However, as the extent of bulk hydrolysis becomes 
significant, diffusional release rate can accelerate. Heller (1985) 
presumed tha t the increase in rate of release was due to an increase in the 
perm eability of polym er arising from increases in chain m obility caused 
by hydroly tic  chain scission.
The effect of copolym er composition on the release of a hormonal 
steroid, levonorgestrel, was studied by Sharon et al. (1984). The release 
of the steroid was directly  related to the susceptibility of each polym er 
to degradation. Copolymers and hom opolymers of 1-LA, dl-LA were 
used. The rank order of polym ers w ith increasing rate of biodegradation 
was P(75% 1-LA/25%GA), P(90%dl-LA/10%GA), P(100%dl-LA),
P(50%dl-LA/50%1-LA) and P(100%1-LA). Two polym ers, P(100%dl- 
LA) and P(50%dl-LA/50%1-LA), were selected for fu rth e r release studies 
of the steroid since they appeared to have potential fo r development of a 
delivery system  w ith a lifetim e of 6 m onths to 1 year.
Wise et al. (1978) reported that the m olecular weight of 
P(50% l-LA/50% dl-LA) had an effect on the rate of release of 
sulphadiazine from  spherical beads. The rate of drug release decreased 
w ith increase in the m olecular weight of the polymer. Below a molecular 
weight of 150,OCX), there was no fu rth er increase in the release rate. In
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another study, Gresser et al. (1984) found that by lowering the
polydispersity of P(75%1-LA/25%GA) (M w = 56000) from 2.0 to 1.4, it
was possible to produce a system  which exhibited a reduced initial rate
of release of estradiol w ith a longer period of constant release. Clearly, 
*
the polym er m olecular weight distribution is an im portant determ inant 
of release characteristic although there are few reports in the literature of 
such studies.
The release rate of a specific drug from  a P(GA/LA) m atrix can be 
adjusted by m anipulation of the concentration of drug in the drug- 
polym er m ixture. The duration of release is also affected by loading of 
drug but can also be m anipulated by m odifying the geometry and 
size of the device. Generally, the higher the loading of a drug in the 
m atrix, the faster w ill be the release rate (Suzuki and Price, 1985). The 
lifetim es of P(GA/LA) system s were also found to be dependent on the 
aqueous solubility of the drug (Gresser and Sanderson, 1984).
5.3.3.3 Release o f  peptides from  P(GA/LA) copolym ers.
*
Generally, high m olecular weight pharmaceuticals, such as 
polypeptides cannot be adm inistered by the oral route. They are 
degraded and deactivated by proteolytic enzymes in the gastro­
intestinal tract and therefore are usually  adm inistered parenterally. 
Since such drugs often have very short half lives, frequent injections 
are required to produce an effective therapy.
For polypeptides and hormones, where the pharmacological use of the 
agent require sustained release, the most appropriate dosage form  is one 
capable of releasing drug continously at a controlled rate over a period of 
weeks or even m onths. Examples of such peptides are the highly 
potent, synthetic analogues of lutenizing hormone releasing
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hormone. The controlled release of such peptides from P(dl-LA/GA) 
system s have been studied extensively (Sanders et al. 1986; 
Hutchinson and Furr, 1987). The uses of such analogues of luteinizing 
hormone releasing hormone are for reversible chemical castration and 
suppression of hormone dependent disease states such as prostatic 
cancer and endometriosis.
Sanders et al. (1984) have^prepared m icrospheres by a phase 
separation method. The peptide, in aqueous solution, was mixed w ith 
a solution of p(50%dL-LA/50%GA) in dichloromethane. A non-solvent 
was then added to precipitate the polym er around the aqueous droplets. 
The release of the peptide from  these microspheres was found to be 
triphasic(see Figure 5.7) . The prim ary  release phase involved diffusion 
of drug from the surface of the microsphere (ie the drug which was not 
trapped w ithin the m atrix). During, the second phase of release the rate 
of release was too low to be therapeutically effective although the 
polym er m olecular weight decreased during this period. Further 
degradation* and dissolution of low molecular weight fragm ents combined 
w ith erosion w ithin the bulk, the polym er then initiated the tertia ry  
release phase of the peptide.
Polypeptides have high molecular weights and are w ater soluble. 
Therefore their release from  polyesters by partition dependent diffusion 
through the polym er is likely to be extrem ely slow. Thus, the 
degradation of the polym er is a crucial factor in determining the release 
of the high m olecular weight polypeptide from  the dosage form .
Hutchinson and F u rr (1987) have reported the degradation 
of P(50%dl-LA/50%GA) in the absence of drug in Mcllvanes buffer, pH
7.4 at 37°C. This is shown in figure 5.8. The polym er degraded by 




















Figure 5 7  The effect of subdermal depots
containing 300 g of ZoladexR in high 
molecular weight PGA/PLA copolymer 
administered to regularly cycling 
adult female rats. The two release 
phases are (1) initial release due to 
leaching from the surface; (2) degradation- 


















Time (days) Time (days)
Figure 5.8 (a) and (b ):— In vitro degradation of 50/50
molar poly ((± ) - lactide - 
co-glycolide] at 37°C in buffer 
at pH 7*4. High molecular weight 
polymers as measured by viscosity 
(a) and yet retain their water 
insolubility (b) only after 
extended time of degradation 
does any weight loss occur. 
(Reproduced from Hutchinson and 
Furr, 1987).
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polym ers dem onstrated by a decrease in intrinsic viscosity. As the 
m olecular weight of the degrading polym er decreased,it became 
increasingly hydrophilic and exhibited enhanced w ater uptake, w hilst 
retaining its w ater insolubility . A fter an extended period of 
degradation, the m olecular weight decreased to a level at which there 
was significant w ater solubility. A t th is point, the polym er began to 
erode homogenously allowing the peptide and also polym er degradation 
products to diffuse aw ay from  the loosening polym er m atrix. This 
la tte r process corresponded to the th ird  phase of peptide release which 
occurred largely by diffusion through - aqueous pores. This 
triphasic release of w ater-soluble macromolecules is typical of 
P(G A/LA ) system s although the general profile can be modified by 
form ulation.
M atrices can be form ulated to give biphasic release avoiding the slow 
secondary phase release (Hutchinson and Furr, 1985). This can be 
achieved by using a low m olecular weight polym er and a higher loading 
of drug; although the rate of release is increased and the duration of 
release is shortened. Sanders et al. (1986) have studied the release of an 
LHRH analogue from  various P(dl-LA /G A ) m elt-extrusion system s using 
polym ers w ith  equal m olecular weights. The copolymer compositions 
(dl-LA /G A ) were 100:0, 95:5, 90:10, 85:15 and 80:20. Increase in the 
content of dl-LA produced a more hydrophobic system which resulted in 
the decrease of the duration of the subeffective secondary phase and an 
increase of the duration of the tertia ry  release phase.
Further studies examined the effect of m olecular weight of P(d-LA) 
on the release of peptide. Use of a high molecular weight polymer ( [  rj ] 
= 1.02 d l/g ) resulted in extension of the secondary phase whereas an 
im plant prepared using a low molecular weight polymer ( [tj ] = 0.36
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dl/g ) exhibited no secondary phase of release. In addition, use of a low 
m olecular weight polym er caused overlap of the prim ary and tertiary 
phases resulting in continuous release of the peptide for more than 8 
m onths. Another disadvantage of using high molecular weight 
polym er was that elevated tem peratures and extended extrusion times 
were required for m anufacture of the im plant which resulted in 
therm al degradation of the peptide.
Redding et al. (1984) compared the effectiveness of adm inistering—**- 
LHRH analogue as microspherical polym eric im plants w ith the 
conventional twice daily subcutaneous injection. A pharmacological 
assay, prostate cancer in rats, was used to compare the tw o therapies. 
These authors found that a greater decrease in tum our weight was 
achieved using the polymeric im plant. Since prostate tum ours are often 
heterogeneous consisting of both hormone dependent and hormone 
independent cells, combination therapy using the im plant and 
m itoxantrone dihydrochloride therapy was studied and proved to be 
effective against prostatic cancer (Schally et al., 1986).
5.4 Other related biodegradable polym ers.
5.4.1 Poly (e-caprolactone)
Poly(e-caprolactone) is likely  to have different properties to PGA 
since it w ill exist in a rubbery state at body tem perature whereas both 
PLA and PGA are glassy. The glass transition tem perature of poly(e- 
caprolactone) is very low (-60  to -70°C).
P itt and Gu (1987) studied the degradation of poly(e- 
caprolactone) films in vitro. The polym er underw ent 2 stages of 
degradation. The first stage involved random chain scission involving 
hydrolytic cleavage of ester group resulting in decrease of the
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m olecular weight of the original polymer. The form ation of carboxylic 
acid end groups catalysed fu rth e r chain scission. These authors were also 
able to show that if the carboxylic acid ends were capped w ith 
ethanol, the subsequent rate of degradation was decreased.
The second stage of degradation involved significant loss of weight
i
which was due to the diffusion of dissolved oligomeric fractions aw ay 
from the bulk polymer. As' the polym er degraded, the degree of 
crysta llin ity  increased from  45% to 90% indicating preferential attack of 
*the am orphous phase.
5.4.2 Poly (orthoesters).
Although polym ers based on lactic and glycolic acid have the 
im portant advantage of degrading to the natural m etabolites of lactic and 
glycolic acid, they are not ideal m aterials for controlled drug release. To 
produce delivery system s having more desirable release kinetics, an 
erosion mechanism based on surface hydrolysis is significantly more 
desirable and it is for this reason that poly(orthoesters) have been 
studied.They have been prepared synthetically  by the Alza Corporation 
(USA) and are m arketed under the tradenam e Alzamer®.
Poly (orthoesters) can be designed to contain pH-sensitive linkages 
which are relatively  stable in basic envrionm ents but w ill hydrolyse at 
progressively increasing rates as the external pH is lowered. (Heller and 
Himmelstein, 1985). Excipients can be incorporated into poly (orthoester) 
system s such that the pH in the surface layers of the device are lower 
relative to the in terior of the device. In th is way, it is possible to ensure 
that hydrolysis proceeds a t a significant rate only in the surface layers 
(Heller et aL, 1983).
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Two different classes of excipients have been used; acidic 
excipients, which were intended to accelerate the rate of hydrolysis, 
and basic excipients, which were intended to stabilize the interior of the 
m atrix. Sodium carbonate has been used as a basic excipient in a study 
of the release of a contraceptive steroid, norethindrone, from 
poly(orthoester) system s. Release was not in fact mediated by
surface erosion of The polym er but rather by the form ation of a swollen 
hydrophilic layer at the surface of the polymer allowing release of the 
drug by diffusion from  the swollen layer. Na2C 0 3, in this case, 
functioned as an osmotic agent and causing uptake of w ater into the 
m atrix.
Based on the results obtained using Na2C 0 3, the use of an insoluble 
acid anhydride was studied. The acid anhydride was intended to act as a 
catalyst since, in the presence of w ater, it would hydrolyse to form  a 
diacid which would then catalyse the erosion of the m atrix. Pthalic
anhydride was used in this w ay by Sparer et al. (1984). These
authors were able to show that the release of a model compound,
m ethylene blue, correlated w ith  the surface erosion of the polym er 
m atrix.
The lifetim es of devices using acid anhydrides as excipients could 
be varied w ithin a range of hours to about one month. However a device 
w ith a lifetim e of more than one m onth has been achieved by Heller et 
al. (1985). This involved the use of a basic excipient, magnesium 
hydroxide, which had sufficiently low solubility to avoid substantial 
uptake of water. Heller and Himmelstein (1985) have pointed out that 
no adverse tissue reaction have been observed during in vivo 
release experiments but genuine toxicological studies have not been 
perform ed.
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5.5 P o ly  (d -j3 -hyd roxybu ty ra te ), (PHB)
5.5.1 B iosyn thesis o f  PHB and  K H B /H V ) copo lym ers
PHB is an optically active aliphatic polyester consisting of d-/3- 
hydroxybutyric  acid as repeating units. It is u su a lly  obtained by 
bacterial biosynthesis and thus has an advantage over synthetic polymers 
in that there are no residual catalysts or monomers in the bulk polymer. 
Providing that solvent-based- extraction is carried out carefully, a pure 
product can be"obtainecT.
PHB can be found in m any bacteria. Its function is to act as an 
energy reservoir, ra ther like glycogen or fat reservoirs in anim als 
(Dawes and Ribbons, 1964; Dawes and Senior, 1973). PHB accumulates 
as sm all spherical granules, 0.1 - 0.7 nm in diam eter and, under
appropriate condition, PHB can account up to 75% w /w  of the d ry  
weight of a bacterial cu ltu re  (Senior, 1984). The synthesis of PHB in 
bacteria has been discussed by Dawes and Senior (1973) and in simple 
term s, PHB is produced in response to an imbalance of growth brought 
about by nu trien t lim itation.
Im perial Chemical Industries (ICI) UK have patented a ferm entation 
method for the mass production of PHB. This ferm entation process 
involves continuous grow th of Alcaligenes sp. under nitrogen 
lim itation condition. The species of Alcaligenes used are faecalis, 
ruhlandi, latus, aquamarinus and eutrophus (ATCC No. 8750, 15749, 
29712, 14440 and 17699 respectively). These organisms, of which
eutrophus is preferred, accum ulate PHB during the growth phase while 
undergoing aerobic ferm entation using a variety  of substrates that 
supply hydrogen and carbon dioxide. M utant strains of A . 
eutrophus are able to utilise glucose which is the preferred raw  
substrate in term s of cost. The application of PHB as a biodegradable
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commodity therm oplastic cu rren tly  is limited by its cost which prevents 
it competing w ith cheap polym ers (polyethylene, propylene, etc.). 
However the cost of the polym er for specialized applications, 
such as pharm aceutical form ulations, is not likely to be prohibitive.
On a sm aller scale production, Doi et aU (1986) have described the 
biosynthesis of PHB and P(HB/HV) copolymers by culturing 
Alcaligenes eutrophus HI 6 in a nitrogen-free mineral medium 
containing organic acids as carbon sources. PHB was synthesized in the 
presence of sodium acetate where as P(HB/HV) copolymers were 
prepared in a medium containing a m ixture of sodium acetate and 
sodium m ethylacetate. Higher contents of /3-hydroxyvalerate can be 
prepared by culturing the strain  in a medium containing only sodium 
methylacetate.
5.5.2 Physicochem ical properties.
The crystal struc tu re  of solid PHB has been examined by 
Cornibert ^nd M archessault (1972) and also by Yokouchi et al. 
(1973). These studies suggested that the conformation of crystalline PHB 
molecules was a 2j helix. M archessault et al. (1970), in another study  
reported that the helical struc tu re  of PHB was retained in chloroform , 
trifluoroethanol and ethylenedichloride but the conform ation of PHB 
in dichloroacetic acid was found a random  coil. These conclusions were 
based on viscosity and optical ro tary  dispersion (ORD) experiments 
where PHB in solution underw ent a sharp change (sim ilar to helix coil 
transitions of polypeptides) when the binary solvent composition 
(dichloroacetic acid : ethylene dichloride) was varied at a fixed
tem perature. However, their viscosity experiments indicated that the 
exponent a  in the M ark Houwink equation for PHB in chloroform was
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more representative of a random coil configuration.
Akita et al. (1976) reported evidence to support the hypothesis that 
PHB is a random coil in both chloroform  and trifluoroethanol. These 
authors used samples of PHB w ith narrow  polydispersities in contrast 
to the samples used by M archessault el al. whose samples had M w/M n 
=6. Akita et al. (1976) used viscometric and. light scattering 
techniques to dem onstrate that PHB exists as a random coil in both 
- s o l v e n t s  —
Recently, Doi et al. (1986) studied the conformation of PHB in 
13chloroform using C-nuclear magnetic resonance spectroscopy. Their 
results suggested that the PHB molecule was not rigid but rather flexible 
in chloroform supporting the random  coil hypothesis.
Lundgren et al. (1965) characterized PHB extracted from different 
bacteria by X -ray diffraction. Samples of PHB extracted from  various 
bacteria had sim ilar X -ray diffraction spectra. The only difference 
between samples were in intrinsic viscosity (i.e. molecular weight) due to 
the difference in the polym erisation of PHB in various bacteria.
The chemical synthesis of P-dl-HB has been described by Agostini 
et al. (1971). This study suggested that the degree of crystallin ty  of 
P-dl-HB was sim ilar to that of P-d-HB. This property is in m arked 
contrast to the properties of P-l-LA and P-dl-LA where the form er is 
37% crystalline but the la tte r is to ta lly  amorphous.
The glass transition tem perature of PHB was found to be in the 
range -4 to 1°C. This value was obtained from  molten PHB using the 
dilatom etric method (Barham et al., 1984). The crystallin ity  of PHB lies 
in the range 60-90% as determ ined by density measurements, w ith a heat 
of fusion for 86% crystalline PHB of 146 J/g  (Barham et al., 1984).
1 2 9
Marchessault et al. (1981) found that PHB molecules in the weight 
range 1K-8K had sim ilar heats of fusion. The values obtained by 
M archessault et al. (1981) were in good agreement w ith those obtained 
by Barham et al. (1984). This indicates that low molecular weight 
polym ers have the same equilibrium  crysta llin ity  as high molecular 
weight polymers.
The degree of crysta llin ity  of PHB can be reduced by incorporating 
d-j3-hydroxyvalerate (HV) into the PHB chain (Holmes, 1985). Mitomo 
et al. (1986) determ ined the degrees of c rysta llin ity  of a series of 
copolymers. When the HV content was increased from  0% to 30 mole %, 
the c rysta llin ity  apparently  decreased from  75% to 39% for solution 
grown crystals. However Bloembergen et al. (1986) reported that for 
solution precipitated and aged P(HB/HV) samples, the degree of 
crysta llin ity  was independent of HV content, but the rate of 
crystallization of the samples was dependent upon and retarded by 
increasing HV content. It is possible that the m easurements reported by 
Mitomo et *al. (1986) were made before equilibrium  crystallin ity  had 
been achieved. Further work, is required to establish the crystalline 
nature of P(HB/HV) copolymers.
Bluhm et al. (1986) studied the effect of copolymer composition on 
the melting tem perature using HV contents from  0% to 47 mole %. The 
m elting point decreased to a m inim um  at 30 mole % HV and then 
increased. To explain this phenomena, these authors introduced the 
concept of isodimorphism which explained their results in term s of tw o 
crystalline phases w ithin the bulk, polymer. A t high HV contents, the 
bulk, sample apparently  included an HV dependent crystalline phase 
which raised the onset of melting.
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Copoly merization of HB and HV leads to changes in the 
mechanical properties of PHB films. A khtar et al. (1987) reported 
the mechanical properties of copolymer films containing 0%, 6.6%, 
12.6% and 20% HV, determined using a static tensile test. Increase in 
HV content resulted in tougher, less brittle  and more pliable materials. 
Mechanical properties were not affected by molecular weight above 
M w ;=  200,000 although films cast from  solution were fragile if the 
m olecular weight was much below Mw = 200000
5.5.3 R andom  d eg rad a tio n  o f PHB
An ability  to control the molecular weight of PHB by degradation in
non-aqueous solution has been an integral part of the present study. It is
of interest to consider w hether or not this degradation occurs by random
chain scission. (M ajid et al., 1987). The kinetics of random chain
scission have been derived by Jellinek (1978). The theory is based on the
rupture  of main chain links according to the law s of probability. Jellinek
(1978) derived equations which described the random degradation,
»
m athem atically, using the following assumptions.
•  the polym er sample was actually  monodisperse (i.e. it 
consisted of linear chains of one length only)
•  the rate of scission of chain links was directly  proportional to 
the num ber of chain links present at any time t of the scission 
process. The main chain links were of equal strength and were 
equally likely to break under the scission process.
The degree of degradation, oc , which represents the probability of 
breaking one link in the original chain at tim e t is given by
where 5 is the average num ber of main chain links which have been
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broken in one original chain at time t.
DP0 is the original chain length of the monodisperse polym er sample, i.e. 
the degree of polymerisation of the polymer. If DP0 is large, equation 5.1 
reduces to
r i ,   <52)
Thus the rate of breaking main chain links, n, in a closed system at tim e t ' 
is given by
=  kn ..... (5.3).d t
The num ber of links, nD, present in the system at tim e t = 0 is related to 
n at any stage of the scission process as follows:
n =  nQ— a  n0 
=  n„ ( 1 -  <x ) ..... (5.4)
Inserting equation 5.4 into 5.3, we then have 
- d  n0( 1 -  a  )
 ^  = k  nD( 1 — a  ) ..... (5.5)
Integrating the above equation (5.5) gives:-
—ln( 1 — a  ) =  k t ..... (5.6)
for small values of a  , equation 5.6 then becomes
a  =  k t ..... (5.7)
or by inserting equation 5.2 to replace a  in equation 5.7
5=DP0 k t  ..... (5.8)
Since num ber-average molecular weight is likely to be obtained 
experim entally, equation 5.9 is used:-
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nDPo(DP0- l ) = n 0 ..... (5.9)
where nDPo is the num ber of chain of original chain length DP0. When s 
links, the average for each original chain, have been scissioned, one has 
for tim e t





Thus the num ber average chain length at any time t of the scission 
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=  k(DPn>t2-D P n,t) ..... (5.13)
Integrating equation 5.13 gives,
- l n ( l - T i — ) =  l a - l n ( l - - = ! - )  ..... (5.14)
Equation 5.14 reduces for large values of DPn t and DP. (i.e small a )  to
Oi
1 1 =  k t ..... (5.15)
DPn,t DPo
This is a useful form  of the theory. From equation 5.15, it can be seen
tha t a plot of 1 1
DPn,t DP0
gives a straight line w ith a gradient equal to
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the rate constant, k, whenever random chain scission occurs.
5.5.3 Aqueous degradation o f  PHB and P(HB/HV) copolym ers.
Recently, M iller and W illiam s (1987) have studied the 
hydrolytic  degradation of PHB monofilaments in term s of changes in 
their mechanical properties w ith time. These authors concluded that 
there was little  degradation of PHB microfilaments both in vivo and in 
vitro. Two j^H B /H V ) copolymers (containing 8 and 17 mole % HV) 
were subjected to accelerated tests in vitro. These were sto red_at higher 
tem perature (60°C and 70°C) at pH 7.4. HV content apparently retarded 
the rate of high tem perature hydrolysis.
In the same study , PHB monofilaments were subjected to various 
intensities of y-irradiation after which the degradation experiments were 
repeated, again by observing changes in the mechanical properties 
of the monofilaments. A m inim um  intensity  of y-irradiation that 
could initiate the degradation process was found (10 MRad). 20MRad 
caused total loss of integrity  of the monofilament as a su ture material 
even before exposure to water.
M iller and W illiam s (1987) found that y -irradiation  has the ability 
to reduce the m olecular weight of the bulk  polym er which 
subsequently increases its susceptibility to degradation. However, the 
molecular weight changes were not determ ined. These authors also 
reported that there was a difference in the rate of in vitro  and in vivo 
degradation following y-irradiation. In  vivo degradation was more rapid. 
They a ttribu ted  th is difference to the involvem ent of enzymes in the 
degradation process in vivo . It should be noted that no attem pt was 
made to study  weight loss or change in m olecular weight in the above 
study. All conclusions were based on m easurem ents of mechanical
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strength. These measurements were variable and the thickness of the 
microti lam ents was not reported in detail.
Holland et al. (1987) have shown that one possible reason for the 
relative stability  of the draw n PHB monofilaments reported by the 
previous authors may have been a high degree of c ry s ta llin ity ^  This is a 
typical consequence of the extrusion process used to produce 
monofilamental fibers. The latter-*,-- authors studied; the in vitro 
degradation of different morphological form s of PHB__ including 
solvent cast films, m elt-pressed discs, injection moulded samples and 
compressed tablets. These different form s were subjected to aqueous 
buffer solutions at pH 2.3, 7.4 and 10.6 at 37°C and at 70°C. 
Degradation was examined by determining the loss in weight as a 
function of time. The various form s of PHB had different resistances 
to hydrolytic attack, the compressed tablet being the least resistant. 
Resistance of PHB complied w ith the following rank order: 
compressed tablets <  solvent cast films <  m elt-pressed discs <  
injection moulded pieces. These differences correlated w ith the 
difference in degrees of crysta llin ity  as measured using a differential 
scanning calorimeter. High degree of crystallin ity  was associated w ith 
high resistance to hydrolytic attack. These authors also reported that 
the rate of degradation increased w ith increase in pH suggesting that 
the degradation mechanism was base-catalysed as would be expected for 
an ester hydrolysis. The degradation rate was also increased by raising 
the incubation tem perature to 70°C.
Holland et al. (1987) have also studied the effect of molecular weight 
and copolymer composition on the hydrolysis of solvent cast films. Two 
molecular weights (36K and 300K) of copolymer containing 20 mole % 
HV were subjected to hydroly tic  degradation. The high molecular weight
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polym er degraded more slowly although no explanation for this finding 
was discussed.
Two high molecular weight copolymers (12 mole % and 20 mole %, Mw = 
350K and 300K respectively) showed different degradation rates; the 20 
mole% HV polym er degraded more rapidly. This may have been due to a 
difference in the crysta llin ity  of the copolymers. The 20 mole % HV - 
polym er, w hilst being more hydrophobic, was less crystalline which may 
-have promote degradation.
5.5.5 Drug release from  PHB and P(HB/HV) copolym ers.
Korsatko et al. (1983a, 1983b) have prepared PHB m atrix tablets as 
sustained release form ulations by compressing homogenous m ixtues of 
PHB and 7- hydroxyethyltheophyline (HET); a model hydrophilic drug. 
The tablets were 2.0mm in thickness and 6.0 mm in diam eter. A variety 
of drug loading were studied between 5% and 80% w /w . The molecular 
weight of PHB used was 260,000. In  vitro release studies were performed 
in non-sterile 0.9% NaCl at 37°C. When drug loadings were below 
30% w/w, the release of drug took place over periods of up to 50 days 
whereas w ith  drug loadings of 60 - 80% w /w  the release was completed 
w ithin  24 hours. Release of drug occured in itially  from the surface and 
then proceeded by diffusion through the aqueous pores form ed by w ater 
penetration of the m atrix  of the tablet. The degradation of PHB had no 
significant effect on the release of HET in vitro.
A comparison of in vitro  and in vivo release rates from  tablets 
containing 10% HET indicate tha t the in vivo release rate was slower 
than that measured in vitro. These authors postulated that a lower 
supply of aqueous fluid around the im planted tablets in vivo could have 
caused the reduced release rate However, the possibility of the release 
rate being increased in vitro  due to microbial degradation of PHB cannot
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be ruled out. Experience at Bath has indicated that non-sterile 
distilled w ater unless absolutely fresh can be contaminated with 
microorganisms which are capable of rapid degradation of PHB. This 
could have explained the higher release of HET in vitro.
Bissery et al. (1984) have prepared PHB microspheres containing an 
anticancer drug, lomustine [ l- (2  chloro-ethyl)-3-cyclohexyl-nitrosourea 
(CCNU)]. A solvent evaporation method was used which involved 
dissolving the drug and PHB in chloroform —and then emulsifying this 
solution in an aqueous solution of polyvinyl alcohol. The emulsion was- 
then stirred  into a solution of m ethylcellulose and mixed until the 
chloroform  had completely evaporated. Microspheres (1-13/im ) were 
obtained by filtration. Microscopic examination revealed that each 
sample of PHB microspheres was composed of a m ixture of individual 
particles and assorted aggregates. Thus, the particles were not entirely 
spherical.
In  vitro  and in vivo release of CCNU was studied. In this buffer, pH
7.2 at 37°C, more than 90% of the loaded drug (7.4% w /w ) was released 
in 10 hours. Comparison of th is release rate w ith that from P-dl-LA 
microspheres containing CCNU, prepared by the same method, showed 
that the P-dl-LA microspheres had a longer sustaining effect (60% of the 
loaded CCNU being released in 90 hours). The authors were not able 
to explain these effects. Their in vivo studies involved monitoring the 
distribution of ^C -lab e lled  PHB m icrospheres (1-12/im ) following an 
intravenous injection into mice. Thus these authors had a targetting 
application in m ind rather than conventional im plantation. One and 
seven days after injection, most of the radioactivity was found in the 
lungs, liver and spleen. Presum ably, the
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larger particles were trapped in lung capillaries and the sm aller particles 
taken up by the reticuloendothelial system . The anticancer activity  of 
CCNU-loaded microspheres was assessed in mice bearing AKR 
leukemia. Intravenous injection of PHB microspheres containing the 
anticancer drug had little  effect on increasing the life span of the 
animals.
Juni et al. (1986) ha^e-^repared PHB microspheres containing an 
anthracycline anticancer drug, aclarubicine hydrochloride, by a sim ilar 
solvent evaporation process. These authors dissolved the required drug, 
an additive and PHB in m ethylene chloride. The solution was then 
dispersed in 1% gelatin solution dissolved in 0.1M phosphate buffer, and 
then stirred to evaporate off the m ethylene chloride. The diam eter of 
microspheres obtained in this case were considerably larger; in the range 
50-400/im . In  vitro release studies from microsphere containing 13% 
aclarubicine hydrochloride (170/u.m in mean diam eter) showed that only 
10% of the drug was released in 5 days in an isotonic sodium chloride 
solution at. 37°C. The release rate was enhanced by the inclusion of 
fa tty  acids in the microspheres. Accelerated release of the drug was 
apparent when the num ber of carbon atoms in the fa tty  acid chain was 
greater than 12; the longer the carbon chain, the faster the release rate. 
The release of the drug could be enhanced fu rther by using an ester of a 
fa tty  acid as the adjuvant.
Brophy and Deasy (1986) have prepared PHB microspheres 
containing sulphamethizole by another solvent evaporation process. The 
am ount of drug incorporated into the m atrix was higher than the 
solubility of the drug in the PHB m atrix  such that the drug existed as a 
dispersion in the m atrix. Their in vitro  studies showed that release 
rate was influenced by the particle size of the dispersed drug. Fine
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particles led to more rapid release.
Brophy and Deasy (1986) also showed, in agreement w ith the 
general properties of m atrix system s, that an increase in drug content 
caused an increase in the fraction of drug released per unit time. In 
common w ith other system s, an initial rapid release was caused by 
diffusion of drug from the surface of the m icroparticles. Coating the 
particles w ith PLA reduced the burst effect observed from non-coated 
particles. ^
Brophy and DEasy (1986) also studied the release of sulphamethizole 
from  P(HB/HV) copolymers containing 17% and 30 mole% HV. Higher 
HV content resulted in slower release of the drug. The authors explained 
that copolymerization m ay have resulted in better alignment and 
deposition of the drug in the m atrix , thereby reducing its diffusivity. 
Release of the drug was essentially due to the diffusion processes and was 
independent of polym er degradation.
Gould et al. (1987) studied the effect of m olecular weight of model 
hydrophilic drugs, fluorescein labelled dextrans, from  direct compressed 
tablets of P(HB/HV) copolymers. Two copolymers were used containing 
12 and 20 mole % HV w ith m olecular weights quoted as 350,000 and
300,000 respectively. The in vitro  release of the dextrans was dependent 
on the copolymer composition and also on the m olecular weights of the 
dextrans. The authors found tha t increasing the HV content from 12 to 
20 mole % resulted in lower release rates of the drugs. This was thought 
to be due to the high com pressibility of the 20 mole % copolymer 
although the m olecular weights of the two polym ers were also different. 
Increase of the m olecular weight of the dextrans from  4000 to 40,000 
resulted in an increase in the release rate from both copolymers. Gould et 
al. (1987) proposed that the release of dextran was controlled by the
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porosity of the m atrix and the rate of the fluid influx into the m atrix. 
Fluid influx was induced artificially by incorporating either lactose or 
m icrocrystalline cellulose into the m atrix . Release rate was increased by 
both adjuvants. Lactose had a greater effect than m icrocrystalline 
cellulose. This was explained by the form ation of a porous netw ork by 
lactose ra ther than the microporous (wicking) netw ork-form ed in the 
presence of m icrocrystalline cellulose.
The 4 ja tu re  of the polym er-drug m atrices described above were 
varied. C learly the m anner in which the drug is mixed with the 
polym er, the effects of its polarity^ and crystallin ity  are im portant 
determ inants for the rates and mechanisms of release. These factors 
require fu rth er study  to aid in the design of drug delivery systems.
5.5.6 In  vivo degradation and biocom patibility of PHB.
Korsatko et al. (1984) studied the biocompatibility of compressed 
PHB tablets im planted in mice. The dimensions of the PHB tablets were
2.0 mm irw thickness and 6.0 mm in diam eter w ith a mean weight of 
60.0mg. There was a fairly  constant degradation rate throughout a 20 
week period. The rate constant fo r degradation was reported to be 2.21 x 
10" * m g/week. These authors assum ed that enzymatic processes had 
contributed to degradation of the polym er resulting in monomeric j3- 
hydroxybutyric  acid. Histological examinations showed that there was 
an acute inflammation at the site of im plantation followed by continuous 
m ild inflammation throughout the 20 weeks period. The inflammatory 
response was considered to be an im portant influence on the degradation 
rate of PHB in tha t it would have provided a source of enzymes from  
cells of the im m une system . Korsatko et al. (1984) also used a tissue 
cu ltu re  technique using mice fibroblasts to determ ine the effect of PHB on
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the cellular growth rate and their metabolic function. These experiments 
indicated no significant differences in cellular growth and metabolism 
between the control and PHB exposed cultures.
Juni and Nakano (1987a) have also reported biocompatibility studies 
using PHB microspheres (diam eter = 100/im) implanted into the thigh 
muscles of rats. The inflamm atory reaction was described as mild and 
was restricted to the im plant site. Four weeks a fte r implantation, the 
microspheres were encapsulated by connective tissues.
Kennedy et al. (1987) used microspheres of 40 fim  in diameter 
prepared by spray-drying for biocom patibility studies. Microspheres 
were im planted into the thigh muscles of rats and the tissue and serum 
levels of acid and alkaline phosphatase were used as a monitor of 
inflammation and as an indicator of biocom patibility. There were 
transient increases of both enzyme levels in the tissue surrounding the 
injection site although there were no differences between test and control 
injections. The m ild acute responses were either due to the vehicle (1% 
m ethylcellulose in phosphate buffered saline, pH7.4) or to the traum a 
caused by the injection itself.
Generally, PHB appears to be acceptable for im plantation but there is 
confusion in the litera tu re  regarding the mechanisms and extent of 
degradation in vivo. A recent report of subcutaneous im plantation of 
sutures has suggested that little  or no degradation occurred after six 
m onths (M iller and W illiams, 1987).
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Chapter 6
DEGRADATION AND RELEASE STUDIES FROM PHB AND 
P(HB/HV) COPOLYMERS : MATERIALS , EQUIPMENT AND 
METHODS
6.1 MATERIALS
6.1.1 C h lo ro fo rm .
Chloroform  for the form ation of PHB films and ~P(HB/HV) 
copolymer films was obtained by distilling standard laboratory reagent 
grade chloroform  obtained from  Fisons (UK). Chloroform for SEC was 
high perform ance liquid chrom atography (HPLC) grade obtained from 
Fisons (UK). Deuterated chloroform , CDCl^ was used to dissolve PHB 
homopolymer and P(HB/HV) copolymer samples for NMR studies. This 
solvent was obtained from Aldrich (UK).
6.1.2 PHB hom opo lym er a n d  P(HB/HV) copolym ers.
PHB and P(HB/HV) copolymers were obtained from  Marlborough 
Biopolymers (UK). The following batches were used:
•  i. High molecular weight PHB (high pu rity  grade). Batch 
num ber Bx IC 83/2  . The viscosity-average molecular weight 
of th is batch as determ ined by SEC was 720K
•  ii. High molecular weight PHB (technical grade). Batch num ber 
Bx GV 9(EE). The viscosity-average molecular weight was 
765K
•  iii. P(HB/HV) copolymer, purchased as 6.6 mole % HV. Batch 
num ber Bx PV 7(EE). The equivalent viscosity-average 
molecular weight as compared to PHB was 465K
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•  iv. P(HB/HV) copolymer, purchased as 12.6 mole% HV. Batch 
num ber Bx PV 12(EE). The equivalent viscosity-average 
molecular weight as compared to PHB was 1050K
•  v. P(HB/HV) copolymer, purchased as 20 mole% HV. Batch 
num ber P /V /l . The equivalent viscosity-average molecular 
weight as compared to PHB was 1480K
The hydroxyvalerate contents of each copolymer were determined by 
"proton NMR (see section 6.3.9). The contents determined in this study, 
expressed as mole %, were as follows: (iii) 6.5% (iv) 12.3% (v ) 19.2%.
6.1.3 Other m aterials
Methanol (analytical grade) was obtained from  Fisons (UK), p- 
Toluene sulphonic acid (pTSA) (standard laboratory reagent) was used as 
obtained from Fisons (UK).
The salts for the preparation of buffer solutions, their respective 
grades and their sources were shown in Table 6.1.
Ethyl acetate for gas chrom atography was high performance liquid 
chromatography grade obtained from Fisons (UK).
T etrahydrofuran for size exclusion chrom atography was high 
performance liquid chrom atography grade obtained from  Aldrich (UK).
n-Propionic acid for gas chrom atography was standard laboratory 
reagent grade obtained from BDH (UK).
W ater was freshly  distilled from an all glass apparatus.
Poly(ethylene glycol) standards for calibration of size exclusion 
columns were obtained from Polymer Laboratories (UK). These 
standards were characterized by the m anufacturer as having narrow 
polydispersity (M w /M n) indices. (M w /M n < l.l)
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Table 6.1: Salts Tor the preparation of various buffer solutions.
Buffer salts Reagent grade Source
Sodium carbonate anhydrous Standard laboratory reagent BDH(UK)
Sodium hydrogen carbonate Standard laboratory reagent BDH(UK)
Citric acid m onohydrous Analytical reagent Fisons (UK)
Trisodium  citrate dihydrous Laboratory reagent BDH (UK)
Disodium hydrogen A nalytical reagent Fisons(UK)
orthophosphate anhydrous
Potassium dihydrogen Analytical reagent Fisons (UK)
orthophosphate anhydrous
Sodium chloride Analytical reagent Fisons (UK)
Sodium hydroxide Analytical reagent Fisons (UK)
Potassium chloride A nalytical reagent Fisons (UK)
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Methyl red which was used as a model compound for release studies 
from polymer films was obtained from BDH (UK).
Poly (1-lactate) (weight average molecular weight quoted as 300,000) 
was obtained from Polyscience Ltd (UK).
Poly (lactate-co-glycolatc) (9:1 mole ratio) was obtained as a gift 
from Cyanamid of Great Britain (UK).
6.2 Equipments
6.2.1 Size exclusion chrom atography.
Molecular weight distributions of PHB were determined using the 
equipm ent described in Chapter Four. Molecular weight distributions of 
copolymers were estim ated as PHB equivalents by using the same 
techniques.
Size exclusion chrom atography was also used for determ ination of 
low molecular weight degradation products of PHB. In this case, the 
column used was Micropak TSK 1000H obtained from  Varian Associates 
Inc (USA).* The column dimensions were 3 /8 H OD, 7.5 mm ID, length 30 
cm. This column packing m aterial was spherical, cross-linked 
styrene/divinylbenzene copolymer particles, 8-10 julm in diam eter w ith a 
pore size of 40A.
6.2.2 Gas liquid chrom atography.
A Perkin Elmer model F33 gas liquid chromatograph was used. The 
column packing for analysis of degradation products of PHB was 10% 
Carbowax 20M on Chromosorb W HP (mesh 100/120). This packing 
m aterial was obtained from  Phase Separation (UK).
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6.2.3 Nuclear M agnetic Resonance Spectroscopy.
^H-NMR spectra were recorded on a JEOL GX270MHz Fourier 
Transform  (FT) nuclear magnetic resonance spectrometer.
6.2.4 D ifferential Scanning C alorim etry.
A Du Pont model 910 Differential Scanning Calorim eter was used in 
association w ith a Du Pont model 9900 Therm al Analyser.
6.2.5 W eighing balance.
A M ettler model AE163 digital balance enabled weighing to a 
precision of ±  0.01 mg. This was used to determ ine the d ry  weight of 
PHB and P(HB/HV) copolymer films during degradation experiments.
6.2.6 Infrared and UV spectrophotom etry.
For infrared studies, a Perkin Elmer model 782 infrared 
spectrophotometer was used. M easurements of visible and UV absorption 
were undertaken using a Perkin Elm er model 550S U ltraviolet/V isible 
spectrophotometer.
6.3 M ethods
6.3.1 C atalytic  degradation o f  PHB in  non-aqueous solution .
1 g of high m olecular weight PHB (Batch num ber : Bx IC 83/2) was 
refluxed in 85 ml chloroform  for 15 minutes. The dissolved polymer 
solution was then cooled to room tem perature. The required mass of p- 
toluenesulphonic acid (pTSA) was added in 15 ml methanol. The 
chloroform /m ethanol solution was refluxed at 60°C during the course of 
a degradation experim ent. The s ta rt of the experim ent was taken to be 
when the solution started  to boil.
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Samples were w ithdraw n for immediate analysis of molecular weight 
distribution using SEC. Two concentrations of pTSA were investigated 
i.e. 0.2% w /v  and 0.02% w /v . A control experim ent was performed 
using the same procedure in the absence of pTSA. The effect of methanol 
concentration on the rate of degradation was studied by varying the 
am ount of methanol from 15% v /v  to 30% v /v  in the absence of pTSA.
For determ ination of m olecular weight d istribution , 1ml of the 
refluxing solution was^rem oved from  the reaction vessel. This was 
diluted to 10ml w ith chloroform and assayed using SEC.
6.3.2 Preparation o f  polym er films.
PHB and P(HB/HV) copolymers, received from  the m anufacturer, 
were purified prior to film casting. 2% w /v  of the required polymer was 
refluxed in redistilled chloroform  until it had dissolved (usually  less 
than 15 m inutes). The polym er was then precipitated in the presence of 
excess methanol. The precipitated polym er was collected using W hatman 
No. 52 filter paper placed in a Buchner funnel. It was then washed w ith 
excess methanol and distilled w ater and dried in an oven at 40°C before 
use.
For the casting of PHB films, a 2% w /v  polym er solution was 
prepared. The solution was then concentrated to a final concentration of 
5% w /v  PHB using a Rotary evaporator (Buchii Rotavapor model R110). 
For the preparation of the P(HB/HV) copolymer films, a 5% w /v  solution 
was prepared. This solution was then concentrated by rotary  evaporation 
to give a final concentration of 10% w /v . Polym er solutions were cast 
onto clean, dry  glass plates using a thin layer chrom atography (TLC) 
applicator.
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The clearance selling of Ihe TLC applicalor was chosen lo produce 
d ry  films of Ihickness 80-90 /jltu. The resullanl casl films were dried 
slow ly in draughl-free condilions for 2 hours and Ihen overnight in a 
vaccuum oven at 40°C. Film s were stored at room tem perature for one 
week prior to use.
6.3.3 P re p a ra tio n  o f  pH buffer so lu tions.
^  Buffer solutions were prepared at constant ionic strength (I = 
0 .153M). Ionic strength was calculated according the Equation 6.1
1 =  I  £ i 2 C .......  (6.1)
where
i is the charge of each of the ionic species
3
C is the concentration of each of the ionic species in m ole/dm
Buffer solutions fo r the degradation experim ents were sterilized, 
using a bench top autoclave, at 121°C for 30 m inutes prior to the 
degradation experiment. The following form ulae were used as shown in 
Table 6.2
6.3.4 D egrada tion  o f  p o ly m er film s in  th e  presence o f  aqueous 
so lu tions.
Cast films were cut into pieces measuring approxim ately 2 cm by 1 
cm. Each piece was weighed individually  and stored. Samples used for 
the degradation experim ents were w ithin 0.3mg of the mean weight.
Degradation experim ents were conducted as follows. 15 pieces of the 
cut films were divided into 3 groups, each group containing 5 pieces. The 
total weight of each group of five was monitored during the degradation 
experiment. The mean weight loss was taken as the mean of the three 
groups.
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Table 6.2 : Formulae for preparation of buffer solutions.
pH Types of salt used Q uantity used
5.0 Trisodium citrate dihydrous 5.71 gm
Citric acid m onohydrous 0.92 gm
Sodium chloride 2.38 gm
Distilled w ater to 1000 ml






Sodium chloride 0.67 gm
Distilled w ater to 1000ml
10.0 Sodium carbonate anhydrous 1.59 gm
Sodium hydrogen carbonate 0.84 gm
Sodium chloride 5.76 gm
Distilled w ater to 1000ml
10.5 Sodium carbonate anhydrous 1.84 gm
Sodium hydrogen carbonate 0.17 gm
Sodium chloride 5.96 gm
Distilled w ater to 1000 ml
11.0 Disodium hydrogen 
orthophosphate anhydrous
3.55 gm
Sodium hydroxide 0.32 gm
Sodium chloride 4.15 gm
Distilled w ater to 1000ml
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Each piece of film was identified and placed in a 30 ml screw-capped 
specimen tube in the presence of 20 ml of the required buffer solution. 
As wxll as the aforem entioned 15 pieces, ano ther set of 10 pieces were 
treated in the same m anner for each degradation experiment. These ten 
pieces were used to study changes in m olecular weight and crystallin ity  
during the degradation process. Samples rem oved for crystallin ity  
studies were stored a t -80°C until DSC was perform ed. Buffer solutions 
were replaced at least once weekly and after ev ery weight determ ination.
Degradation experim ents were perform ed at 37°C, to simulate 
physiological tem perature, and at higher tem peratures to enable study of 
degradation at an accelerated rate. Samples w ere stored at physiological 
tem perature, 37±  1°C, in a therm ostatted room.
High tem perature experiments were carried out in ovens (usually 
Gallenkamp vacuum ovens) set at the appropriate  tem perature. The 
tem perature of these ovens was alw ays w ith in  1.0°C of the stated 
tern perature.
6.3.5 D eterm ination o f  w eight loss
Samples were removed from  the buffer so lu tions at regular intervals 
and were dried in a vacuum dessicator over phosphorus pentoxide for 
tw elve hours. A fter drying, samples were weighed to determine the 
cum ulative weight loss. A fter weighing, the individual film samples 
were returned to storage with fresh buffer solution.
6.3.6 Gas liquid chrom atography o f  degradation products
1 gm of PHB was boiled with 50ml 0.1M sodium  hydroxide for 24 
hours to obtain alkali-soluble degradation products. The solution was 
filtered and the filtrate acidified to pH 1.0 (using 1M hydrochloric acid
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solution) to ensure that earboxylic acid derivatives were unionized.Thc 
solution was extracted twice with 50ml ethyl acetate. The ethyl acetate 
portions were pooled and concentrated to about 5 ml using a rotary 
evaporator. The concentrated product was then injected onto the gas 
liquid chromatograph operating under the following conditions:
injection volume:- 2 jj.1
oven tem perature:- 100°C
injector and detector tem perature:- 150°C
column:- 10% carbowax 20M on chromosorb W HP (mesh 
100/ 120)
length : 1 metre
internal diam eter : 1.75 mm.
carrier gas :- nitrogen
pressure of nitrogen used :- 151b/in2
flow rate of nitrogen:- 15m l/m in
detector :- flame ionization detector
operating condition of detector: hydrogen : 17 lb /in2
air : 25 lb /in2
A sim ilar extraction and assay process was carried out a fte r boiling 
lg  PHB in 50ml phosphate buffer (pH 7.4) for 48 hours.
The GLC column for th is experiment was chosen on the basis of its 
reported ability to separate earboxylic acids. The resolution of the GLC 
method was investigated using tw o aliphatic earboxylic acids, (n - 
propionic acid and n -bu ty ric  acid) and tw o hydroxy acids (lactic 
acid and 0-hydroxybutyric  acid). The ethyl acetate extraction process 
was tested by extracting the above acids from  HC1 solutions using the
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standard extraction procedure.
6.3.7 Size exclusion chrom atography o f low  m olecular w eight 
degradation products.
6.3.7.1 Calibration o f colum n.
Polyethylene glycol molecular weight standards were used to 
calibrate a Micropak TSK 1000H column. This column is designed to 
separate molecules which are soluble in tetrahydrofuran  and have 
relative molecular masses below 1000. An infrared spectrophotometer 
was used as a flow-through detector as described in section 3.2.
The infrared spectrum for poly(ethylcne glycol) was obtained by 
placing a liquid oligomer between sodium chloride cells. The strong peak 
at 2930 cm"^ which corresponded to the C-H stretching band, was used 
to detect the elution of poly(ethylene glycol).
Standards were dissolved in te trahydrofuran  (0.5% w /v ) and 20 /il 
of each solution was injected onto the column to obtain a calibration plot.
6.3.7.2 SEC o f non-aqueous degradation products.
5 gm of low molecular weight PHB (approxim ately 20K) was 
refluxed in 90ml chloroform . 2 gm p-toluene sulphonic acid (pTSA) 
was added in 100ml m ethanol. The mixed solution w as refluxed for 
3 days. During this period, samples were taken for analysis of 
molecular weight d istribution. The chloroform and methanol were 
removed from these samples by ro tary  evaporation un til a viscous 
liquid was obtained. 0.1ml of the viscous liquid w as dissolved in 
10ml tetrahydrofuran (THF). This solution was dilu ted 1 in 10 in THF 
before injection onto the SEC column.
The aqueous solubility of the non-aqueous degradation products of
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PHB was examined as follows. 3 ml of the viscous liquid referred to 
above was mixed with 100ml distilled water. The m ixture was shaken 
for 5 m inutes and filtered through a W hatman membrane filter type 
WCN (pore size = 0.45 fim  ). The w ater was removed from the filtrate 
using a ro tary  evaporator. The remaining liquid was collected and 
about 0.1 ml was dissolved in THF, diluted 1 in 10 as before and 
injected onto the SEC column.
6 3 * 1 3  SEC o f  aqueous degradation products
1 g PHB was boiled w ith 50ml of 0.1M sodium hydroxide for 3 
days. The solution was filtered through W hatman No. 1 filter paper to 
remove the suspended polymer. The filtrate obtained was acidified to 
pH 1.0 using 1M hydrochloric acid. The acidified solution was then 
evaporated to dryness using a ro tary  evaporator. 10ml of 
tetrahydrofuran  was added to the dried products and the solution was 
injected onto the SEC column.
6.3.8 DilfeVential scanning calorim etry
6.3.8.1 Introduction.
Differential scanning calorim etry (DSC) was used to study the 
melting behaviour of PHB homopolymer and PHB/PHV copolymers. In 
addition DSC was used to provide estim ates of polym er crystallinity .
In the event of a therm al transition occuring w ithin the sample pan, 
the DSC is required to supply different quantities of heat to the sample 
and reference pans to m aintain isothermal condition between the two 
pans. This therm al change is equivalent to the energy absorbed or 
evolved and is represented by the peak area of a DSC thermogram.
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The peak areas for any transition can be quantified provided the 
instrum ent has been calibrated w ith a reference m aterial of known heat 
of fusion.
The degree of crysta llin ity  of a polym er can be estim ated using 
equation 6.2, provided that the heat of m elting for a 100% crystalline 
polym er is known.
AHm of sem icrystalline polym er 
je rc c ff lt  c rysta llin ity  =  AHm of io o % crystalline polym er
6.3.8.2 Experim ental m ethods
In this study  the differential scanning calorim eter was calibrated 
w ith  indium. (AHm=  28.47 K J/kg) . Approxim ately 3 mg polym er was 
accurately weighed into alum inium  pans using a microbalance and the 
sam ples were covered w ith alum inium  lids. Test samples were placed in 
one DSC cell and an em pty alum inium  pan was placed in the other cell as 
the reference. The pans were heated from ambient tem perature to 220°C 
at a heating rate of 10°C/min unless otherwise stated. The values of heat 
of fusion, onset and peak m elting tem peratures were obtained using the 
computerized therm al analyser.
6.3.9 Nuclear M agnetic Resonance spectroscopy.
50mg PHB hom opolym er or P(HB/HV) copolymers were dissolved in 
deuterated chloroform  and the spectra of the polym ers were determined 
using nuclear magnetic resonance. These spectra (Figures 6.2 to 6.5 ) 
used to determ ine the hydroxyvalerate composition of the copolymers 
supplied by their m anufacturer. Figure 6.2 shows the NMR spectrum of 
the homopolymer, PHB and the assigned chemical sh ift of various proton 
groups of PHB. Figures 6.3 to 6.5 represent the NMR spectra of 
copolymers w ith increasing hydroxyvalerate (HV) content.
Figure 6 . 2  270 - MHz H NMR spectrum of PHB homopolymer
in dueterated chloroform. Chemical shifts 
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Fiqure 6.3  270 - MHz 1H NMR spectrum of a copolyester containing
/3-hydroxybutyrate and /3-hydroxyvalerate units in 
dueterated chloroform. Chemical shifts are ppm 
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Figure 6 . 4 1270 - MHz 'H NMR spectrum of a copolyester containing 
|3-hydroxybutyrate and jft-hydroxyvalerate units in 
dueterated chloroform. Chemical shifts are ppm
downfield from Me^Si. The amount of HV unit = 12*3 mole %
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Figure 6.5 270 - MHz H NMR spectrum of a copolyester containing
-hydroxybutyrate and j3-hydroxyvalerate units in
dueterated chloroform. Chemical shifts are ppm





The amount of HV was calculated by integrating the areas under the 
m ethyl proton peaks for HV and HB. This amount of HV, expressed as 
mole percent of HV, was obtained by dividing the area of peak which 
correspond to the m ethyl proton of HV by the sum of areas which 
correspond to m ethyl protons of HV and HB .
6.3.10 Release o f  M ethyl Red from  polym er films.
6.3.10A  Assays o f  M ethyl Red in phosphate butter (pH 7.4), 0.1M  
sodium hydroxide and chloroform .
Methyl red was assayed by visible light spectrophotometry in both 
aqueous and organic solvents.
Stock solutions of m ethyl red in the above solvents were prepared 
in the range of 5 x 1CT5 M . From these stock solutions, samples were 
taken and diluted to obtain a range of concentrations of m ethyl red in the 
appropriate solvent. The absorption spectra of m ethyl red in each solvent 
were obtained by scanning the absorption of electromagnetic radiation 
from  400ilm to 600nm. The wavelength corresponding to maximum 
absorption was noted in each case and Beer-Lambert calibration plots 
were obtained fo r each solvent. Absorption coefficients from Beer- 
Lambert plots were used in the normal manner and the day-to-day 
performance of the spectrophotometer was monitored using solutions of 
known concentration.
6.3.10.2 Preparation o f  film s containing m eth yl red.
Polymer solutions in chloroform were prepared as described in 
section 6.3.2 . M ethyl red was dissolved in the chloroform solutions of 
polymers to give the desired ratio of drug to polymer. Films were cast 
and dried in the norm al m anner (section 6.3.2). The mass of m ethyl red
in the resultant films was determ ined by dissolving a known mass of film 
in a known volume of chloroform  and assaying for m ethyl red using a 
spectrophotometric technique (section 6.3.10.1).
6.3.10.3 Release experim ents.
A rectangular glass tem plate measuring 2 cm by 7 cm was used to 
cut specimens from polym er films. The release of m ethyl red was 
examined using two specimens from  each film. The mean cum ulative 
mass of m ethyl red released from each film was calculated. Two films 
were prepared to represent each concentration of drug in each polym er 
although the exact concentratons of m ethyl red in films could not be 
replicated precisely. Release experiments were usually  perform ed at 
37°C in phosphate buffer (pH 7.4). A ll experiments were perform ed in 
50ml conical flasks containing 50 ml buffer solution w ithout agitation. 
The polym er was fu lly  submerged w ithout significant contact w ith the 
vessel walls. A separate set of experiments was performed to determine 
the effect of polym er degradation on the release of m ethyl red from 
various polym er films. These experiments were performed at 37°C in 
0.1M sodium hydroxide which increased the rate of degradation of the 
polyesters.
Sink conditions were m aintained throughout the release studies by 
ensuring that the concentration of m ethyl red in the aqueous phase was 
alw ays lower than 1% of its solubility. It was assumed that the 
therm odynam ic activity of m ethyl red in each polym er film was in excess 
of that in the aqueous phase.
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Chapter 7
DEGRADATION AND RELEASE STUDIES FROM PHB AND  
P(HB/HV) COPOLYMERS : RESULTS AND DISCUSSION
7.1 Degradation o f  PHB in non-aqueous solution .
Degradation of PHB in non-aqueous solution to obtain a range of 
molecular weights of PHB was carried out in m ethanol-chloroform  
m ixtures in the presence of a catalyst, p-toluenesulphonic acid 
(pTSA). It was of interest to determine the kinetics of degradation 
under the influence of the catalyst and to determ ine w hether or not the 
degradation process was random. In addition, the effect of refluxing 
PHB in the absence of the catalyst was im portant. Refluxing was 
necessary to dissolve high molecular weight PHB, thus it was of 
interest to determ ine w hether or not any changes in molecular weight 
occurred during 15-30 m inutes refluxing in organic solvents. Size 
exclusion chrom atography was used to m onitor the degradation process 
as described in Part I of this thesis.
Figure 7.1.1 shows the variation in the num ber-average m olecular 
weight of PHB afte r refluxing in m ethanol-chloroform  m ixtures in the 
absence of pTSA. The concentration of PHB was l% w /v  in all cases. The 
methanol was used as a cosolvent to allow dissolution of both PHB and 
pTSA. Concentrations of 15% and 30% v /v  m ethanol were studied. 
Higher contents of m ethanol were not used as these caused precipitation 
of PHB as a gel. Each point on Figure 7.1.1 represents the mean Mn 
from two separate experiments. Standard deviations shown for the data 
obtained in chloroform were representation of the other data. Replicate 
experiments in each solvent were conducted w ith polym er sampled from
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the same batch. The large values of standard deviation were a reflection 
of the polydispersity of the samples or the precision of the assay at high 
m olecular weights. The difference between the mean values obtained in 
chloroform  and the other solvents were a result of the use of different 
batches of polymer. Figure 7.1.1 indicates that there was no measurable 
change in Mn in any of the non-aqueous solvents a fte r refluxing for three 
hours in the absence of pTSA.
^ .^ g g ^ ig u re  7.1.2 and Figure 7.1.3 show the changes in the weight-average 
m olecular weight and the polydispersity index, M w/M n, respectively 
during the same experiments. The variability  in Mw was less than the 
variab ility  in Mn. There were no significant differences in Mn or 
polydispersity  index throughout the refluxing process. These results 
indicated that refluxing could be used as a means of dissolving polymer 
fo r film casting w ithout fear of causing degradation.
Degradation of PHB in the presence of catalyst was carried out at 
tw o different concentrations of pTSA; 0.02% w /v  and 0.2% w /v . The 
solvent use’d was m ethanol-chloroform  in the ratio 15:85 (volume 
ratio). Tables 7.1.1, 7.1.2 and 7.1.3 show the number-average, 
weight-average m olecular weights and degrees of polydispersity, Mn, 
Mw and M w /M n respectively, as a function of tim e during the 
degradation of PHB in the presence of 0.02% pTSA. Each sample was 
examined twice by SEC and the experim ents were replicated to determine 
the sources of error.
Tables 7.1.4, 7.1.5. and 7.1.6. list the equivalent data obtained at the 
higher concentration, 0.2% w /v  pTSA. There were no significant 
differences between replicate degradation experiments. The standard 
deviation of the assay, on replicate injection was usually  w ithin ±  5% of 
the mean although as one would expect the precision of the assay was a
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Table 7.1.1 : Changes in the number-average molecular weight ( Mn )
with time for non-aqueous degradation of PHB in the presence of
0.02% w /v  pTSA
Tim e
(m inutes)
Num ber-average molecular weight
( M . )
1 st experim ent 2nd experiment
0 182000 ±  6000 177000 ±  700
15 171000 ±  9000 176000 ±  4000
30 145000 ±  3000 149000 ±  7000
45 129000 ±  9000 138000 ±  2000
60 122000 ±  0 126000 ±  700
90 107000 ±  1000 108000 ±  700
120 97000 ±  700 102000 ±  4000
150 91000 ±  5000 88000 ±  700
180 83000 ±  0 85000 ±  0
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Table 7.1.2 : Changes in the weight-average molecular weight ( Mw )
with time for non-aqueous degradation of PHB in the presence of
0.02% w /v  pTSA
Time
(m inutes)




0 844000 ±  45000 761000 ±  18000
15 723000 ±  30000 692000 ±  18000
30 624000 ±  28000 604000 ±  49000
45 530000 ±  18000 532000 ±  34000
60 471000 ±  13000 465000 ±  4000
90 384000 ±  3000 398000 ±  9000
120 323000 ±  3000 339000 ±  6000
150 282000 ±  2000 286000 ±  8000
180 248000 ±  1000 254000 ±  5000
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Table 7.1.3 : Changes in the degree of polydispersity ( Mw/M n )
with time for non-aqueous degradation of PHB in the presence of 0.02%




( M ■ ')M,
1st experiment 2nd experiment
0 4.64 ±  0.09 4.31 ±  0.08
15 4.25 ±  0.06 3.95 ±  0.04
30 4.31 ±  0.11 4.05 ± 0 .1 4
45 4.12 ±  0.16 4.01 ±  0.03
60 3.85 ± 0 .1 1 3.71 ±  0
90 3.59 ±  0.01 3.68 ±  0.04
120 3.36 ±  0.01 3.34 ±  0.07
150 3.12 ±  0.18 3.28 ±  0.05
180 . 2.98 ±  0.03 2.99 ±  0.08
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Table 7.1.4 : Changes in the number-average molecular weight ( )
with time for non-aqueous degradation of PHB in the presence of
0.2% w /v  pTSA
Time
(m inutes)
N um ber-average m olecular weight
( X  )
1 st experim ent 2nd experiment
0 192000 ±  6000 187000 ±  16000
15 110000 ±  6000 107000 ±  0
30 49000 ±  2000 65000 ±  3000
45 39000 ±  2000 51000 ±  0
60 33000 ±  700 42000 ±  700
90 25000 ±  0 29000 ±  0
120 20000 ±  700 25000 ±  0
150 17000 ±  0 20000 ±  0
180
•
15000 ±  0 17000 ±  0
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Tabic 7.1.5 : Changes in the weight-average molecular weight ( Mw )
with time for non-aqueous degradation of PHB in the presence of
0.2 % w /v  pTSA
Time
(m inutes)
W eight-average m olecular weight 
(A/.. )
1st experiment 2nd experiment
0 836000 ±  37000 821000 ±  37000
15 418000 ±  24000 414000 ±  4000
30 154000 ±  0 214000 ±  6000
45 118000 ±  4000 151000 ±  1000
60 94000 ±  1000 118000 ±  3000
90 70000 ±  1000 82000 ±  1000
120 52000 ±  1000 64000 ±  1000
150 43000 ±  0 52000 ±  1000
180 37000 ±  1000 43000 ±  0
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Tabic 7.1.6 : Changes in the degree of polydispersity ( ) w ith
iVin




Degree of polydispersity 
)
A*n ~
1st experiment 2nd experiment
0 4.36 ±  0.04 4.41 ±  0.18
15 3.81 ±  0.01 3.87 ±  0.03
30 3.18 ±  0.13 3.28 ±  0.04
45 3.06 ±  0.04 2.94 ±  0.01
60 2.89 ±  0.02 2.82 ±  0.11
90 2.73 ±  0.06 2.84 ±  0.04
120 2.64 ±  0.04 2.59 ±  0.01
150 2.56 ±  0.02 2.55 ±  0.08
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Figure 7.1.1:- The variation of the number-average
molecular weight (Mn) of PHB with 
time during reflux in various non- 
aqueous solutions. ( •), 1% w/v 
polymer in chloroform; ( ■ ), 1% w/v 
polymer in 85:15 chloroform:methanol 
(volume ratio); (A), 1% w/v polymer 
in 70:30 chloroform; methanol (volume 
ratio)
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Figure 7.1.2:- The variation of the weight-average
molecular weight (Mw) of PHB with 
time during reflux in various non- 
aqueous solutions. ( •), 1% w/v 
polymer in chloroform; ( ■ )f 1% w/v 
polymer in 85:15 chloroform: methanol 
(volume ratio); ( a ) ,  1% w/v polymer 
in 70:30 chloroform: methanol (volume 
ratio)









ISO 2000 50 100
Time (minutes)
Figure 7.1.3:- The variation of the degree of
polydispersity (Mw/Mn) of PHB 
with time during reflux in various 
non-aqueous solutions. (• ), 1% w/v
polymer in chloroform; ( ■ ), 1% w/v 
polymer in 85:15 chloroform: methanol 
(volume ratio); ( a  ) 1% w/v polymer 
in 70:30 chloroform: methanol (volume 
ratio)
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function of retention time; longer retention was associated with greater 
precision.
Figures 7.1.4, 7.1.5 and 7.1.6 are plots of mean Mn, Mw and M w/M n 
respectively against time, pooling all the data for each concentration of 
pTSA. From these three figures, it can be seen that Mn, Mw and M w/M n 
decreased progressively w ith time. Closer inspection of Figure 7.1.6 
suggests that the polydispersity index, M w /M n, was approaching a 
m inim um  value of 2 which represents, the most probable m olecular 
weight d istribution (MW D). Theoretically, the most probable MWD of 2 
is achieved when random chain scission is operative. Random chain 
scission implied that each polym eric repeat unit has the same probability 
of undergoing scission. If non-random  chain scission was operative, the 
MWD would be narrow er than that obtained by random chain scission 
usually  leading to a polydispersity index is in the range of 1-2 (Scott, 
1974). Figure 7.1.6. is not sufficient to show which of these processes is 
operative for the pTSA degradation. However a more detailed criteria 
can be used to establish the occurrence of random main chain scission. 
The theory is based on equations developed by Scott (1974). Linear 
polym ers undergoing random  main chain scission possess a Schulz-Zimm 
m olecular weight d istribution (MW D). The use of this analysis is 
discussed below.
Tables 7.1.7. and 7.1.8 show the relative changes in molecular 
weights for each degradation in the presence of 0.02% w /v  and 0.2% w /v  
pTSA respectively. The results from  each experiment were calculated 
separately since the initial average molecular weights differed slightly.
u ' 2 u ' j
Figure 7.1.7. shows a plot of  against  in comparison with the
u2 U1
theoretical Schulz-Zimm plot which should be obtained during random 
chain scission of a linear polym er (see
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Figure 7.1.4:- Decrease in the number-average
molecular weight (Mn) of PHB 
with time during reflux in the 
presence of pTSA. ( O ), 0»2% 
w/v pTSA; ( •), 0*02% w/v pTSA.
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Figure 7.1.5:- Decrease in the weight-average
molecular weight (Mw) of PHB with 
time during reflux in the presence 
of pTSA. ( • ), 0-02% w/v pTSA ( O ),
0*2% w/v pTSA.
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Figure 7.1.6:- Decrease in the degree of
polydispersity (Mw/Mn) of PHB 
with time during reflux in the 
presence of pTSA. ( • ), 0-02% 
w/v pTSA } (O)* 0*2% w/y pTSA.
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Table 7.1.7 : Relative change in num ber-average molecular weight ,
U j'/U j , and weight-average molecular weight , / i ^ ,  against tim e











0 1.000 1.000 1.000 1.000
15 0.940 0.857 0.994 0.909
30 0.797 0.739 0.841 0.794
45 0.709 0.628 0.780 0.699
60 0.670 0.558 0.712 0.611
90 0.588 0.455 0.610 0.523
120 0.500 0.334 0.497 0.376
150 . 0.500 0.334 0.497 0.376
180 0.456 0.294 0.480 0.334
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Table 7.1.8 : Relative change in number-average molecular weight,
u j7  Uj , and weight-average m olecular weight, u ^ / ^ 2  » a£ainst 
















0 1.000 1.000 1.000 1.000
15 0.573 0.500 0.572 0.504
30 0.255 0.184 0.348 0.260
45 0.203 0.141 0.273 0.184
60 0.172 0.112 0.225 0.144
90 0.130 0.084 0.155 0.100
120 ' 0.104 0.062 0.134 0.078
150 0.089 0.051 0.107 0.063
180 0.078 0.044 0.091 0.052
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below). The linear polym er was assumed to have a Schulz Zimm MWD 
w ith  a polydispersity index (M w /M n) of 4.40 at zero time. This value 
was taken to represent the average value of the polydispersity indices of 
PHB samples measured by SEC (see Table 7.1.6). The theoretical plot 
was obtained using Equations 7.1 and 7.2 as shown below:-
—  =  ..... (7.1)Ui 1 + x
u
Ui xH i + ± [ ( i+ *  r b- i]  x b (7.2)
where
u'j and u '2 are, respectively,the num ber and weight-average 
degrees of polymerization a fte r scission
Uj and u 2 are the corresponding values before scission.
x is the num ber of scission per initial num ber-average 
m olecular weight molecules.
H is the degree of polydispersity (or M w /M n).
b is equal to the inverse of (H -l)
As can be seen from  figure 7.1.7, there is a close sim ilarity  between 
the degradation of PHB in the presence of pTSA and the theoretical 
Schulz-Zimm plot for a random  chain scission. Hence it can be assumed 
that in the presence of pTSA, PHB degrades by a process modelled by 
random  chain scission and that the m olecular weight distribution of PHB 
w ill tend tow ards tha t represented by the Schulz-Zimm distribution, 
[(Mn + M z)/M w  = 2 and 1 < M z/M w < 2].
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Figure 7.1 . 7 : - The relative change in weight average 
molecular weight, u^/u-/ versus the 
relative change in number average 
molecular weight, u'/u^, during reflux 
of PHB in the presence of pTSA.
O and A experimental data obtained using 
0•02%w/v PTSA
□ and ■ experimental data obtained using 
0-2% w/v pTSA
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In order to determine the rate of bond cleavage, Jellinek (1978) 
stated that for random chain scission in solution, the following 
relationship should hold (see section 5.5.3);
1 1
DP DP0 =  k t ..... (7.3)
where
DP is the degree of polymerization at tim e t 
DP0 is the initial degree of polymerization.
Tables 7.1.9 and 7.1.10 show the function w ith respect
Ur Ur  o
to tim e for each experiment in the presence of 0.02% w /v  and 0.2%
w /w  pTSA respectively. The differences between the values obtained
for the tw o experiments again reflect the polydisperse nature of the high
molecular weight PHB being used and also the lim ited precision of the
SEC column. The assay used during this study could be improved by the
use of several PL gel colum ns linked in series although this would result 
0
in the practical disadvantage associated w ith long retention times.
Values of _J——_ L _  are plotted according to Jellinek’s equation in
Ur Ur  o
Figure 7.1.8. The plots were linear fo r both concentrations of pTSA and 
the rate constant for each concentration was calculated from  the slope 
of the curve. The rate constants were (2.68 ±  0.09) X 10-5 min-1 and 
(0.31 ±  0.01) X 10-5 m in-1 for degradation in the presence of 0.2% w /v  
and 0.02% w /v  pTSA, respectively . pTSA proved to be a useful 
catalyst fo r controlled degradation of PHB in th is non-aqueous system. 
Since the purification of PHB from ferm entation m ixtures involves 
precipitation from  chloroform  into excess methanol followed by 
filtration, it would be easy to include a pTSA degradation step to obtain 
lower molecular weights as required.
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Figure 7.1.8:- The relationship between the
function (J 1_ ) with time
DP DP0 
for degradation of PHB in the 
presence of pTSA. ( •), 0*02% 
w/v pTSA (O), 0-2% w/v pTSA.
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Table 7.1.9 : Changes in the function of ( 1/DP - 1/DPq ) with time in 
the presence of 0.02% w /v  pTSA
Time
(minutes)
( 1/DP - 1/DPq ) 
( x  104 )










Tabic 7.1.10 : Changes in the function of ( 1/DP - 1/D Pq ) with time in 
the presence of 0.2% w /v  pTSA.
Time
(m inutes)
( l/D P  -1 /D Pq ) 
( X 1 0 4 )
1st experiment 2nd experiment
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7.2 Degradation o f PHB and P(HB/HV) copolym ers in aqueous 
solution .
H ydrolysis studies of PHB were carried out using solvent-cast films 
at different values of pH at 37°C. Figure 7.2.1 shows the weight loss of 
these films as a function of storage time. The weight loss from polymer 
films followed a zero-order pattern. This could be explained by surface 
erosion if degradation took place through a constant surface area such 
that the degradation from  the sides of the film were not significant 
compared to degradation from  the planar surface.
However, th is conclusion was draw n w ith caution, since the zero- 
order fit was not alw ays significantly better than a first -order fit, as 
can be seen in Figure 7.2.2, which expresses the degradation of films at 
pH 7.4 and 37°C plotted on a logarithm  scale against time. Such 
uncertain ty  is not surprising since the degradation of PHB probably 
results in the form ation of pores which change the effective surface area 
throughout the degradation process. This phenomenon was observed by 
Holland et al. (1987) who studied the degradation of PHB discs. These 
authors studied the morphology of PHB discs using scanning electron 
microscopy and found tha t the surface of the discs became more 
porous as a result of degradation. Generally, the data obtained 
during the present study was best modelled using a zero-order plot. 
Therefore subsequent data is plotted as cum ulative weight loss against 
time.
Each point on Figure 7.2.1 represents the mean of three experiments. 
The standard deviations obtained at each tim e were w ithin 2% of the 
mean values. The linear rate  constants for the degradation of PHB 
films in various pH buffers were obtained from  the gradient of the 

























Figure 7.2.1:- Progressive weight loss of PHB film
in buffer solutions at 37°C; (A ), 
pH 1-0; ( O ), pH 7*4; ( ■ ), pH 10-0; 
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Figure 7.2.2:- First - order plot of weight loss
of PHB film in phosphate buffer 
(pH 7*4) at 37°C.
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Tabic 7.2.1 : Rate constants for degradation of PHB in different pH at 
37°C
pH Rate constant(k)
( % weeks”* xlO ^ )
1.0 4.0 ±  1.9
7.4 32.9 ±  2.8
10.0 43.7 ±  4.9-
13.0 81.9
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Figure 7.2.3 shows the rate constants for the degradation of PHB 
films at 37°C plotted against pH. This figure shows that there was 
m inim al degradation at pH 1 and a progressive increase in degradation as 
the pH was increased. The degradation appeared to be base-catalysed but 
not acid-catalysed.
The mechanism of ester hydrolysis can be explained by the 
hypothesis put forw ard by Schnabel (1981) according to which tw o 
types of bond cleavage can occur depending on the pH of the solution. 
In acidic conditions, hydrolysis is initiated by a protonation process 
which is followed by the addition of w ater and the cleavage of the ester 
linkage as shown on the opposite pages. In the case of PHB, presum ably, 
this mechanism is slow.
In contrast in alkaline media, hydroxyl ions attack the carbonyl 
carbons resulting in rapid hydrolysis of ester linkages as illustrated on 
the same page as above. Thus the degradation of PHB appears to be 
sim ilar to copolymers of polyethylene oxide/polyethylene terepthalate 
(PEO/PET)* which are known to be pH-sensitive (Reed and Gilding, 
1981).
Figure 7.2.1 shows tha t the m axim um  weight loss determined during 
degradation experim ents at 37°C over a 50 week period was about 36%. 
This partial degradation study cannot tru ly  represent the whole 
degradation process. Hence, accelerated testing was carried out to obtain 
inform ation on the course of the degradation process as it proceeded until 
most of the film had degraded. It was also hoped that an extrapolation 
procedure could be used to model the degradation process which would 
take place in the physiological environm ent at pH 7.4 and 37°C.
Figure 7.2.4 shows the degradation of PHB films in 0.1M sodium 
hydroxide as a function of tem perature. Degradation rate increased w ith
1 8 8
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Reaction 2 : Degradation of polyesters in acidic solutions.
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Reaction 3 Degradation of polyesters in basic solutions. 
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Figure 7.2.3:- Variation of linear degradation
rate constant for PHB films as a 
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Figure 7.2.4:- Progressive weight loss of PHB film in
0*1M NaOH as a function of temperature.
( ■ ), at 37°C; ( • ), at 65°C;
( a  ) , at 75°C; ( O ), at 85°C;
( □ ), at 95°C.
1 9  2
tem perature as expected. Table 7.2.2 shows the linear degradation rate 
constants (k ) obtained at each tem perature (T) from the slope of the
graphs. The values of -i- (K_1) and log k are also tabulated. These
values were used to plot log k against (Figure 7.2.5) according to the 
A rrhenius ' equation as shown below:-
lnk.  =  l n A - J L  ..... (7 .4) T
where
E is the activation energy
R is the gas constant
k is the rate constant
T is the absolute tem perature in K
A is the pre-exponential factor.
The slope of the straight line gives the value of the activation energy 
calculated as 16.6 ±  0.6 kcal/m ole. This value is lower than tha t 
obtained for the hydroly tic  degradation of poly(esterurethanes) (PUR) 
by Cohen and Van Aartsen (1973). These authors determ ined that the 
activation energy fo r the hydrolysis of PUR which occured through 
backbone cleavage w as 23.8 ±  0.9 kcal/m ole.
The effect of pH on the hydrolysis of PHB films at high tem perature 
was studied as a comparison w ith the results obtained at 37°C. Figure 
7.2.6. shows weight loss as a function of time at 75°C. Linear 
degradation rate constants for each pH are shown in Table 7.2.3. The 
change from  physiological' tem perature (Table 7.2.1) to 75°C (Table 
7.2.3) caused an increase in degradation rate throughout the pH range 
studied. The increase in the degradation rate in 0.1M sodium hydroxide
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Tabic 7.2.2 : A rrhenius’ plot for the effect of tem perature on the 
degradation of PHB in 0.1M sodium hydroxide.
Tem perature(T) 1/T Rate conslant(k) In k
(°C) ( K '1 X103 ) ( % days’  ^ X10
37 3.2 1.2 -2.12
65 3.0 10.2 0.02-
75 2.9 22.0 0.79
85 2.8 52.8 1.66
95 2.7 163.8 2.80
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Figure 7.2.5:- Arrhenius' plot for the hydrolytic



























Figure 7.2.6:- Progressive weight loss of PHB films
in buffer solutions at 75°C; ( ■ ),
pH 7 • 4 ; ( □ ), pH 10; ( • ), pH 10-5;
( o  ), pH 11-0; ( a ), pH 11-5?
(A ), pH 13-0.
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Table 7.2.3 : Rate constant for degradation of PHB in different pH at 
75°C
pH Rate constant(k)
( % weeks- * XlO^ )
1.4 4.9 ±  0.7
10.0 26.1 ±  2.6
10.5 41.0 ±  2.5
11.0- 59.2 ±  4.0
11.5 76.6 ±  2.9
13.0 154.0 ±  2.3
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was about tw enty  fold when the tem perature was increased from 37°C to 
75°C.
Figure 7.2.7 shows the relationship between linear degradation 
rate  constant and pH at 75°C. The general shape of the curve is the same 
as tha t obtained at 37°C (Figure 7.2.3). These results suggest that 
degradation a t 75°C proceeded by the same mechanisms as degradation at 
37°C and that accelerated tests could be used to extrapolate the 
kinetics of degradation to lower tem peratures. The advantage of the 
high tpmppratnp ^  study was tha t the complete profile of PHB 
degradation was obtained w ithin a short duration.
The degradation of PHB was compared w ith that of P(HB/HV) 
copolym ers to determ ine the effect of HV content on degradation. The 
mole fractions of hydroxy valerate in the copolymers used, measured by 
proton NMR spectroscopy, were 0.065, 0.123 and 0.193.
Figures 7.2.8 to 7.2.10 show weight loss at pH 7.4 and 37°C from 
PHB and copolymer films as a function of HV content. Linear 
degradation rate constants from these experiments are shown in Table 
7.2.4, although it should be noted tha t the data obtained for tw o of the 
copolym ers (Figures 7.2.8 and 7.2.9) did not fit a zero-order model 
convincingly.
Table 7.2.4 shows that all of the copolymers degraded more 
rapid ly  than PHB bu t the maximum degradation rate  occured at 12.3 
mole % PHV. The copolym er containing 19.3 mole % HV degraded at 
a slightly higher rate than PHB (Figure 7.2.11). These differences in 
degradation rate could be explained in term s of the crystalline natures 
and polarities of the copolymers. The crysta llin ity  of PHB is 
decreased by the introduction of HV. This decrease in crystallin ity  is 
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Figure 7.2.7:- Variation of linear degradation rate
constant as a function of pH for PHB 
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Figure 7.2.8:- Progressive weight loss of PHB/PHV
copolymer (6*5 mole % HV) film 
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Figure 7.2.9:- Progressive weight loss o f (12*3 mole % HV)






















0 10 20 40
Time (weeks)
Figure 7.2.10:- Progressive weight loss of (19*3 mole %)
PHB/PHV copolymer films in pH 7-4 
at 37°C.
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Tabic 7.2.4 : Rate constant for degradation of PHB and its copolymers in 
pH 7.4 ( 1 = 0.153M ) at 37°C
Polymer composition Rate constant (k) 
(mole % HV) ( % weeks XlO )
3.3 ±  0.3
6.4 ±  0.9 
7.9 ±  1.0



























Mole % of hydroxyvalerate (HV) in PHB/PHV
copolymers
Figure 7.2.11 : - Variation of linear degradation
rate constants as a function of 
PHB/PHV copolymer composition for 
films stored in phosphate buffer 
(pH 7-4) at 37°C.
2 0 4
Table 7.2.5 : Heats of fusion, AHj- , for PHB and P(HB/HV) copolymer 
films
Polymer composition Heat of fusion
(mole % HV) AHf ( —)
g
86.0 ±  7.7
64.4 ±  0.6
44.5 ±  3.7






for each copolymer is tabulated. AH^ was obtained using differential 
scanning calorim etry. The degree of crystallin ity  would not in this 
case be proportional to the value of AHp since the values of AHj. 
would be different for mixed crystals of HV and HB. However the steep 
fall in overall AHj. - i s  indicative of a substantial change in 
crystallin ity  which decreases steadily w ith increase in HV content.
Keller (1957, 1962) introduced the concept of chain folding to 
explain crystallin ity  in polymers. According to Keller,jpolym£r crystals 
arise from  the lam ellar folding of polym er chains in such a way that the 
thickness of a crystal is determined by the fold length of the polymer 
chain. Following the introduction of this concept, M andelkem (1975) 
represented the morphology of a sem icrystalline polym er as shown in 
Figure 7.2.12. When the amorphous content is increased, as in this study 
by the intoduction of HV units, more polymer chain-ends are exposed to 
the degradative process. Hence, when the degree of crystallin ity  
decreases, the degradation rate increases. This effect of the degree of 
crystallin ity  on polym er degradation has been demonstrated in vivo 
(M iller et al, 1977) for P(LA/GA) system s.
Despite the decrease in degree of crystallin ity , which continued for 
the P(HB/HV) copolymers as HV content increased, there was a change in 
behaviour as the HV content increased from 12.3 to 19.3 mole %. The 
degradation rate was slower for the polym er containing 19.3 mole% HV. 
This may have been due to an increase in hydrophobicity which may 
have reduced wetting or penetration of w ater at the polym er/solution 
interface.
The precise crystalline nature of P(HB/HV) copolymers is yet to be 
determined and there is some confusion in the literature. Certainly the 
copolymers are not am orphous in the manner of P(LA/GA) copolymers.
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A mo rp ho us  or 
Interzonal
I n t e r fo c i a l  Zone
C ry s t a l l i n e
Figure 7.2.12:- Schematic representation of
crystalline and associated 
non crystalline regions in 
polymers (from Mandelkern, 1970).
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It was reported by Bluhm el al. (1986) that over the range of copolymers 
containing between 0 and 47 mole % HV, there exists an unexpected 
minim um  in the heat of fusion ( AH^ ) at approxim ately 30 mole % of 
HV. They attributed  this phenomenon to the isodimorphism of these 
copolymers such that two crystalline phases due to /3-hydroxybutyric 
acid (HB and HV units exist on either side of this m inim um  value heat of 
fusion). It is possible that as HV contents increase tow ards 30 mole %, the 
regions of HV content are associated in the am orphous regions causing 
increased hydrophobicity. At higher HV contents, the major crystalline 
areas would be based on the unit cell for HV. More work on the 
crystalline nature of copolymers is required so that the nature of 
polym er-drug m ixtures can be understood. A t present the degree of 
randomness in the copolymer chain is not known. At present it can be 
assumed that the degradation of P(HB/HV) copolymers containing 
between zero and 30 mole % HV depends on the balance between the 
crystallin ity  and the hydrophobicity of the polym er. Such a balance has 
been shown to control the degradation of P(LA/GA) copolymers over a 
wide range of composition. (Gilding and Reed, 1981).
Figure 7.2.13 shows the accelerated degradation study  of P(HB/HV) 
copolymer in 0.1M sodium hydroxide at 75°C. These weight loss profiles 
show that the rank order of degradaton rates is in agreement w ith that 
obtained under physiological conditions (at 37°C and pH 7.4).
Table 7.2.6. and Figure 7.2.14 show the linear degradation rate 
constants obtained from  the slopes of Figure 7.2.13. There was no 
significant difference between the linear rate constants for the 6.5 mole % 
HV and 19.2 mole % HV copolymers. The 12.3 mole % HV copolymer 
had the highest degradation rate constant and the general shape of the 
























30S 10 15 20 250
Time (days)
Figure 7.2.13:- Progressive weight loss of PHB/PHV
copolymer films stored in 0«1M 
sodium hydroxide at 75°C; ( • ), PHB; 
( A ), 6-5 mole % H V ; ( O ) , 12-3 
mole % HV; ( ■ ), 19-2 mole % HV.
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Tabic 7.2.6 : Linear rate constant lo r degradation of PHB and 
P(HB/HV) copolymers in 0.1M sodium hydroxide a t 75°C
Polymer composition Rate constant (k.) 
(mole % HV) ( % days- * )
0  2.2 ±  0.1
6.5 6.4 ±  0.1
12.3 ^  8.9 ±  0.4











Mole % of hydroxyvalerate (HV) in PHB/PHV
copolymers
Figure 7.2.14:- Variation of linear degradation rate
constants as a function of PHB/PHV 
copolymer composition for films stored 
in 0•1M sodium hydroxide at 75°C.
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main difference between the data obtained under physiological conditions 
and those obtained under accelerated conditions was that, in the latter 
case, PHB homopolymer degraded much more slowly than all 
copolymers. However it would appear that the accelerated tests could be 
used as an indicator of changes in degradation rate.
Figure 7.2.15 shows the weight loss profile for P-l-LA and P(LA/GA) 
containing 10 mole % glycolate. The degradation rate for P-l-LA was 
slower than that forJP(LA/GA). This was expected due to the nature of 
P-l-LA which is relatively hydrophobic and more crystalline than the 
P(LA/GA) copolymer. A comparison of these results w ith those obtained 
using PHB under the same conditions shows that the relative order of 
increasing resistance of hydrolysis was P(GA/LA) <  PLA <  <  PHB.
Previous studies of P(LA/GA) system s have shown that these 
polym ers degrade by bulk  hydrolysis followed by extensive mass loss 
(Reed and Gilding, 1981). It was of interest to compare the mechanisms 
of degradation of P(LA/GA) system s w ith PHB. SEC studies were 
carried o u t’ to observe changes in the molecular weight of the polym er 
during degradation. Such data are shown in Table 7.2.7. These were 
determined during the degradation of PHB in 0.1M sodium hydroxide at 
85°C. The m olecular weight of the bulk polym er remained constant as 
the film progressively lost weight. Ths implies that the mass loss occured 
through surface hydrolysis while the bulk m atrix of PHB remained 
unchanged. The same study was also carried out on P-l-LA using an 
assay of PHB m olecular weight-equivalent. The weight-average 
molecular weight (M w ), decreased from  258K to 15K w ithin one day of 
degradation. The rem aining weight of PLA after this degradation was 
22%. Thus PLA degraded by both hydrolysis of the surface and bulk 
polym er chains. H ydrolysis of the chains within the bulk was
2 1 2
Tabic* 7.2.7 : Weight loss and changes in molecular weight during









0 ' 0 609000 ±  85000
2 14.9 ±  1.5 607000 ±  54000*
7 43.3 ±  1.9 629000 ±  37000
9 56.7 ±  1.8 607000 ±  54000

























Figure 7.2.15:- Progressive weight loss of PGA/PLA
copolymer (10 mole % glycolate)
( • ) and PLA homopolymer ( A )  films 
stored in phosphate buffer (pH 7*4) 
at 75°C.
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responsible for the decrease in bulk molecular weight. Table 7.2.8 shows 
changes in the molecular weights and masses of various polymer films 
during degradation under various conditions. The degradative conditions 
to which these polym ers were exposed are stated in the table (Table 
7.2.8). P(HB/HV) copolymers degraded in the same m anner as PHB 
homopolymer, that is, by surface hydrolysis w ithout any change in the 
m olecular weight of the bu)k copolymer films. This studied showed 
clearly that the degradation of P(LA/GA) copolymer occurred by 
hydrolysis of the surface and polymeric chains.
Differential scanning calorim etric (DSC) studies of the degraded films 
were also undertaken. Films removed after degradation were stored at 
-80°C until the DSC studies were carried out to avoid any equilibration 
of degree of crystallin ity . The heats of fusion,AHj. , obtained before and 
after degradaton are shown in Table 7.2.8. There were no changes in 
AHj. for PHB or P(HB/HV) copolymers after degradation indicating no 
changes in the bulk properties of the polymers. This is a conformation 
that degradaton proceeded by surface erosion. Thermograms for the P-l- 
LA and P(LA /G A ) films were different before and after degradation. The 
melting endotherm  peaks were broader after degradation indicating bulk  
changes in these tw o polymers but the values of AH|* were lower a fte r 
degradation. These values of AH .^ indicate lower degrees of crystallin ity  
after degradation; an unexpected result, although there was some doubt 
associated w ith  these values due to difficulties in establishing the 
baselines of the therm ogram s a fte r degradation.
7.3 A n alysis o f  w ater-soluble degradation products
Although weight loss and molecular weight determ inations 
provide inform ation relating to the mechanisms of polym er degradation, 
they do not establish the degradation products which are released into
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Tabic 7.2.8 : Changes in the weight,weight-average molecular weight and 
heats of fusion for various polyesters









Heat of fusion 
AHf
(J/g )
Initial Final Initial Final
PGA/PLA( 1:9) in pH 7.4 76.6 94K 12K 25.0 17.6
at 75°C - -
PLA in pH 7.4 at 75°C 69.5 258K 113K 40.2 28.6
PHB in pH 7.4 at 37°C 15.6 868K 868K 86.0 86.3
6.5 mole % PHB/PHV 78.9 430K 430K 64.4 64.0
in 0.1 M NaOH at 75°C
12.3 mole % PHB/PHV 87.2 1050K 1050K 44.5 44.2
in O.IM NaOH at 75°C
19.2 mole % PHB/PHV 76.6 1480K 1480K 35.3 35.6
in O.IM NaOH at 75°C
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aqueous solution. These degradation products may provide fu rther 
inform ation on the mechanisms of degradation and arc of interest from a 
toxicological viewpoint. Studies on the presence of w ater-soluble 
degradation products focused on w hether the monomer or oligomers were 
released from  polym er films as a resu lt of surface hydrolysis.
Since the monomer released from PHB would be d-/3-hydroxybutyric 
acid, initial studies on w ater-soluble degradation products were aimed at 
— ^detection of /3-hydroxybutyric acid. Two simple methods that have been 
used to quan tify  /3-hydroxybutyric acid; the spectrophotometric method 
used by Slepecky and Law (1960) and the gas liquid chrom atography 
used by Cosmi et al. (1983). /3-hydroxybutyric acid is freely available as 
its sodium salt but dim ers, trim ers and higher oligomers are not available 
from  chemical suppliers. A fractionation method fo r oligomers having 
degrees of polymerization ranging from  10 to 20 has been developed by 
Coulombe et al. (1978) and methods for synthesis of dim ers and trim ers 
have been reported. A method allowing detection of the monomer and 
low m olecular weight oligomers sim ultaneously would be preferable and 
hence efforts were directed tow ards th is aim.
One series of experim ents used gas liquid chromatography(GLC) on a 
column capable of resolving carboxylic acids, such as n -butyric  acid and 
propionic acid (see Chapter 6). Figure 7.3.1a shows the separation of n - 
butyric  acid and propionic acid using this column. Butyric acid was 
retained longer due to its hydrophobicity and lower molecular weight. 
When dl-lactic acid and /3-hydroxybutryric acid were injected into th is 
column, no separation between these tw o compounds was observed, as 
shown in Figure 7.3.1b. This indicated tha t the colum n was not capable 
of resolving low m olecular weight hydroxy acids presum ably due to their 







a) Attenuation:- 100 x 512 
Retention time for 
i^ n-propionic acid = 2.8
= 5.6
(b) Attenuation:- 100 x 8
Retention time = 2 . 8  min
butyric acid
l l i
(c) Attenuation:- 100 x 80 
Retention time = 2.8 min
Figure 7.3.1 : - Gas liquid chromatograms (G L C ) of
(a) n-butyric acid and propionic acid.
(b) dl-lactic acid and jft-hydroxybutyric 
acid (c). Aqueous soluble product!s) 




GLC. When the w ater-soluble degradation products were injected into 
the column, only one peak was observed w ith a retention time 
corresponding to that of /3-hydroxybutyric acid. No higher molecular 
weight peaks were detected suggesting that dim ers and trim ers of /3- 
hydroxybu tyric  acid were not present in aqueous solution.
-*L
U nfortunately  this could not be established because no standards were 
available to test for chrom atographic retention. Synthesis of dim er and 
trim er was beyond the scope of th is study. Olsen et al. (1965) has shown 
tha t the chemical synthesis of the dimeric ester of /3-hydroxybutyric acid 
involves a sequence of several reactions and higher oligomers are difficult 
to pu rify .
A second chromatographic method was examined; namely, low 
m olecular weight size exclusion chrom atography (SEC). A column was 
available which separated molecules below a threshold of about 1000 
daltons. This column was calibrated w ith poly(ethylene glycol) (PEG) 
standards. Direct calibration of th is column w ith PHB standards was not 
possible due to lack of pure oligomers as mentioned above.
Figure 7.3.2 shows the infrared  spectrum  of polyethylene glycol. 
Calibration of the SEC column was facilitated by detection of PEG at 
2930 cm- * which corresponded to the C-H stretching region. Degradation 
products of PHB were detected by infrared absorption in the C=0 
stretching region as in previous experiments.
Table 7.3.1 shows the m olecular weights of PEG fractions 
(M w /M n < l .l )  used for the calibration curve and their corresponding 
retention times. The calibration curve obtained is shown in Fiugre 7.3.3. 
The column was expected to resolve oligomers of PHB from  the monomer 
to the hexamer.
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Figure 7.3.3:- SEC Calibration curve of
polyethylene glycol
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T a b le  7.3.1 : SEC ca l ibrat ion  c u r v e  o f  p o lyC e th y le n e  g ly c o l  )
Peak Retention times






Figure 7.3.4a shows the chromatographic retention of the monomer, 
j3-hydroxybutyric acid. Based on the calibration curve of poly(cthylene 
glycol), this retention time corresponded to a molecular weight slightly 
lower than the exact molecular weight of /3-hydroxybutyric acid. (True 
MW = 104). A small unidentified peak at higher molecular weight was 
evident in the reagent supplied.
Figure 7.3.4.b shows the chromatogram for w ater-soluble
J B t
degradation products ^obtained from  PHB film. Only one peak was 
evident w ith a retention time corresponding to that of the monomer. 
This data suggests that the degradation of PHB films occurs through 
surface hydrolysis such that the monomer breaks off from  the chain end. 
A lternatively, if dim ers or higher oligomers are released into the aqueous 
phase, they are rapidly degraded to the monomer.
Figure 7.3.4c shows the chromatogram of degradation products 
obtained from P(HB/HV) copolymer film containing 12.3 mole % HV. 
The main peak eluted w ith a retention time corresponding to that of /3- 
hydroxybtftyric acid. The overlapping higher molecular weight peak was 
presum ably due to /3-hydroxyvaleric acid, indicating that copolymers 
degrade by the same process as PHB.
In sum m ary, both the SEC and GLC studies indicate th a t aqueous, 
surface hydrolysis of PHB and P(HB/HV) copolymers is achieved by 
cleavage of monomers f  rom the exposed chain ends.
When random chain scission of polymers occurs in non-aqueous 
solution, a whole range of oligomers are produced, as has been 
dem onstrated in Part I of this study. It was of interest to test the 
resolution of the SEC method for oligomers of PHB obtained by pTSA 
catalysed degradation. In addition an attem pt was made to determ ine 
aqueous solubility of oligomers.
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Figure 7.3.4:- Size exclusion chromatograms of
(a) /3-hydroxybutyric acid (b). 
Degraded product obtained from 
degradation of PHB film in 0*1M 
NaoH (c). Degraded products from 
12*3 mole % PHB/PHV copolymer film 
in 0*1M NaOH.
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Figures 7.3.5a and 7.3.5b show the SEC chromatograms of products 
from degradation of PHB in chloroform  in the presence of pTSA and 
those products which appeared to dissolve in water.
Figure 7.3.5a shows that three peaks were obtained after 
extensive degradation of th is sample and their retention times are shown 
in Table 7.3.2. Based on the calibration curve of poly(ethylene glycol) the 
m olecular weights for these peaks corresponded roughly to those of the 
monomer, dimer, and  trim er ■respectively; The value - of- the-m olecular 
weight for the th ird  peak was higher than that of trim er although one 
would not expect SEC to perform  ideally at low molecular weights when 
solute geometry is highly dependent on molecular weight.
Figure 7.3.5b indicates that the monomer, dim er and trim er appeared 
to be soluble in w ater. This was in agreement w ith Dawes and Ribbons 
(1964) who showed tha t dim er and trim er exist as part of the metabolic 
pathw ay in microorganisms. It appeared that dim er and trim er are 
capable of dissolving in water. This re-emphasised the finding that 
erosion of 'films occurred prim arily  by cleavage of monomer from  the 
su rf ace.
However, fu rth er studies of th is type have shed doubt on this 
evidence. Figures 7.3.6a and 7.3.6b show equivalent experiments 
perform ed after a partial degradation in the presence of pTSA. The 
length of degradation was reduced to 19 hours. The chromatogram for 
pTSA degradation, shown in Figure 7.3.6a, indicates the presence of 
monomer, dim er , trim er, tetram er and other oligomers which appeared in 
the void volum e of the column. Figure 7.3.6b shows that 
chromatogram of degradation products which were apparently soluble in 
water. It is unlikely that these high molecular weight oligomers were 
genuinely soluble in w ater but m ay have been suspended as a colloidal
2 2 5
Table 7.3.2 : Retention times and PEG-equivalent molecular weights 
for degraded products from pTSA degradation








Figure 7.3.5: - Size exclusion chromatograms of
(a) degraded products from pTSA 
degradation (3 days refluxing with 
2 % w /v pTSA)
(b) water-soluble fractions recovered 
from the above product after 
extraction as detailed in text.
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Figure 7.3.6:- Size exclusion chromatogram of (a)
degraded products from pTSA degradation 
(19 hours refluxing with 2% w /v pTSA)
(b) 'water-soluble' fraction recovered 
from the above product after extraction 
as detailed in text.
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microemulsion which resisted filtration. Thus higher molecular weight 
fragm ents of PHB were transfered onto the column artificially (see 
section 6.3.7.3).
Further work is required to establish the degradation products of PHB 
and PHV. The synthesis of dim ers and trim ers for validation of 
chrom atrographic methods is necessary.
7.4/Release o f  m eth y l red from  polym er films.
Several w orkers (Korsatko et al. 1983, Brophy and Deasy, 1986 and 
Gould et al., 1987) have investigated the effect of form ulation on the 
release of drugs from  PHB and P(HB/HV) m atrices. The aim of the 
present study has been to examine the factors which affect release of 
chloroform -soluble compounds from  PHB and copolymers films. 
Chloroform  is a good solvent for the polymers. Thus films could be cast 
from  solutions containing drug and polymer. M ethyl red was chosen as a 
model compound because it is readily soluble in w ater and chloroform and 
was easily essayed by ultraviolet spectrophotom etry.
Figure 7.4.1 shows the u ltraviolet spectra of m ethyl red in different 
pH buffers and chloroform . It can be seen that there was no change in the 
absorption m axim um  above pH 7.4 due to the sim ilarities in the fraction 
of dye ionised at pH 7.4, 10.0 and 13.0. The pKa of m ethyl red is 5.1 
(M artin et al., 1969) and hence the degree of ionisation a t pH 7.4 and 
above would be alm ost 100 % . This indicates the su itability  of m ethyl 
red as a model compound for the release studies under physiological 
conditions (pH 7.4 at 37°C) and also under extrem e conditions of 
degradation (O .IM  sodium hydroxide).
The loading of m ethyl red in cast PHB and copolymer films was 
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Figure 7.4.1:- Ultraviolet spectra of methyl red
in chloroform and aqueous pH 
buffer solutions; (1) 0*1M sodium 
hydroxide; (2) pH 10 bicarbonate 
buffer; (3) pH 7*4 phosphate buffer; 
(4) chloroform; (5) 0«1M hydrochloric 
acid.
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Figure 7.4.2 and Table 7.4.1 show the calibration curve obtained and the 
reproducibility of the assay.
The release of m ethyl red from  polym er films was studied at pH 7.4 
and in 0.1M sodium hydroxide. Figure 7.4.3 and Table 7.4.2 show the 
calibration curves and their reproducibility at pH 7.4. Figure 7.4.4 and 
Table 7.4.3, show the analogous assay of m ethyl red in 0.1M sodium
i
hydroxide.
7.4.1 Effect o f  m eth y l red loading on its  release.
The cum ulative release of m ethyl red under static conditions was 
plotted against tim e for different loadings of m ethyl red in PHB films and 
this is shown in Figure 7.4.5 for films containing 0.71% w /w , 2.78% w /w , 
5.21% w /w  and 7.36% w /w  m ethyl red. Data plotted is the mean of 
three replicate release studies from  each film. The highest standard 
deviation fo r the data was less than 2% of the mean. The higher the 
initial loading the faster was the release rate. The release of methyl 
red from  . films containing more than 10% w /w  m ethyl red was 
completed w ith in  six hours. In these cases the release mechanism was 
thought to be through pores and channels.
High loading probably resulted in crystals of m ethyl red w ithin the 
film which were in close contact. Dissolution of m ethyl red at the 
surface w ould have allowed fu rth e r penetration of w ater gradually 
form ing a series of interconnecting pores throughout the m atrix. The 
lower loadings of m ethyl red would have led to few er points of contact 
between crystallites of m ethyl red. Thus pore form ation would have 
been more tortuous leading to a slower rate of release.
The role of diffusion through the polym er itself was thought to be 
minimal a t high drug loadings although it m ay have played a part at
2 3  t




E ^  for 1cm cell 
±  standard deviation
Correlation
coefficient
1 47000 ±  450 079980
2 45000 ±  200 0.9990
3 40000 ±  900 0.9993
4 43000 ±  900 0?9993
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Figure 7.4.2:- Beer Lambert plot of methyl red
in chloroform.
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E ^  for 1cm cell 
±  standard deviation
Correlation
coefficient
1 —*620CT± 200 0.9994
2 15700 ± 4 0 ----- 0.9999
3 16300 ±  200 0.9994
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Figure 7.4.3:- Beer Lambert plot of methyl red in
phosphate buffer (pH 7*4, I = 0-153M).
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E ^  for 1cm cell 
±  standard deviation
Correlation
coefficient
1 19000 ±  92 0.9999
2 19000 ±  81 0.9999
3 18000 ±  230 0.9996
4 22000 ±  220 0.9997
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Figure 7.4.5:- Release of methyl red from PHB films, as a function of
methyl red content in film, after storage in phosphate 
buffer (pH 7*4) at 37°C; Loading of methyl red:
( ■ ), 0*71% w/w ; ( • ), 2*78% w/w ; ( A ), 5*21 % w/w ;





low drug loadings. The involvement of diffusion through the polymer 
w ould have been a function of the morphology of the m ixtures. For 
films containing low loading an attem pt was made to determ ine the 
morphology of m ethyl red in the films using DSC. It was of interest to 
determ ine w hether m ethyl red existed as a suspension of crystallines or 
w hether the m ethyl red was dispersed at a m olecular level in PHB films. 
U nfortunately  the results of this study  were inconclusive since the 
"melting pom t'oF-m ethyl re^w as^too  close to that of PHB and could~not 
be separated from  the large polym er m elting endotherm. Visual and 
microscopic inspection of the films showed that despite the high solubility 
of m ethyl red in chloroform , most of the drug existed as a suspension in 
PHB m atrix. Presum ably, the highly crystalline nature of PHB was not 
disrupted by the presence of m ethyl red.
Brophy and Deasy (1987) have used the following equation to describe 
the in vitro release of sulphamethizole from PHB microparticles.
f( t)= B j t* - B 2 t ......  (7.3)
where f( t)  is the fraction of drug released at tim e t.
Equation 7.3 can be derived by extending the theory used by 
Higuchi (1962). A complete derivation is shown in Appendix 3. This 
theory has been used in the present study to model release of m ethyl red 
from  polym er films. Equation 7.3 was a good model for the 
experimental release of m ethyl red from  PHB and P(HB/HV) films. An 
example is shown in Figure 7.4.6 which represents the release of 
m ethyl red from  P(H B/H V) film containing 6.5 mole % HV in pH 7.4 and 
37°C. The values of Bj and B2 were used to characterise the release of 
m ethyl red from PHB and copolymer films throughout our study. These 
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Figure 7.4.6:- Release of methyl red from PHB/PHV copolymer film
(6*5 mole% HV) after storage in phosphate buffer 
(pH 7*4)  at 37°C ( o  ) experimental data ( • ) release 





curve such that the intercept and the slope giving the values of B] and 
B2 respectively (see Appendix 3).
Figure 7.4.7, 7.4.8 and 7.4.9 show the relationship of the function
f ( t ) 2 i i( [—-— ]1/j) against the square root of timer ( ) fo r PHB films containing
0.71% w /w , 0.89% w /w  and 0.82% w /w  m ethyl red. The objective of 
th is study  was to determ ine the variation between replicate batches of 
film. It was not possible to Teplicate the drug loading precisely in-th is 
study  bu t these three films had sim ilar loadings. The data obtained 
from  the 0.71% loading (Fig. 7.4.7) was not as good a fit to the model as 
these obtained for other films. There was no obvious explanation for th is 
concept tha t the 0.71% loading was the lowest used and the data m ay 
have indicated a change in the mechanism of release at very low 
loadings. Values of Bj and B2 obtained from these three films are shown 
in Table 7.4.4. Statistical t-test analysis of the values of B2 and B2 
showed tha t there were no significant differences between these values at 
95% level of confidence fo r the 0.82% and 0.89% films. Thus the release 
of drug from  sim ilar batches of film was reproducible.
f ( t ) 2Figures 7.4.10 to 7.4.12 show the function ([—-— ]1/j ) plotted against
the square root of time, ( t 1^  ), for PHB films containing 2.78%, 5.21% w /w  
and 7.36% w /w  m ethyl red. The values of Bj and B2 obtained are 
shown in Table 7.4.5. The values of B! and B2 obtained from  m ethyl 
red loading of 2.78% w /w  were not significantly different to  those obtained 
for the 0.89% w /w  film (Table 7.4.4). However, comparison between data 
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2Figure 7.4.7:- The f u n c t i o n ( t )  ^  ^ against-^t
for release of methyl red from PHB
film containing 0*71% w/w methyl red
(in pH 7*4 at 37°C).
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2Figure 7.4.8:- The function^£ttT^  ^ against-^t
for release of methyl red from PHB
film containing 0*89% w/w methyl red






Figure 7.4.9:- The function
time (hours2 ) 
2
> agaii n s t - ^ t
for release of methyl red from PHB
film containing 0*82% w/w methyl red
(in pH 7*4 at 37°C).
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Tabic 7.4.4 : Kinetic param eters for release of m ethyl red from PHB 
films stored in phosphate buffer (pH 7.4, I = 0.153 M ) at 37°C
Percent w /w  m ethyl red 
in PHB film
Rate constant 
( hours- * XlO^ )
i
Bi b2
0.71 76.2 ±  3.2 2.40 ±  0.22
0.82 89.4 ±  3.7 2.62 ±  0.30
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2Figure 7.4.10:- The f u n c t i o n ^ f (t )2 ^ against-^t
for release of methyl red from PHB
film containing 2*78% w/w methyl red
















Figure 7.4.11:- The funct i o n (t ) ^  j against-y^t
for release of methyl red from
PHB film containing 5*21% w/w
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Figure 7.4.12:- The f u n c t i o n f (t ) 2  ^ against'^t
for release of methyl red from PHB
film containing 7*36% w/w methyl red
(in pH 7*4 at 37°C).
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Table 7.4.5 : Kinetic param eters for release of m ethyl red from PHB 
films in phosphate buffer (pH 7.4 , 1= 0.153M ) at 37°C
Percent w /w  m ethyl red 
in PHB film
Rate constants 
( hours- * XlO^ )
Bi b2
2.78 90.9 ±  1.8 _2.44 ±  0.20
5.21 107.0 ±  1.5 3.37 ±  0.20
7.36 123.1 ±  2.5 2.46 ±  0.40
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7.4.2 Effect o f copo lym er com position  on th e  release o f m e th y l red.
Figure 7.4.13 shows the cum ulative release of m ethyl red from 
P(HB/HV) copolymer films containing approxim ately 1% w /w  m ethyl red 
at pH 7.4 and 37°C. The precise loadings of m ethyl red in copolymers 
containing 6.5 mole % HV, 12.3 mole w /w  HV and 19.2 mole % HV were
1.03 % w/w, 0.86 % w/w and 0.78 % w /w  respectively. The relationships
f ( t ) 2between the function ( [—-— ]*A ) and ( t 1^  ) for various copolymer
films are shown in Figures 7.4.14 to 7.4.17 and the functions Bj and B2 
are summarised in Table 7.4.6.
The tw o loading studied using 6.5 mole% HV copolymer films 
(1.03% and 0.86% w /w  m ethyl red) had very different values of Bj and B2 
. Both released drug at a slower rate than sim ilar PHB films. There were 
large differences in rates of release from  the other copolymer films ( Table 
7.4.6 ). A t 12.3 and 19.2 mole % HV , the rate of release was rapid. The 
most likely reason for this rapid release lies in the more amorphous nature 
of P(HB/HV) copolymers. Penetration of w ater and movement of drug 
away from  the polym er was probably slower for polym ers having a 
higher degree of c rysta llin ity  (Gordon, 1963).
However the m olecular weights of the polym ers were somewhat 
different and the morphology of polym er drug matrices was not examined 
in this study. A more comprehensive study of the factors affecting the 
release from copolymers is required. This study has indicated that 
release can be controlled by selection of the polymer as well as the loading 
of the drug. Polymers of equal molecular weight should be used and a 
knowledge of the effect of polymer crystallin ity  on the morphology of 
the drug would be required to intepret the results of
o . 0 ------------- 1--------------I--------------1--------------1--------------1--------------L-
0 50 100 150
TIME (HOURS)
Figure 7.4.13:- Release of methyl red from PHB/PHV copolymer films
stored in phosphate buffer (pH 7-4) at 37°C. ( • ),
6*5 mole % HV (1*03% w/w methyl red loading); ( O ) ,  
12*3 mole % HV (0-86 % w/w methyl red lqading);
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Figure 7.4.14:- The f u n c t i o n ^ f (t ) 2 ^ against
for release of methyl red from 
PHB/PHV copolymer film (6*5 mole % 
HV) containing 1*03% w / w methyl red 














Figure 7.4.15:- The function /, f (t )
t ime (hours2 )
2  r
} against~yt
for release of methyl red from PHB/PHV 
copolymer film (6-5 mole % HV) 
containing 0*86% w/w methyl red 
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Figure 7.4.16:- The f u n c t i o n ^ f(t)2  ^ a g a i n s t ^ t
for release of methyl red from PHB/PHV 
copolymer film ( 1 2 * 3  mole % HV) 
containing 0*74% w / w methyl red (in 
pH 7 - 4  at 3 7 ° C ) .
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Figure 7.4.17:- The funct
time (hours2 ) 
2i o n ^ f i t
)
against
for release of methyl red from PHB/PHV 
copolymer film (19*2 mole % HV) 
containing 0*78% w/w methyl red (in 
pH 7-4 at 37°C).
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Table 7.4.6 : Kinetic param eters for release of m ethyl red from 
copolymer in phosphate buffer ( pH 7.4 , 1 = 0.152M ) at 37°C
Polymer composition 
( mole % HV )
M ethyl red 
loading 
(% w /w )
Rate constants 
(hours-  ^ X103)
B, b2
6.5 1.03 59.0 ±  1.2 1.41 ±  0.08
6.5 0.86 24.5 ±  1.1 0.58 ±  0.08
12.3 0.74 233.3 ±  10.9 16.58 ±  1.70
19.3 0.78 279.0 ±  5.8 22.70 ±  1.41
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release studies. Brophy and Deasy (1986) observed that the in vitro 
release of sulpham ethizole from PHB m icroparticles was dependant on 
polym er m olecular weight. As the polym er m olecular weight decreased, 
the release rate  also decreased. This could explain the slow release rate 
from  the 6.5 mole % HV films used in th is study, which were lower 
in m olecular weight than other films used.
However there is no obvious explanation for the effect of molecular 
weight on drug release since the crystallin ity  of the polym ers used in this 
study  was not dependant on molecular weight. In addition the work 
of A khtar et al. (1987) showed tha t there were no changes in the 
mechanical propeties of polym er films over the m olecular weight range 
used in the release studies reported here. Thus differences between 
release rates from  the copolymers were probably a genuine function of 
morphology of the m atrices rather than their m olecular weights but a 
conclusion cannot be draw n from the available data.
7.4.3 Effect o f  degradation on the release o f  m eth y l red.
The release studies reported here took place over a timespan which 
appeared to be too short to be influenced by degradation of the polymers. 
This hypothesis was tested by comparing release rates at 37°C in 0.1M 
sodium hydroxide w ith  those obtained previously a t pH 7.4.
f ( t l2Figures 7.4.18 to 7.4.21 show the function of ( [—-— P  ) plotted
against ( t 1/5t ) for a representative series of four films, one for each 
polym er studied. The values of B1 and B2 obtained from  these 
relationships are shown in Table 7.4.7. Data for release from  these films 
a t pH 7.4 is shown in tables 7.4.5 and 7.4.6. Using a student t-test, it 
was found th a t the values of B! and B2 obtained in 0.1M sodium 
hydroxide were significantly higher than the values obtained a t pH
2 5 7
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Figure 7.4.18:- The function^ f (t )
for release of methyl red
film containing 0*71% w/w
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Figure 7.4.19:- The function
y ^ )
against-w t
for release of methyl red from PHB/PHV 
copolymer film (6*5 mole % HV) 
containing 0-86% methyl red (in 
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Figure 7.4.20:- The function f  ( f (t )  ^ against-^/t
for release of methyl red from PHB/PHV 
copolymer film (12*3 mole % HV) 
containing 0*74% w/w methyl red in 
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Fiaure 7.4.21:- The functio against-w t
for release of methyl red from PHB/PHV 
copolymer film (19*2 mole % HV) 
containing 0*78% w/w methyl red (in 
0-1M sodium hydroxide at 37°C).
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Table 7.4.7 : Kinetic param eters for release of m ethyl red from 
copolym er films in 0.1 M sodium hydroxide at 37°C
Polym er 
composition 
(mole % H y )
M ethyl red 
loading 




0 0.71 83.5 ±  3.0 2.45 ±  0.20
6.5 0.86 35.7 ±  1.2 0.78 ±  0.08
12.3 0.74 263.1 ±  15.3 20.83 ±  5.25
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Figure 7.4.22:- The effect of degradation on the release of methyl red
from P(GA/LA) copolymer and I>LA films after storage in
0•1M NaOH at 37°C.
( A ), 10 mole % glycolic acid (1*03% w/w methyl red







7.4. These data indicate tha t release of m ethyl red frm  the films was
influenced by an increased rate of surface erosion of the polymer.
However the proportional increase in release was generally 10-20%
whereas the increase in degradation rate was approxim ately threefold
(Figure 7.2.3). Thus, fo r PHB and its copolymer films the release of
m ethyl red a t pH 7.4 occured by diffusional processes w ith  a m inor
contribution from  polym er erosion. This was in contrast w ith  release of 
x
m ethyl red from  P-l-LA and P(LA/GA ) films which was significantly 
affected by erosion and was drastically  different in 0.1M NaOH. The 
release profiles for these tw o films are shown in Figure 7.4.22 showing 
tha t drug from  these films occured by a m ixture of m atrix diffusion 
and erosion. Consequently, the modified m atrix release equation 
(Equation 7.3) was inappropriate fo r these systems.
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Chapter 8
GENERAL CONCLUSIONS AND SCOPE FOR FUTURE WORK.
8.1 General conclusions.
Viscosity m easurem ents of d ilu te  solutions of molecular weight 
fractions of PHB in chloroform  at 25°C allowed calculation of the 
intrinsic viscosities. From the Huggins’ plots of each fraction, the 
value of Huggins’ constant, k ’, was found to be in the range between 
0.3 to 0.4. This indicated that the molecular conform ation of PHB in 
chloroform  was essentially a random coil and that chloroform  was a good 
solvent fo r PHB.
Size exclusion chrom atography was employed to obtain the molecular 
weight d istribution of PHB. The quantitative evaluation of 
chrom atographic data involved a universal calibration of the column 
using polystyrene standards and an iterative process leading to the 
establishm ent of M ark-H ouw ink constants for PHB. SEC proved to be a 
pow erful, rapid method fo r determ ination of M ark-H ouw ink constants 
and, once the calibration had been perform ed, proved to be a rapid 
method for determ intion of m olecular weights d istributions for PHB. 
Only 10-20mg polym er was required for assay. However, the precision 
of the assay using one mixed gel column was not high enough to 
determine small changes in molecular weight. Several columns in series 
could be used to increase precision. Low molecular weight samples of 
PHB could be obtained from  initially  high molecular weight PHB using 
p-toluenesulphonic acid (pTSA) to catalyse degradation in chloroform - 
methanolic m ixtures. Degradation of PHB under these conditions occured 
by random chain scission. During this non-aqueous degradation,
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the polydispersity of PHB samples was determined, in term s of the 
m olecular weight averages, and the ratios obtained indicated that the 
m olecular weight distribution approached the Schulz-Zimm distribution.
The use of SEC and weight loss experiments during aqueous 
degradation of PHB and its copolymer films indicated that the 
degradation occurred by surface hydrolysis. However, the rate of surface 
hydrolysis was very slow and could be enhanced b ^  making the 
hydroly tic  medium more alkaline. A ltering the P(HB/HV) copolymer 
composition changed polym er resistance to surface hydrolysis. DSC 
studies indicated that increase in the valerate content caused a decrease 
in crystallin ity , hence exposing more chain ends to degradation. 
However,there is some doubt as to the crystallin ity  of the P(HB/HV) 
copolymers at present.
Degradation products were isolated and characterized from  in vitro 
experiments. Chromatographic studies indicated that surface hydrolysis 
of PHB and P(HB/HV) copolymer films occurred through the scission of 
monomers from chain ends resulting in release of monomers.
In  vitro  studies of release of m ethyl red from  polym er films have 
shown that the release form  PHB and P(HB/HV) copolymers was 
dependent on the loading and the crystallin ity  of these polymers. 
Increasing the loading of m ethyl red produce an increase in the 
release rate. Comparative release studies on different copolymer 
compositions w ith sim ilar loading of m ethyl red have indicated tha t 
films containing 10-20 mole % HV cause more rapid release for low 
molecular compounds compared to the homopolymer. The in vitro release 
profiles can be modelled by a modified Higuchi’s equation which takes 
into consideration the release over longer times. This equation 
adequately described the in vitro  release of m ethyl red a t loadings
2 6 6
between 1% and 10% w /w . Release of m ethyl red from PHB and 
P(HB/HV) polymers at pH 7.4 was controlled by diffusional processes in 
contrast to release from PLA or P(LA/GA) system s where the polym er 
degradation process was im portant.
8.2 Future w ork.
Investigation of the in vitro  degradation of PHB and P(HB/HV) 
copolymer films has shown tha t degradation occurs only by surface 
hydrolysis. Thus if drugs could be trapped w ithin the polym er m atrix, 
their release could be controlled by the area of polym er surface exposed 
to the aqueous environm ent. This may be of particular value in delivery 
of macromolecules such as peptides. Thus, there is great scope fo r 
form ulation in PHB or P(HB/HV) polym ers and entrapm ent of drug need 
to be studied in detail.
However, before such biomedical applications can be 
contemplated experiments m ust be carried out to determine the 
degradation process which occurs in vivo and also the blood and tissue 
com patibility of these polymers. In  vivo degradation studies should be 
aimed at providing inform ation regarding the contribution of enzym e- 
catalysed degradation to the mechanism and the rate of degradation of 
these polymers. Experience w ith other polym ers indicates the need fo r 
such studies. For example, poly(€-caprolactone) was found to 
degrade in vitro  by non-enzym atic random hydrolytic  cleavage of 
ester linkages (Schindler et al., 1977). In contrast to the above 
mechanism, W oodward et al. (1985) found that the in vivo degradation 
of low molecular weight poly (e-caprolactone) powders in ra ts 
occurred m ainly through enzym atic degradation. Tissue com patibility 
should be studied to determ ine the toxicology and mutagenicity of
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PHB and the copolymers. Blood com patibility testing may also be 
useful in view of possible uses of PHB for targetting of drugs to 
macrophages and the use of PHB in surgery.
Release studies w ith  the model compound, m ethyl red, showed that 
erosion played a m inor part in the release of the m arker. In a practical 
sense, th is is not desirable since the degradation of these polym ers was 
slow, thus the absorption of the depleted device would be slow in 
comparison to its useful life as a delivery system. PLA or P(LA/GA) 
system s would be a more appropriate choice for delivery of low 
m olecular system s. A more desirable approach would be to utilize the 
surface hydrolysis as a rate lim iting step for the release of higher 
m olecular weight drugs; utilizing the special surface erosion properties of 
PHB.
However, the possibility of accelerating degradation could be 
investigated for low m olecular weight compounds through the 
incorporation of basic agents, such as amines, in the polymer 
m atrix . Ad example of such a process occuring was shown by Maulding 
et al. (1986) where the hydrolysis of PLA microspheres was 
increased by incorporating thioridazine, which is a tertia ry  amino 
compound, into the m atrix . An analogous approach has been studied 
extensively w ith  poly (ortho-esters), although these compounds 
showed the reverse sensitivity  to degradation. The control of drug 
release from  these polym ers was achieved by incorporating acid 
anhydrides into the polym er m atrix (Shih et at., 1984; Nguyen et al., 
1984). The incorporation of higher m olecular weight compounds has 
been reported by Sandow and Siedel (1986) and Koenig et al. (1985). In 
both examples, a polypeptide, buserelin acetate, was incorporated into 
PHB microspheres.
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A part from the suggestions being discussed previously, a fu ll 
characterisation of the release experiments presented in the thesis would 
be useful. In this thesis, the effect of the environm ental diffusion layer 
(or hydrodynam ic layer) on the rate of release has been to tally  neglected. 
A more rational evaluation of drug relase would incorporate studies of 
the intrinsic release profile of m ethyl red from  polym er films. From the 
literature, the method that can be adopted for the intrinsic release has
T
been described by Collett et al. (1972) and this has been applied to 
m atrix-type drug delivery system s using the Higuchi’s model
(Tojo,1985). An update version w ith  using the modified Higuchi’s
equation m ay be useful to evaluate the experimental release data from
this study. Further studies on release of low molecular weight
compounds should include morphological studies which were not possible 
by DSC for m ethyl red.
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APPENDIX 1: Data for viscosity experiment o f  PUB fractions.







0 116.12 116.20 116.08
1.001 168.20 168.28 168.34
0.871 160.97 160.94 161.05
0.646 155.45 155.50 155.62
0.556 143.86 143.57 143.69
0.488 140.18 140.06 140.04
0.393 135.13 135.04 135.07







0 116.03 115.99 115.96
0.871 160.67 160.72 160.74
0.770 155.22 155.11 155.11
0.646 148.47 148.37 148.23
0.556 143.63 143.52 143.48
0.488 140.02 139.94 139.93
0.435 137.11 137.20 137.17
Fraction
2 9 0







0 116.02 116.08 116.08
0.224 186.16 186.12 186.09
0.177 169.85 169.89 169.89
0.158 163.45 163.48 163.47
0.142 158.30 158.23 158.29
0.129 154.41 154.30 154.51







0 116.06 116.07 116.09
0.243 192.13 192.17 192.27
0.192 174.77 174.69 1 74.64
0.159 163.80 163.65 163.60
0.144 158.80 158.99 158.79
0.132 155.00 154.80 154.90
0.121 151.71 151.66 151.63
0.107 147.31 147.21 147.14










0 116.08 116.03 116.03
0.353 151.12 151.12 151.07
0.312 146.88 146.82 146.83
0.280 143.48 143.53 143.45
0.239 139.18 139.16 139.14
0.166 131.93 131.79 131.91






0 116.03 116.00 116.01
0.353 150.66 150.62 150.73
0.307 146.05 145.95 145.97
0.272 142.37 142.25 142.26
0.221 137.29 137.24 137.12
0.202 135.30 135.21 135.22
0.157 130.89 130.83 130.81
2 9  2






0 115.98 116.03 115.98
0.288 160.45 160.35 160.37
0.248 154.01 154.03 154.03
0.218 149.19 149.15 149.15
0.171 141.70 141.76 141.72
0.157 139.40 139.44 139.27






0 116.06 116.03 115.95
0.595 220.50 220.30 220.34
0.476 196.95 197.04 196.83
0.410 184.21 184.22 184.41
0.360 175.22 175.34 175.14
0.321 168.03 168.17 168.13
0.283 161.07 161.07 161.13
0.253 155.81 155.79 155.75
2 9 3






0 115.98 116.04 115.97
0.117 174.85 174.82 174.74
0.093 161.80 161.73 161.67
0.084 157.14 156.98 157.04
0.073 151.12 151.00 151.00
0.064 146.59 146.50 146.44







0 116.03 116.04 116.03
0.147 195.42 195.69 195.58
0.130 185.17 185.15 185.07
0.117 177.17 177.25 177.14
0.106 170.84 170.94 170.89
0.081 156.57 156.76 156.47
0.072 151.85 151.76 151.47







0 116.11 116.05 116.02
0.289 187.11 187.23 187.17
0.272 182.60 182.38 182.56
0.250 176.57 176.65 176.57
0.231 171.60 171.63 171.61
0.215 167.30 167.21 167.28
0.201 163.55 163.62 163.60
0.189 160.43 160.33 160.33
0.178 157.59 157.58 157.57







0 116.00 116.05 116.10
0.256 178.22 178.13 178.11
0.223 169.73 169.34 169.39
0.197 162.73 162.70 162.65
0.177 157.49 157.37 157.43
0.151 150.66 150.82 150.78
0.131 145.87 145.86 145.91
0.116 142.37 142.25 142.30
Fraction
2 9 5







0 116.40 116.17 116.24
0.129 198.73 198.60 198.77
0.112 186.38 186.31 186.48
0.099 177.04 177.14 177.11
0.083 165.97 165.98 165.74
0.072 158.50 158.35 158.40
0.063 152.76 152.83 152.63
0.056 148.67 148.60 148.41







0 115.83 115.90 115.91
0.126 197.43 197.48 197.52
0.110 185.46 185.34 185.33
0.097 176.17 176.35 176.30
0.082 165.56 165.39 165.69
0.070 157.90 157.86 157.91
0.062 152.31 152.18 152.14











0 116.10 116.07 116.04
2.000 179.84 180.00 180.03
1.739 170.75 170.75 170.71
1.539 163.91 163.84 163.82
1.290 155.54 155.42 155.41
1.111 149.46 149.33 149.47
0.976 145.06 145.20 145.32
0.870 141.72 141.60 141.98
0.784 139.08 139.16 139.29







0 116.02 116.05 116.01
2.000 180.42 180.39 180.46
1.600 166.05 166.20 166.12
1.427 160.41 160.28 160.18
1.290 155.45 155.73 155.72
1.111 149.86 149.47 149.56
0.784 139.23 139.04 139.51
2 9 7







0 116.12 116.08 116.07
0.492 174.10 174.13 1 74.09
0.410 163.51 163.56 163.60
0.352 156.35 156.34 156.44
0.308 150.91 150.97 150.92
0.274 146.80 146.97 146.78
0.246 143.70 143.58 143.55
0.224 140.89 140.98 141.10
0.205 138.85 138.83 138.83







0 115.98 116.01 116.02
0.409 170.55 170.58 170.55
0.356 162.81 162.80 162.88
0.315 157.19 157.46 157.00
0.282 152.47 152.46 152.40
0.256 148.89 148.71 148.76
0.221 143.92 143.98 143.89
0.195 140.47 140.43 140.50
0.174 137.76 137.69 137.66
f Fraction 11
Fraction 11







0 115.97 116.00 116.04
0.311 157.77 157.50 157.56
0.281 153.20 153.13 _ 153.16
0.256 149.78 149.59 149.66
0.235 146.66 146.66 146.51
0.218 144.12 144.03 144.11
0.202 141.94 141.87 141.89
0.189 140.09 140.00 140.03







0 115.99 116.02 115.94
0.373 170.55 170.75 170.71
0.321 162.35 162.33 162.39
0.282 156.22 156.16 156.21
0.245 150.66 150.60 150.57
0.222 147.17 146.97 147.04
0.203 144.38 144.16 144.20
0.186 141.77 141.69 141.73
Fraction
2 9 9







0 115.92 116.05 115.97
0.290 223.49 223.56 223.53
0.249 205.70 205.69 205.67
0.235 200.18 200.22 200.24
0.218 192.99 193.02 193.05
0.202 187.14 186.97 187.01
0.189 181.62 181.63 181.64
0.178 177.16 177.13 177.09
0.167 173.07 173.00 172.95







0 115.94 115.99 116.03
0.243 209.33 209.33 209.33
0.203 191.57 191.65 191.75
0.168 176.92 176.83 176.91
0.143 167.07 166.95 167.11
0.125 159.78 159.85 159.79
0.113 155.29 155.26 155.38
0.104 151.64 151.63 151.66
Fraction 13
Fraction 13
3 0  0







0 116.12 116.15 116.10
0.276 208.23 208.14 208.20
0.197 1 79.03 179.06 179.10
0.178 172.48 172.41 172.23
0.163 167.01 166.99 166.97
0.149 162.61 162.50 162.51
0.138 158.89 158.70 158.77
0.123 153.52 153.57 153.61
T able  24 : Flow tim es fo r different concentrations
(Experim ent 2)
Concentration 




0 115.93 115.91 115.90
0.290 208.54 208.59 208.66
0.241 191.38 191.33 191.34
0.200 176.80 176.72 176.78
0.176 168.65 168.67 168.70
0.157 162.46 162.42 162.44
0.141 157.62 157.58 157.59




APPENDIX 2 : Data for v iscosity  experiment o f  polystyrene standards.
T able 1 : Flow times for different concentrations of polystyrene standard 






0 115.99 116.02 115.98
0.107 149.84 149.80 149.80
0.097 146.48 146.49 146.51
0.085 142.55 142.47 142.50
0.075 139.43 139.40 139.42
0.068 136.99 137.02 137.08
0.062 135.07 135.09 134.99
0.056 133.43 133.37 133.39
0.052 130.80 130.77 130.78
T able 2 : Flow times for different concentrations of polystyrene standard 






0 116.00 115.98 115.97
0.168 171.45 171.39 171.42
0.140 161.68 161.59 161.61
0.124 156.32 156.31 156.25
0.108 150.64 150.67 150.64
0.096 146.46 146.38 146.45
0.088 143.88 143.85 143.87
0.078 140.37 140.39 140.36
3 0 2
Table 3 : Flow times for different concentrations of polystyrene standard






0 116.03 116.06 116.00
0.233 160.02 160.10 160.06
0.186 150.55 150.59 150.54
0.166 146.58 146.60 146.58
0.150 143.40 143.46 146.43
0.137 140.83 140.86 140.83
0.116 136.93 136.96 136.90
Table 4 : Flow times for different concentrations of polystyrene standard 






0 116.07 115.99 116.03
0.267 167.14 167.10 167.14
0.232 159.82 159.80 159.87
0.191 151.34 151.35 151.39
0.167 146.68 146.60 146.62
0.144 142.24 142.25 142.23
0.133 140.16 140.08 140.24
0.121 137.86 137.83 137.89
3 0 3
Table 5 : Flow times Tor different concentrations of polystyrene standard






0 115.91 115.91 115.87
0.338 148.95 148.91 148.91
0.302 145.23 145.13 145.17
0.273 142.23 142.17 142.17
0.249 139.81 139.76 139.82
0.217 136.48 136.46 136.50
0.201 134.94 134.96 134.97
0.188 133.63 133.63 133.62
0.176 132.47 132.46 132.48
Table 6 : Flow times for different concentrations of polystyrene standard 






0 116.14 116.12 116.14
0.375 151.90 151.98 152.02
0.326 147.10 147.08 147.05
0.268 141.34 141.38 141.35
0.227 137.40 137.36 137.37
0.208 135.59 135.54 135.62
0.192 133.99 134.10 134.05
0.171 131.89 131.98 131.92
3 0 4
Table 7 : Flow times for different concentrations of polystyrene standard






0 116.04 116.03 115.98
1.006 161.07 160.97 161.10
0.869 154.43 154.42 154.47
0.708 146.60 146.65 146.61
0.637 143.33 143.42 143.38
0.579 140.79 140.71 140.79
0.503 137.26 137.37 137.26
T able 8 : Flow times for different concentrations of polystyrene standard 






0 116.16 116.12 116.09
1.071 164.78 164.81 164.79
0.925 157.63 157.62 157.63
0.754 149.36 149.28 149.22
0.636 143.52 143.58 143.65
0.582 141.11 141.09 141.12
0.509 137.75 137.80 137.70
3 0 5
Table 9 : Flow times for different concentrations of polystyrene standard





1 2 - 3
0 115.90 115.94 115.97
1.847 159.94 159.95 160.05
1.595 153.48 153.46 153.42
1.350 147.22 147.19 147.22
1.210 143.81 143.73 143.79
1.097 141.03 141.05 141.04
1.003 138.82 138.79 138.73
0.877 135.71 135.76 135.73
T able 10 : Flow tim es for different concentrations of polystyrene standard 






0 116.10 116.10 116.11
1.963 162.86 162.81 162.89
1.554 152.10 152.15 152.15
1.381 147.85 147.86 147.83
1.166 142.43 142.49 142.46
1.008 138.65 138.70 138.74
0.888 135.75 135.83 135.78
3 0 6
APPENDIX 3
D erivation o f  modified Higuchi’s equation.
According to Higuchi (1961) , the following assumptions were made:
• A region with depleted drug is penetrating into the matrix.
• The rate of diffusion of drug per unit area (the mass flux) throughout this 
depleted region is independent of this position on the surface.
If C(x) be the concentration of dissolved drug at the parallel surface (at a distance x 
from the boundary of the matrix),lhen Fick’s first law is given by:
A Is the total area of the depleted region of drug.
D is the diffusion coefficient.
Since <f> is not dependent upon x, equation (1) may be integrated as follows:





Assuming at sink condition, then C(0)= 0
for 0 < x < x *  • • • (2 )
3 0 7













-i _ 1 . cx , cx
2
1 - — 1 + — + + • • •A X A A
1 , cx
X  ~JJ (3)
Substituting equation (3) into equation (2)
C U ) . ± f 1 + CXX  A7 dx
0 r 
TadT^ o 1 +
cx dx
0
Ta d T x+c 2A (4)
Al the diffusion front.
C =C(x’); 0TadT x'+c 2A (5)
A-cx
Eliminating <f> by dividing (4) by (5) ,
The total amount of dissolved drug remaining in the depleted region is
= JrC(x)A(x)dx
■CJ
Ax cx2 cx c2x3 c2x2
2x* 2 (2Ax‘) 2A
dx
Ax2 cx3 cx2 c2x4 . c2x3




The amount of dissolved drug remaining between 2 parallel surfaces at a distances
3 0 9
amount at (x'+dx) — amount at x’
= C« x’+dx‘ 5——--C x'+dx'
2 A , 5 ,2-—X — — — cx
12 2 12
= C, A . . 5— dx ——-c  2 12 2x'dx'+(dx')2
= C. A 5 ,T  6TCX dx‘ • • • (8)
The mass balance ( for the region between the two parallel surfaces ) becomes
0d t~C oA(x')dx'—Cs A 5 .2 6 CX dx'
Cn A—cx' dx'—C A 5 ,T ~ 6 CX dx'







Putting (10) into (9)
DC-A
x'+c-
^  c s 5 _  _-dt= c  —
0 2
A dx'+ ■g-cCs—cC0 x'dx*
2A
DCLAdt= Adx'+ —cCs-cC 0 x'dx* x'+c-2A
C - ° !  ° 2 Ax'dx'+ -c C s-cC u x'2dx' +






C -  - -- ° 2 x'dx'+
5 cCn cCs«/ /> /^ i I V 5_cC s-cC <1+ _ - _ x'2dx'
= A Cn~- x'dx'—c — c s 2 12 s x'~dx' ( 11)
Integrating (11) by using x'=0 when t=0
J  DCsAdt= y* A CsC0- — x'—c
c0 1 I "J o X “0 2 2 12 3 dx*
Hence
DC,At= A
CsC - — 1 1 " — CsT 0 2 3 2 12 s
CsC -  —  
0 2 C ~ l C- ( 12)
From (5) again . </> as a function of x’ was obtained as follows:
0=
ADCS _ ADCs -l








Looking at equation (12) again and putting x’ = 1/q , then
3 1 t
I fence
2D C stq 3
C — —  
2




( 1 4 )
Equation (14) is in the form of the equation as shown below where:
aty3= y —a  • • • (15)
To solve equation (15) in terms of y , the following root can be used where













Putting equation (16) into (15):
at — L _ + 3 A + 3 - i L + 8 3
atvat al vat
+ 8- a
—3—+ 38+3 [ %/at 182+alS3= —3— + 8—o? 
vat ' ' vat
28=—a
c a  c
T 6X c „ - ’ c s
-1
a - . (17)
3 1 2












~6A C ——C 0 6 s
-l
(18)































cDCs (6C0-7 C s J+9 j2C0- C s ]
2t 18 (2C0-C S)
Cs * cDCs f If I-1c  —
0 2 18









Integrating (19) (Remember : <f> = dM/dt and using M=0 when t=0)
t t
/ dM(t)= /  dt
o o v2
3 1 3
M (t)-M «»= B ',2l l - B 2t 
v2
= N/2B',t‘/?-B 2t
M(i ) = n/2A
I)CS
2
2C0-C S| t* -B ,t
= A DC, 2Ce-C s 11 —B 2i  • • • ( 2 0 )
Equation (20) can be represented by a general equation as shown below 
M (t)=B1tV2-B 2t
where
B'j^A DCS Csr  —0 2





AP PE ND IX 4 : LIS TINGS OF CO M P U T E R  PR OGRAM  IN BBC BASIC
USED FOR SIZE E X C L U S I O N  C H R O M A T O G R A P H Y
P RO GRA M 1





60 PRINT "WHAT NAME DO YOU WANT ID GIVE TO "
70 INPUT "YOUR DATA FILE",FILES
80 INPUT "ENTER TIME OVER WHICH DATA IS TO BE COLLECTED (min)
90 ST%=DT*6000/1000
100 PRINT"PRESS G TO START A CHROMATOGRAPHIC RUN"
110 *FX15,1
120 STARTS=GET$







200 FOR I%=1 TO 1000 •
210 CT%=TIME
220 AV=0





280 PRINT 1%;" " ; I)S (1%)
290 PRINT£X,1%,DS(1%)





PROG RAM  2





















220 PRINT MDO YOU WISH TO RUN THE SAME DATA AGAIN7Y/N”;: INPUT Y$ 
230 IF Y$=”Y” OR Y$="yM THEN 150 ELSE 240 
240 PRINTMHAVE YOU FINISHED ? Y/N”
















410 DEF PROCALTER 
420 VDU28,0,3,39,0
430 PRINTMA - INC.PEAK START Z - DEC.PEAK START”
440 PRINT”: - INC.PEAK END / - DEC.PEAK END”
450 PRINT”SPACE - NO FURTHER CHANGE"
460 *FX15,1
470 PROCKEY3






(XS31Vv (0 )d )*dX30+ ( L )d= ( L )d OIOI
(Zv (0 )d )/d X 3 0 + (9 )d = (9 )a  0001
(0)d/dX3CH-(9)d=(9)d 066
(8 V(0 )d)*dX3D+(V)d=(W d 086
(z jo )d )* d x a o + (8 )d = (e )d  oL6
(0)d*dXaD+(Z)d=(2)d 096
dX aO + (l)d= (l)d  096 
( ( %ds-%i) * ( ( %ds-%da) /  ( ( %ds) s a -  (%da) s a ) ) )  -dxao=dxao ot  ^6
(% ds)sa-(% i)sa= dxao  086
( ( (9+( ( SUL/(ML-(0 0 0 9 /(%I*%XS)) )  )*V) )*( US3XV+I )/(TVOV+I) ) )
+ ( (x s a x v n ) / (U s a x M /T v o a )o c n ) ) )vo i= (o )a  026
%dH QL I+%dS=%I HOd 016 
iLXSN 006 
0=(% I)d 068 
01 CXLO=%I HOd 088 
MWOOHd d aa  0Z.8 
• 098
OOHdON3 098
o o i+ (o o o i* (% d a )sa )‘oox+%da‘9xcnd o*8 
00l+(000t=M % dS)Sa)‘00I+%dSt WMTId 0C8 
(OOI+(OOOI*(%d3)Sa)‘OOI+%da)XOOHd 028 
(00I+(000l*(%dS)SCI)*OOT+%dS)XOOHd 018
3svaooHd daa  oos 
: 06A
OOHdON3 08 L 
92-%A‘%X‘9J/JId 0 LL
92+%A‘%X‘ fcim d 09Z, 
%A‘92-%Xt 9XOId 09 L 
%A‘ 92+%X‘ t7XCnd OVL 
(%A‘%X)XDOHd d aa  0£L  
' 02 L
OOHdONd O I L
(o o i+ (o o o t* (% d a )sa )‘ooT+%da)xooad ool  
(OOT+(OOOI*(%dS)Sa)‘OOI+%dS)XQOHd 069 
0001=%d3 N3HL 0001<%d3 d l  089 
I=%dS N3HL T>%dS d l  0 1 0  
I-%d3 =%d3N3HX 9=%d d l  099 
I+%d3=%d3N3KL V=%d d l  099 
I-%dS=%dSN3HL 8=%d d l  0t>9 
t  +%dS=%dSN3H! 2=%d d l  089
(o o i+ (o o o i* (% d a )sa )‘oox+%da)xooad 029
(OOI+(OOOI*(%dS)Sa)‘OOI+%dS)XDOHd 019 
OU N3H1 0=%d d l  009 
9=%d M3HL I-= (90I-)A aX N I d l  069 
p=%d N3KL \ - - ( £ L ~ )A3HNI d l  089
8=%d N3HL I-=(86-)A 3X N I d l  02,9
2=%d N3KL I-=(99-)A 3XN I d l  099
I=%d N3HL ! - = ( 6 6 - )AdMNI d l  099
0=%d 0^9




1040 DEF PROCPRINT 
1050 VDU2




1100 PRINT"TEST POLYMER:- "PTEST$







1180 PRINT"DATA COLL TIME:- "DT" min"
1190 PRINT"NUM. AV. MOL. WT.:- "F(l)/F(5)
1200 PRINT"WT. AV. MOL. WT.:- "F(2)/F(l)
1210 PRINT"VISC. AV. MOL. WT.:- "(F(7)/F(1))~(1/ATEST) 
1220 PRINT"Z-AV. MOL. WT.:- "F(3)/F(2)
1230 PRINT"(Z+1)-AV. MOL. WT.:- "F(4)/F(3)





1290 DEF PROCCH 
1300 *FX229,1
1310 PRINT ADVAL(l)













1450 FOR I%=1 TO 1000 
1460 INPUT£X%,1%,DS(1%)
























INPUT "DATE OF EXPT. "DATE$
PRINT "ENTER MARK HOUWINK DATA " 
INPUT "K OF STD. POLYMER "KCAL 
INPUT "K OF TEST POLYMER "KTEST 
INPUT "a OF STD POLYMER "ACAL 
INPUT "a OF TEST POLYMER "ATEST 
INPUT "STD. POLYMER " PCAL$
INPUT "TEST POLYMER "PTEST$
INPUT "MOBILE PHASE "PHS$
PRINT "FLOW RATE= "SP 
INPUT "TEMP. "TMP$
INPUT "VOID VOLUME TIME(min) "TN 
INPUT "STAT. PHASE VOL. TIME (min) 
INPUT "SLOPE OF CALIBRATION "A 
INPUT "Y INTERCEPT "B 
ENDPROC
"TS
